fibrinogen has been researched along with Coronary Disease in 743 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 263 (35.40) | 18.7374 |
1990's | 222 (29.88) | 18.2507 |
2000's | 200 (26.92) | 29.6817 |
2010's | 54 (7.27) | 24.3611 |
2020's | 4 (0.54) | 2.80 |
Authors | Studies |
---|---|
Amini, A; Arabzadeh, E; Avazpour, S; Shirvani, H | 1 |
Bo Qin, -; Dequan Jia, -; Jie Huang, -; Xiaomei Wei, - | 1 |
Chen, YY; Dong, Y; Duan, L; He, XH; Liu, YM; Ma, RF; Wang, J; Wu, GJ; Yang, XC; Zhang, Y | 1 |
Bai, L; Du, Y; Han, K; Lu, Q; Wang, TZ; Zhu, WJ | 1 |
Charbonneau, H; Mayeur, N; Pasquie, M | 1 |
Huo, M; Qiao, Y; Wang, Z; Wu, D; Zhang, Y | 1 |
Debray, TPA; Moons, KGM; Riley, RD | 1 |
Amouyel, P; Arveiler, D; Empana, JP; Evans, A; Ferrieres, J; Gaye, B; Kee, F; Montaye, M; Ruidavets, JB; Tafflet, M; Wagner, A | 1 |
Becker, DM; Becker, LC; Bielak, LF; Bielinski, SJ; Boerwinkle, E; Bowden, J; Brody, JA; Chasman, DI; Chen, YI; Davey Smith, G; de Maat, MPM; de Vries, PS; Dehghan, A; Delgado, G; Dörr, M; Franco, OH; Fu, YP; Giulianini, F; Groß, S; Guo, X; Hartwig, FP; Hemani, G; Huffman, JE; Johnson, AD; Jukema, JW; Kacprowski, T; Kardia, SLR; Kleber, ME; Koenig, W; März, W; Mathias, RA; McKnight, B; Meitinger, T; Morrison, AC; Müller-Nuraysid, M; O'Donnell, CJ; Pankratz, N; Peters, A; Petersman, A; Peyser, PA; Psaty, BM; Ridker, PM; Rotter, JI; Sattar, N; Smith, JA; Smith, NL; Song, C; Strauch, K; Tang, W; Taylor, KD; Tracy, R; Trompet, S; Uitterlinden, AG; Waldenberger, M; Ward-Caviness, CK; Wiggins, KL; Yanek, LR; Yao, J | 1 |
Benn, M; Davey Smith, G; Lawlor, DA; Nordestgaard, BG; Tybjaerg-Hansen, A; Zuccolo, L | 1 |
Chen, ST; Geng, J; Wang, L | 1 |
Cohen, BE; Epel, ES; Neylan, TC; Prather, AA; Whooley, MA | 1 |
Galán, I; Guallar-Castillón, P; Rodríguez-Artalejo, F; Valencia-Martín, JL | 1 |
Meade, T; Ten Cate, H | 1 |
Barbosa-Leiker, C; Hoekstra, T; Twisk, JW; Wright, BR | 1 |
Cohen, BE; Jarvie, JL; Regan, MC; Sin, NL; Whooley, MA | 1 |
Danaei, G; Ezzati, M; Hajifathalian, K; Lu, Y; Rimm, EB | 1 |
Chiolero, A | 1 |
Baldassarre, D; Clarke, R; de Faire, U; Gigante, B; Goel, A; Golabkesh, Z; Hamsten, A; Humphries, SE; Silveira, A; Strawbridge, RJ; Tremoli, E; Veglia, F; Velasquez, IM; Watkins, H | 1 |
Gorokhova, VG; Koryakina, LB; Kuril'skaya, TE; Kuznetsova, EE; Pivovarov, YI | 1 |
Cushman, M; Howard, G; Howard, VJ; O'Neal, WT; Safford, MM; Soliman, EZ; Zakai, NA | 1 |
Byun, YS; Cho, SW; Goh, CW; Kim, BG; Kim, BO; Kwon, HM; Lee, BK; Rhee, KJ | 1 |
Chadli, A; El Aziz, S; El Hammiri, A; Farouqi, A; Ghalim, N; Habbal, R; Kabine, M; Kamal, N; Kotbi, S; Mifdal, H; Mjabber, A; Nourichafi, N; Oukkache, B | 1 |
Kovačić, J; Varnai, VM | 1 |
Bremner, JD; Brennan, ML; Dai, J; Goldberg, J; Hazen, SL; Jawed, F; Jones, L; Lindau, F; Miller, AH; Murrah, NV; Ritchie, JC; Su, S; Vaccarino, V; Veledar, E | 1 |
Ge, S; He, QM; Liu, TJ; Meng, S; Wu, YF; Zhao, L | 1 |
Beilby, JP; Carter, KW; Foo, BT; Hung, J; Jennens, M; Leow, YC; McCaskie, PA; McQuillan, BM; Palmer, LJ; Powell, BL; Thompson, PL; Wiltshire, S | 1 |
Leschke, M | 1 |
Armitage, J; Clarke, R; Collins, R; Harris, W; Shipley, M | 1 |
Amouyel, P; Arveiler, D; Assmann, G; Bauer, KA; Ben-Shlomo, Y; Benderly, M; Berglund, G; Bingham, A; Brennan, P; Brunner, E; Cantin, B; Chambless, L; Cooper, JA; Cremer, P; Curb, JD; Cushman, M; D'Agostino, R; Dagenais, GR; Danesh, J; Davey Smith, G; de Maat, MP; De Stavola, B; Despres, JP; Di Angelantonio, E; Ducimetiere, P; Elwood, PC; Engström, G; Eriksson, H; Evans, AE; Ferrieres, J; Feskens, EJ; Folsom, AR; Ford, I; Fowkes, FG; Goldbourt, U; Harald, K; Haverkate, F; Hedblad, B; Hense, HW; Iso, H; Jackson, D; Jousilahti, P; Juhan-Vague, I; Kannel, WB; Kaptoge, S; Kiechl, S; Kitamura, A; Knottenbelt, C; Koenig, W; Kostis, JB; Lamarche, B; Lappas, G; Lee, AJ; Levy, D; Lewington, S; Loewel, H; Lowe, GD; Marchioli, R; Meade, TW; Miller, GJ; Nagel, D; Naito, Y; Nyyssönen, K; Palmieri, V; Palosuo, T; Psaty, BM; Rasi, V; Ridker, P; Robertson, M; Rodeghiero, F; Rodriguez, B; Rosenberg, RD; Rosengren, A; Rudnicka, A; Salomaa, V; Salonen, J; Sarwar, N; Sato, S; Schulte, H; Shepherd, J; Shipley, M; Smith, FB; Sweetnam, PM; Thompson, SG; Tofler, G; Tosetto, A; Tracy, RP; Tunstall-Pedoe, H; Tuomainen, TP; Tybjaerg-Hansen, A; Vahtera, E; Valagussa, F; Walker, M; Watson, S; White, I; White, IR; Wilhelmsen, L; Willeit, J; Wilson, AC; Wilson, PW; Wood, AM; Woodward, M; Wu, K; Yano, K; Yarnell, JW; Yeh, JL | 1 |
Arsenault, BJ; Boekholdt, SM; Côté, M; Després, JP; Kastelein, JJ; Khaw, KT; Ninio, E; Rana, JS; Talmud, PJ; Wareham, NJ; Wouter Jukema, J | 1 |
Efthimiadis, G; Gavrilidis, S; Gemitzis, K; Giannoglou, G; Hatzimiltiadis, S; Hatzitolios, A; Koskinas, K; Paraskevaidis, S; Parharidis, G; Savopoulos, C; Souliou, E; Ziakas, A | 1 |
Casas, JP; Drenos, F; Hingorani, AD; Humphries, SE; Palmen, J; Smeeth, L; Talmud, PJ | 1 |
Arnett, DK; Boerwinkle, E; Davis, BR; Eckfeldt, JH; Ford, CE; Leiendecker-Foster, C; Lynch, AI | 1 |
Fountoulaki, K; Gialeraki, A; Kremastinos, DT; Lekakis, I; Politou, M; Rallidis, LS; Sourides, V; Travlou, A | 1 |
Eriksson, AC; Hedbäck, B; Jonasson, L; Lindahl, TL; Whiss, PA | 1 |
Ak, K; Arsan, S; Eksioglu-Demiralp, E; Iqbal, O; Isbir, S; Tetik, S; Yardimci, T | 1 |
Azhar, M; Hanif, M; Hussain Bokhari, SA; Izhar, M; Khan, AA; Tatakis, DN | 1 |
Chakravarti, A; Couper, DJ; Folsom, AR; Kucharska-Newton, AM; Pankow, JS; Prineas, RJ; Rea, TD; Rosamond, WD; Siscovick, DS; Sotoodehnia, N | 1 |
An, DQ; Ma, N; Sun, HY; Wang, YL; Zhu, M | 1 |
Engström, G; Hedblad, B; Li, C | 1 |
Ben-Shlomo, Y; Lowe, GD; Patterson, CC; Rumley, A; Smith, AE; Yarnell, JW | 1 |
Breitner, S; Frampton, MW; Hampel, R; Koenig, W; Peters, A; Phipps, RP; Rückerl, R; Schneider, A; Wichmann, HE | 1 |
Aybay, C; Biberoğlu, G; Ezgü, F; Hasanoglu, A; Ozbay, F; Tümer, L | 1 |
Collins, R; Danesh, J; Di Angelantonio, E; Kaptoge, S; Lowe, G; Pepys, MB; Thompson, SG | 1 |
Aliberti, G; Del Porto, F; Proietta, M; Pulignano, I; Tammeo, A; Trappolini, M | 1 |
Daviglus, ML; He, K; Jacobs, DR; Liu, K; Morris, JS; Stevens, J; Xun, P | 1 |
Danesh, J; Kaptoge, S; Perry, P; Thompson, S; White, I; Wood, A | 1 |
Bonura, F; Caccamo, G; Evola, G; Evola, S; Grisanti, MR; Novo, G; Novo, S; Vitale, G | 1 |
Dent, TH | 1 |
Amouyel, P; Arveiler, D; Canouï-Poitrine, F; Ducimetiere, P; Empana, JP; Evans, A; Ferrieres, J; Haas, B; Jouven, X; Kee, F; Luc, G; Montaye, M; Morange, P; Ruidavets, JB; Tafflet, M; Yarnell, J | 1 |
Riley, RD | 1 |
Carney, RM; von Känel, R; Whooley, MA; Zhao, S | 1 |
Cunningham, J; Hodge, A; Maple-Brown, LJ; Nandi, N; O'Dea, K | 1 |
Didelez, V; Meng, S; Sheehan, NA | 1 |
Garg, A | 1 |
Lin, QQ; Lin, R; Ren, F; Wang, WR; Yang, LN; Zhang, H; Zhang, KF | 1 |
Androulakis, E; Antoniades, C; Briasoulis, A; Papageorgiou, N; Stefanadis, C; Tousoulis, D | 1 |
Cohen, BE; de Jonge, P; Duivis, HE; Na, BY; Penninx, BW; Whooley, MA | 1 |
Brennan, DM; Hoar, B; Hoogwerf, BJ; McQuade, C; Skugor, M; Stevenson, C | 1 |
Brooks, MM; Frye, RL; Genuth, S; Hardison, RM; Huber, K; Krishnaswami, A; McBane, RD; Pratley, RE; Schneider, DJ; Sobel, BE; Wolk, R | 1 |
Agrawal, A; Gupta, BK; Gupta, R; Khatri, M; Panwar, RB; Raja, S; Vaishnav, J | 1 |
Burgess, S; Casas, JP; Lawlor, DA; Seaman, S; Thompson, SG | 1 |
Meade, TW; Stirling, Y | 1 |
Cai, G; Chen, M; Chen, Q; Fu, W; Hua, X; Liu, D | 1 |
Drenos, F; Humphries, SE; Ken-Dror, G; Kivimaki, M; Kumari, M | 1 |
Liu, H; Wang, XF; Zhai, XQ | 1 |
de Maat, MP; Deckers, JW; Leebeek, FW; van Domburg, RT; van Loon, JE | 1 |
Dulak, J; Guzik, TJ | 1 |
Azhar, M; Bokhari, SA; Butt, AK; Hanif, M; Izhar, M; Khan, AA; Tatakis, DN | 1 |
Hansen, JB; Jørgensen, L; Løchen, ML; Mathiesen, EB; Njølstad, I; Nyrnes, A; Skjelbakken, T; Wilsgaard, T | 1 |
Allison, MA; Berger, JS; Dowd, JB; Hale, L; Martin, LW; Parente, V; Sands, M; Song, Y | 1 |
Almenar Bonet, L; Arnau Vives, MA; Martínez Dolz, LV; Morillas Blasco, P; Osa Sáez, A; Osca Asensi, J; Palencia Pérez, MA; Quesada Carmona, A; Rueda Soriano, J; Sanjuán Máñez, R | 1 |
Andreotti, F; Bruno, P; Burzotta, F; Di Pietrantonio, F; Gaudino, M; Iacoviello, L; Lapenna, E; Maseri, A; Nasso, G; Possati, G; Santarelli, F; Schiavello, R; Zamparelli, R | 1 |
Agarwal, S; Deepa, R; Dwarakanath, V; Mohan, V; Saravanan, G; Velmurugan, K | 1 |
Chen, X; Hu, Y; Jang, Y; Li, G; Wang, J; Xing, X; Yang, W | 1 |
Sehnal, E; Slany, J | 1 |
Grant, P; Mansfield, M; Mills, J | 1 |
Alfredsson, L; de Faire, U; Fransson, E; Hallqvist, J; Hammar, N; Knutsson, A; Nilsson, T; Theorell, T; Westerholm, P | 1 |
Adler, Y; Behar, S; Boyko, V; Goldbourt, U; Haim, M; Matetzky, S; Mekori, YA; Reshef, T; Tanne, D | 1 |
Andreotti, F; Donati, M; Gaudino, M; Iacoviello, L; Minniti, G; Nasso, G; Possati, G; Schiavello, R | 1 |
Huang, CH; Lai, WT; Lee, KT; Lin, TH; Lu, YH; Sheu, SH; Voon, WC; Wang, WM; Wu, DC; Yen, HW | 1 |
Büttcher, E; Ehlers, R; Eltzschig, HK; Helber, U; Hoffmeister, HM; Kazmaier, S; Szabo, S | 1 |
El-Hazmi, MA | 1 |
De Backer, G; de Smet, P; Dramaix, M; Kittel, F; Kornitzer, M; Leynen, F; Mak, R; Stam, M | 1 |
Hansson, LO; Jensen-Urstad, M; Johansson, J; Krakau, I; Viigimaa, M | 1 |
Amouyel, P; Arveiler, D; Dos Santos, C; Evans, A; Ferrières, J; Juhan-Vague, I; Luc, G; Scarabin, PY | 1 |
Altman, R; González, C; Rouvier, J; Scazziota, A | 1 |
Laxmi, R; Sesikeran, B; Vani, A | 1 |
Grip, L; Linder, R; Nørgaard, BL; Oldgren, J; Siegbahn, A; Wallentin, L | 1 |
Klatsky, AL | 1 |
Homolková, H; Kvasnicka, J; Kvasnicka, T; Malíkova, I; Sauerová, R; Teplá, E; Umlaufová, A; Viklický, O | 1 |
Iturbe, T; Moreno, JA; Recaséns, Mdel V; Romero, MS | 1 |
Alvarez, L; Arocha-Piñango, CL; Arteaga-Vizcaíno, M; Campos, G; Diez-Ewald, M; Fernández, N; Rivero, F; Ryder, E; Torres, E; Vizcaíno, G | 1 |
Aseichev, AV; Azizova, OA; Drinitsyna, SV; Dudnik, LB; Lopukhin, YM; Pogoretskaya, IL; Pokrovskaya, MA; Savchenkova, AP; Solov'eva, NP | 1 |
Ahn, JY; Ahn, TH; Choi, IS; Han, SH; Kim, DS; Koh, KK; Park, GS; Shin, EK; Son, JW | 1 |
Chrysohoou, C; Panagiotakos, DB; Pitsavos, C; Skoumas, J; Stefanadis, CI; Toutouza, M; Toutouzas, PK | 1 |
Amouyel, P; Arveiler, D; Bard, JM; Ducimetiere, P; Evans, A; Ferrieres, J; Fruchart, JC; Juhan-Vague, I; Luc, G | 1 |
Cooper, JA; Crook, D; Miller, GJ; Oakley, FR; Sanders, TA | 1 |
Brull, DJ; Hingorani, AD; Humphries, SE; Jones, L; Lowe, GD; Montgomery, HE; Rumley, A; Serrano, N; Sharma, P; World, MJ; Zito, F | 1 |
Bengtsson, BA; Hulthe, J; Johannsson, G; Leonsson, M; Oscarsson, J; Wiklund, O; Wikstrand, J | 1 |
Adamiec, R; Gosk-Bierska, I; Szuba, A | 1 |
Cupples, LA; D'Agostino, RB; Feng, D; Larson, MG; Levy, D; Lindpaintner, K; O'Donnell, CJ; Tofler, GH; Yang, Q | 1 |
Chernyad'eva, IF; Kukharchuk, VV; Rogoza, AN; Shil'nikova, SV | 1 |
Berg, K; Eikvar, L; Retterstol, L | 1 |
Bots, ML; Broekmans, WM; Kardinaal, AF; Klöpping-Ketelaars, IA; Kluft, C; Princen, JM; van Poppel, G; Witte, DR | 1 |
GILCHRIST, E; TULLOCH, JA | 1 |
DANIELESCU, D; ILIESCU, CC; ROLANT, F; ROMAN, L | 1 |
Choudhury, SR; Curb, JD; Nakagawa, H; Okayama, A; Okuda, N; Rodriguez, B; Saitoh, S; Sakata, K; Ueshima, H | 1 |
DJORDJEVIC, BS; STRASER, T | 1 |
KOZHEVNIKOVA, TL | 1 |
SEMENOVICH, NI | 1 |
BRITOV, AN | 1 |
BETETTO, D; CRISTINA, P; SPANIO, G | 1 |
EASTHAM, RD; MORGAN, EH | 1 |
JAROSCHEWSKI, AJ; SHAWORONKOWA, EK | 1 |
IAROSHEVSKII, AIa; ZHAVORONKOVA, EK | 1 |
DOBROVOLSKAIA, TI | 1 |
AMRIS, A; AMRIS, CJ | 1 |
HUME, R; MACKAY, N | 1 |
CARROLL, RT; ERSLEV, AJ; HAURANI, FI; REGAN, J | 1 |
KISELEVA, EN; PETROVA, TR | 1 |
MCANDREW, GM; OGSTON, D | 2 |
CHAKRABARTI, R; FEARNLEY, GR; HOCKING, ED | 1 |
MCANDREW, GM; OGSTON, CM; OGSTON, D | 1 |
JOHNSON, R; QUENNEVILLE, G | 1 |
Aktan, M; Altunkeser, BB; Düzenli, A; Gök, H; Ozdemir, K; Ozeren, A; Tokaç, M | 1 |
Bouter, KP; de Jongh, BM; Diepersloot, RJ; Kelder, JC; Plokker, TH; Rahel, BM; Suttorp, MJ; Visseren, FL | 1 |
Amouyel, P; Arveiler, D; Blankenberg, S; Cambien, F; Ducimetière, P; Evans, A; Ferrières, J; Luc, G; Tiret, L | 1 |
Gadzhieva, ZG; Khasaev, ASh | 1 |
Janket, SJ; Meurman, JH; Nuutinen, P; Qvarnström, M | 1 |
Caspi, A; Gorinstein, S; Goshev, I; Libman, I; Trakhtenberg, S; Zemser, M | 1 |
Chen, J; Hamm, LL; He, J; Kusek, JW; Muntner, P; Whelton, PK | 1 |
Macleod, J; Smith, GD | 1 |
Davey Smith, G; Ebrahim, S; Harbord, R | 1 |
Melloni, C; Miaton, RA; Montebugnoli, L; Prati, C; Servidio, D; Tricoci, P | 1 |
Beevers, GD; Blann, AD; Felmeden, DC; Lip, GY; Martin, SC; Spencer, CG | 1 |
Chatzopoulos, D; Kountouras, J; Zavos, C | 1 |
Ford, I; Lowe, GD; McMahon, AD; O'Reilly, DS; Packard, CJ; Rumley, A | 1 |
Christodoulou, G; Chrysohoou, C; Panagiotakos, DB; Papageorgiou, C; Pitsavos, C; Stefanadis, C; Tsetsekou, E | 1 |
Caspi, A; Gorinstein, S; Katrich, E; Lerner, HT; Libman, I; Trakhtenberg, S | 1 |
Parish, JM; Somers, VK | 1 |
Alte, D; Felix, SB; John, U; Robinson, DM; Schwahn, C; Völzke, H | 1 |
Amouyel, P; Arveiler, D; Bingham, A; Dallongeville, J; Ducimetière, P; Evans, A; Ferrières, J; Hass, B; McCrum, E; Montaye, M; Ruidavets, JB; Yarnell, J; Yu, S | 1 |
Jousilahti, P; Salomaa, V | 1 |
Can, G; Hergenç, G; Onat, A; Sansoy, V; Sari, I; Uyarel, H; Uzunlar, B; Yazici, M | 1 |
Dobordzhginidze, LM | 1 |
Aggarwal, A; Schneider, DJ | 1 |
Boehm, BO; Hoffmann, MM; März, W; Scharnagl, H; Winkelmann, BR | 1 |
Chudakova, DA; Minushkina, LO; Nosik, VV; Zateĭshchikov, DA | 1 |
Aznaouridis, K; Boskou, G; Chiou, A; Feliou, G; Karatzi, K; Karatzis, E; Kontoyiannis, D; Lekakis, J; Matsouka, C; Mavrikakis, M; Papamichael, C; Sitara, M; Zampelas, A | 1 |
Lowe, GD; Mackie, IJ; Rumley, A | 1 |
Evans, A; Lowe, G; McCrum, E; Patterson, C; Rumley, A; Salomaa, V; Yarnell, J | 1 |
Brown, CA; Carson, AP; Folsom, AR; Rose, KM; Sanford, CP; Stang, PE; Szklo, M | 1 |
Hu, DY; Liu, MY; Liu, RH; Liu, WH; Yan, L | 1 |
Altun, A; Tatli, E; Tugrul, A; Ugur-Altun, B | 1 |
Dimcevski, G; Holm, J; Kristensen, LL; Montvilas, P; Mouritsen, EA; Rasmussen, IH; Suciu, G; Von Eyben, FE; Von Eyben, R | 1 |
Melandri, G; Melloni, C; Miaton, RA; Montebugnoli, L; Prati, C; Servidio, D; Tricoci, P | 1 |
Charvát, J; Chlumský, J; Kvapil, M; Michalová, K; Táborská, K; Vojácek, J | 1 |
Fomin, VV; Kopelëva, MV; Martynov, AI; Moiseev, SV; Mukhin, NA; Paramonov, AD; Stankevich, LI | 1 |
Cannuscio, C; Curhan, G; Hankinson, SE; Ma, J; Manson, JE; Rifai, N; Rimm, EB; Shai, I; Stampfer, MJ | 1 |
Lowe, GD | 2 |
Meade, TW | 5 |
Ebrahim, S; Lawlor, DA; Lowe, GD; Rumley, A; Smith, GD | 1 |
Hamsten, A; Mannila, MN; Silveira, A | 1 |
Cooper, JA; Humphries, SE; Miller, GJ | 1 |
Chambless, LE; Folsom, AR; Nieto, FJ; Wattanakit, K | 1 |
James, SK; Johnston, N; Lindbäck, J; Oldgren, J; Siegbahn, A; Wallentin, L | 1 |
Bhatia, M; Rothwell, PM | 1 |
Ebrahim, S; Harbord, R; Milton, J; Smith, GD; Sterne, JA | 1 |
Gardemann, A; Haberbosch, W | 1 |
Amouyel, P; Arocha-Piñango, CL; Arveiler, D; Assmann, G; Bauer, KA; Ben-Shlomo, Y; Benderly, M; Bingham, A; Brunner, E; Campos, G; Cantin, B; Collins, R; Cooper, JA; Cremer, P; Curb, JD; Cushman, M; D'Agostino, R; Dagenais, GR; Danesh, J; Davey Smith, G; de Maat, MP; De Stavola, B; Després, JP; Dickinson, A; Diez-Ewald, MP; Ducimetiere, P; Elwood, PC; Eriksson, H; Espinosa, R; Evans, AE; Fernandez, V; Ferrieres, J; Feskens, EJ; Folsom, AR; Ford, I; Fowkes, FG; Goldbourt, U; Harald, K; Haverkate, F; Hedblad, B; Ireland, B; Jousilahti, P; Juhan-Vague, I; Juzwishin, K; Kannel, WB; Kaptoge, S; Kiechl, S; Kitamura, A; Knottenbelt, C; Koenig, W; Kostis, JB; Kromhout, D; Lamarche, B; Lappas, G; Lee, AJ; Lewington, S; Lind, P; Loewel, H; Lowe, GD; Marchioli, R; Meade, TW; Memon, A; Mijares, M; Miller, GJ; Nagel, D; Nagy, E; Naito, Y; Nyyssönen, K; Palmieri, V; Palosuo, T; Pekkanen, J; Psaty, BM; Rasi, R; Ridker, P; Robertson, M; Rodeghiero, F; Rodriguez, B; Rodriguez-Larralde, A; Rodriquez-Roa, E; Rosenberg, RD; Rosengren, A; Rudnicka, A; Ryder, E; Salomaa, V; Salonen, JT; Sarwar, N; Sato, S; Schulte, H; Shepherd, J; Shipley, M; Smith, FB; Sweetnam, PM; Thompson, SG; Tofler, G; Torres, E; Tosetto, A; Tracy, RP; Tunstall-Pedoe, H; Tuomainen, TP; Tybjaerg-Hansen, A; Vahtera, E; Valagussa, F; Walker, M; Wheeler, J; White, I; Wilhelmsen, L; Willeit, J; Wilson, AC; Wilson, PW; Wood, A; Woodward, M; Wu, K; Yano, K; Yarnell, JW; Yeh, JL | 1 |
Einecke, D | 1 |
Ben-Shlomo, Y; Lowe, G; Patterson, C; Rumley, A; Smith, A; Yarnell, J | 1 |
Cleutjens, KB; Daemen, MJ; Heeneman, S; Kooi, ME; Lobbes, MB; Lutgens, E; Nelemans, PJ; van Engelshoven, JM | 1 |
Jungers, P; Landais, P; Massy, ZA; Taupin, P | 1 |
Fruchart, JC; Gervois, P; Pauletto, P; Staels, B; Zambon, A | 1 |
Bella, JN; Best, LG; Devereux, RB; Kizer, JR; Lee, ET; Liu, JE; Palmieri, V; Roman, MJ | 1 |
Boomsma, DI; de Geus, EJ; de Lange, M; Kluft, C; Meijer, P; Snieder, H; van Doornen, LJ | 1 |
Beijerinck, D; Deurenberg, JJ; Maas, AH; Mali, WP; van der Graaf, Y; van der Schouw, YT | 1 |
Bentivoglio, C; Cozzolino, D; Nuzzo, I; Paolillo, R; Rizzo, A; Romano Carratelli, C | 1 |
Holá, D; Pálová, S; Zamrazil, V | 1 |
Aiach, M; Alhenc-Gelas, M; Benetos, A; Bydlowski, S; Consoli, SM; Ducimetiere, P; Guize, L; Kierzin, JM; Lahlou-Laforet, K; Pornin, M; Scarabin, PY; Seigneur, E | 1 |
Hu, DY; Liu, MY | 1 |
Clark, S; Collins, R; Danesh, J; Delépine, M; Keavney, B; Lathrop, M; Palmer, A; Parish, S; Peto, R; Youngman, L | 1 |
De Stavola, BL; Humphries, SE; Meade, TW | 1 |
Bolaman, Z; Kadikoylu, G; Ozgel, N; Yenisey, C | 1 |
Chambless, LE; Folsom, AR; Mosley, TH; Ohira, T; Rosamond, WD; Shahar, E | 1 |
Drenos, F; Humphries, SE; Miller, GJ | 1 |
Meade, TW; Mt-Isa, S; Rudnicka, AR | 1 |
Borozanov, V; Bosevski, M; Kostoska, S; Tosev, S | 1 |
De Stavola, BL; Meade, TW | 1 |
Cai, WW; Fu, Q; Li, XM; Liu, GX; Xing, HY | 1 |
Bielak, LF; Coutinho, Tde A; Kullo, IJ; Peyser, PA; Sheedy, PF; Turner, ST | 1 |
Donati, MB; Iacoviello, L | 1 |
Badimon, JJ; Choi, BG; Fuster, V; Vilahur, G; Viles-Gonzalez, JF; Vorchheimer, DA; Zafar, MU | 1 |
de Maat, MP; Hofman, A; Kardys, I; Uitterlinden, AG; Witteman, JC | 1 |
Carney, RM; Duntley, SP; Freedland, KE; Miller, GE; Rich, MW; Stein, PK; Steinmeyer, B | 1 |
Barontini, R; Bianchi, C; Corfini, M; Del Prato, S; Di Cianni, G; Giovannitti, MG; Malloggi, L; Miccoli, R; Penno, G | 1 |
Ali, S; Caska, CM; Hendrickson, BE; Ho, J; Rourke, MA; Whooley, MA | 1 |
Abe, M; Fujioka, D; Hasebe, H; Iwaoka, M; Kawabata, K; Kitta, Y; Kobayashi, T; Kodama, Y; Kugiyama, K; Mende, A; Nakamura, T; Obata, JE; Saito, Y; Takano, H | 1 |
Bennermo, M; Ekström, M; Eriksson, P; Silveira, A; Tornvall, P | 1 |
Bhagavan, NV; Chen, R; Curb, JD; Ha, CE; Launer, L; Masaki, KH; Petrovitch, H; Remaley, AT | 1 |
Akalin, F; Ayabakan, C; Dereli, FY; Guran, O; Haklar, G | 1 |
Ahn, ES; Carnethon, MR; Choi, YH; Fernhall, B; Heffernan, KS; Jae, SY; Lee, MK | 1 |
Barry, MK; Bilfinger, TV; Caso, G; Garlick, PJ; McNurlan, MA; Vosswinkel, JA | 1 |
Bogar, L; Juricskay, I; Kenyeres, P; Kesmarky, G; Mühl, D; Tarsoly, P; Toth, K | 1 |
Borazan, A; Demircan, N; Ilikhan, S; Kadayifci, S; Kuvandik, G; Ozer, C; Pocan, B; Tekin, IO; Ucar, E | 1 |
Chen, XY; Fang, YM; Ge, JB; Huang, W; Ma, HL; Ma, YL; Sun, AJ; Wang, KQ; Wang, Y; Zou, YZ | 1 |
He, Y; Jiang, B; Li, LS; Wan, ZH; Zheng, QS | 1 |
Holmes, RA; Tow, DE; Wagner, HN | 1 |
Brozovié, M; Chakrabarti, R; Haines, AP; Meade, TW; North, WR; Stirling, Y; Thompson, SG | 1 |
Abbate, R; Gensini, GF; Laureano, R; Neri Serneri, GG; Parodi, O | 1 |
Pickart, L | 2 |
Etherington, MD; O'Brien, JR | 1 |
Haines, AP; Imeson, JD; Meade, TW; Stirling, Y; Thompson, SG | 1 |
Chakrabarti, R; Mann, JI; Meade, TW; Simpson, HC; Stirling, Y; Woolf, L | 1 |
Crompton, MR; Howarth, DJ; Meade, TW; Stirling, Y; Welch, TP | 1 |
Cannon, PJ; Kaplan, KL; Nichols, AB; Nossel, HL; Owen, J; Sciacca, RR | 1 |
Bisetti, P; Chioin, R; Girolami, A; Patrassi, GM; Procidano, M | 1 |
Bertina, R; Briët, E; Kolff, J; van der Laarse, A; van Hulsteijn, H | 1 |
Buniak, OA; Butylin, IuP | 1 |
Burns, JC; Clarke, SH; Glode, MP; Hathaway, WE; Wiggins, J | 1 |
Dudaev, VA; Gorin, VV; Ivanov, AS; Torkhovskaia, TI | 1 |
Abbate, R; Brunelli, C; Chierchia, S; Favilla, S; Gensini, GF; Mugnaini, C; Neri Serneri, GG; Parodi, O | 1 |
Cai, BL | 1 |
Beiküfner, P; Panzram, G; Schmechel, H | 1 |
Deriagina, GP | 2 |
Bodnar, PN; Donish, RM; Pristupiuk, AM | 1 |
Fallon, JT; Gold, HK; Grossbard, E; Guerrero, JL; Hoyng, CF; Khaw, BA; Leinbach, RC; Newell, JB; Vislosky, FM; Yasuda, T | 1 |
Cederholm-Williams, S; Copper, S; Cotter, L; O'Connor, NT | 1 |
Bergmann, SR; Collen, D; Fox, KA; Sobel, BE; Ter-Pogossian, MM | 1 |
Krosch, H; Schäbitz, J | 2 |
Chizhova, AI | 1 |
Palamarchuk, VI | 2 |
Bodnar, PN; Buglak, NI; Donish, RM; Panasiukova, OR | 1 |
Acciavatti, A; Del Bigo, C; Di Perri, T; Forconi, S; Galigani, C; Guerrini, M; Pieragalli, D | 1 |
Neirotti, M; Pernigotti, L | 1 |
Assennato, P; Caimi, G; Raineri, A; Sarno, A | 1 |
Baluda, MV; Khovanskaia, TP; Novikova, IV; Sokolov, EI | 1 |
Zajtchuk, J; Zajtchuk, R | 1 |
Cowley, MJ; Fisher, LM; Garrett, R; Hastillo, A; Hess, ML; Vetrovec, GW | 1 |
Crump, JH; Maxwell, VB; Thorp, J | 1 |
Davies, MJ; Woolf, N | 1 |
Cristal, N; Hagay, Z; Hart, A; Ronen, M; Silverman, C; Slonim, A | 1 |
Baker, IA; Eastham, R; Elwood, PC; Etherington, M; O'Brien, JR; Sweetnam, PM | 1 |
Muthukrishnan, V; Singh, M | 1 |
Bol'shakova, RM; Furkalo, NK; Kuts', VA; Progonnaia, VV; Romanenko, AI | 1 |
Pilgeram, LO | 2 |
Korkushko, OV; Kovalenko, AN | 1 |
Arora, RC; Arora, S | 1 |
Panchenko, EP | 1 |
Arora, RC; Arora, S; Gupta, RK | 1 |
Cuffari, MA; Fiore, CE; Gibiino, S; Mangiafico, RA; Marzella, C; Miano, MF; Petralito, A | 1 |
Barbenel, JC; Drummond, MM; Forbes, CD; Hutton, I; Lorimer, AR; Lowe, GD; Prentice, CR | 1 |
Bremner, WF; Drummond, MM; Forbes, CD; Lawrie, TD; Lowe, GD; Prentice, CR; Third, JL | 1 |
Caimi, G; Catania, A; Francavilla, G; La Bruzzo, S; Romano, A; Sarno, A | 1 |
Blakeston, C; Camm, AJ; Carrington, D; Leatham, E; Levy, J; Mendall, MA; Molineaux, N; Patel, P; Seymour, CA; Strachan, DP | 1 |
Dunn, FG; Lip, GY; Lowe, GD; Metcalfe, MJ; Rumley, A | 2 |
Ehnholm, CP; Jauhiainen, M; Myllylä, G; Pekkanen, J; Pursiainen, M; Rasi, VP; Salomaa, VV; Vahtera, EM; Vartiainen, E | 1 |
Deutsch, M; Fischer, M; Halbmayer, WM; Haushofer, A; Radek, J; Schön, R | 1 |
Eber, B; Esterbauer, H; Gasser, R; Kaufmann, P; Klein, W; Luha, O; Schumacher, M; Tatzber, F | 1 |
Assmann, G; Heinrich, J; Köhler, E; Schönfeld, R; Schulte, H | 1 |
Braun, P; May, E; Merz, M; Park, JW; Vermeltfoort, M | 1 |
Kienast, J | 1 |
de Bono, DP; More, RS | 1 |
Benowitz, NL; Fitzgerald, GA; Wilson, M; Zhang, Q | 1 |
Elkana, Y; Friedlander, Y; Kark, JD; Sinnreich, R | 1 |
Folsom, AR; Greenberg, B; Harada, S; Iida, M; Iso, H; Koike, K; Komachi, Y; Sato, S; Shimamoto, T; Winkelmann, JC | 1 |
Assmann, G; Funke, H; Heinrich, J; Köhler, E; Rust, S; Schönfeld, R; Schulte, H | 1 |
Bao, WD; Hu, XL; Song, FR | 1 |
Barasch, E; Behar, S; Benderly, M; Caspi, A; Goldbourt, U; Graff, E; Pelled, B; Reicher-Reiss, H; Reisin, L; Roguin, N | 1 |
Ankri, A; Drobinski, G; Grosgogeat, Y; Montalescot, G; Thomas, D; Vicaut, E | 1 |
Koenig, W | 2 |
Nieuwenhuizen, W | 1 |
Fowkes, FG | 1 |
Ehnholm, C; Jauhiainen, M; Myllylä, G; Pekkanen, J; Rasi, V; Salomaa, V; Vahtera, E; Vartiainen, E | 1 |
Hamsten, A | 1 |
Carrington, D; Goggin, P; Leatham, E; Mendall, MA; Northfield, TC; Patel, P; Strachan, DP | 1 |
Del Prete, R; Miragliotta, G; Mosca, A | 1 |
Wilson, PW | 1 |
Angós, JA; Cornudella, R; Gálvez, MM; Gutiérrez, M; Moreno, JA; Romero, MS | 1 |
Dawes, J; Elton, RA; Fowkes, FG; Housley, E; Lowe, GD; MacGregor, IR; Rattray, A; Rumley, A | 1 |
Assmann, G; Heinrich, J; Köhler, E; Malinow, MR; Schönfeld, R; Schulte, H; Upson, B; von Eckardstein, A | 1 |
Ernst, E | 5 |
Cesnik, H; Lechner, H; Lechner, P; Walzl, B; Walzl, M | 1 |
Folsom, AR; Green, D; Liu, K; Ruth, KJ | 1 |
van der Merwe, CF | 1 |
Berge, LN; Bønaa, KH; Nordøy, A | 1 |
Imiya, M; Kario, K; Kayaba, K; Kuroda, T; Matsuo, H; Matsuo, T; Nago, N; Shimada, K | 1 |
Venter, CS; Vorster, HH | 1 |
Glueck, CJ; Glueck, HI; Hamer, T; Speirs, J; Stroop, D; Tracy, T | 1 |
Jespersen, J; Juhan-Vague, I; Thompson, SG | 1 |
Fujino, A; Ogyu, A; Saito, T; Sano, R; Takenaka, K; Toyota, T; Yahata, Y | 1 |
Brunner, EJ; Etherington, MD; Kearney, EM; Marmot, MG; O'Brien, JR; Slavin, BM; Smith, GD; White, IR | 1 |
García-Closas, R; Segura, R; Serra-Majem, L | 1 |
Assmann, G; Balleisen, L; Heinrich, J; Schulte, H; van de Loo, J | 1 |
Arigliano, PL; Carlini, S; Manzato, F; Montresor, G; Negri, M; Sheiban, I; Tonni, S | 1 |
Accadia, M; Granato Corigliano, G; Spadaro, P | 1 |
Lakka, TA; Salonen, JT | 1 |
Friesewinkel, O; Marbet, GA; Ritz, R | 1 |
Jing, TY; Phillips, GB; Resnick, LM; Yang, XC | 1 |
Lee, AJ; Lowe, GD; Tunstall-Pedoe, H; Woodward, M | 1 |
Dimitri, G; Graziani, MS; Menegatti, G; Modena, N; Nicoli, M; Righetti, G; Vassanelli, C; Zanolla, L | 1 |
Bolibar, I; Fechtrup, C; Kienast, J; Matthias, R; Niessner, H; Thompson, SG | 1 |
Folsom, AR; Iida, M; Iso, H; Koike, K; Komachi, Y; Sato, S; Shimamoto, T; Wu, KK | 1 |
Althaus, U; Nydegger, U; Oppliger, R; Zoppi, M | 1 |
Bielenda, CC; Drews, FR; Fava, M; Halperin, P; Lamon-Fava, S; Littman, AB; MacLaughlin, RA; Oleshansky, MA | 1 |
Ho, CH; Jap, TS; Wang, SP | 1 |
Gawaz, M; May, A; Mössmer, G; Neumann, FJ; Ott, I; Schömig, A | 1 |
Brennan, PJ; Meade, TW; Roderick, PJ | 1 |
Cauley, JA; Gutai, JP; Kuller, LH; Macy, EO; Meilahn, EN; Tracy, RP | 1 |
van de Loo, J | 1 |
Baumstark, MW; Berg, A; Halle, M; Keul, J | 1 |
Dominguez, LJ; Sowers, JR; Walsh, MF | 1 |
Arveiler, D; Bara, L; Behague, I; Cambien, F; Cambou, JP; Evans, A; Green, F; Luc, G; Nicaud, V; Poirier, O; Scarabin, PY | 1 |
Abbott, RD; Burchfiel, CM; Curb, JD; Rodriguez, BL; Sharp, DS; Tracy, RP; Yano, K | 1 |
Behar, S; Benderly, M; Brunner, D; Goldbourt, U; Graff, E; Reicher-Reiss, H | 1 |
Becker, DJ; Ellis, D; Kuller, LH; Lloyd, CE; Orchard, TJ; Wing, RR | 1 |
Rosengren, A; Wilhelmsen, L | 1 |
Amudha, B; Maheswari, RU; Muthu, R; Padma, P; Sathyaraj, D; Shanmugasundaram, KR; Sharada, V; Srinivas, K; Sundaram, P; Veeraraghavan, V | 1 |
Cowan, LD; Fabsitz, RR; Howard, BV; Lee, ET; Robbins, DC; Welty, TK; Yeh, JL | 1 |
Anagnostou, ED; Chatzidimitriou, GI; Megalou, AA; Papageorgakis, NH; Rallidis, LS; Tsitouris, GK | 1 |
Marian, AJ; Roberts, R; Safavi, F; Yu, Q | 1 |
Ashton, WD; Coley, J; Daggett, AM; Davies, B; Duckett, K; eL-Sayed, M; Rowlands, DJ; Wallace, PC | 1 |
Rosito, GB; Tofler, GH | 1 |
Abbate, R; Brunelli, T; Cappelletti, C; Cellai, AP; Fedi, S; Gensini, GF; Gianni, R; Hagi, MI; Pepe, G; Prisco, D; Santoro, E | 1 |
Blümchen, G; Brestrich, M; Claus, J | 1 |
Jax, TW; Leschke, M; Schoebel, FC; Stein, D; Strauer, BE | 1 |
Bush, TL | 1 |
Folsom, AR; Iso, H; Koike, KA; Komachi, Y; Lida, M; Sato, S; Shimamoto, T | 1 |
Andreotti, F; Davies, GJ; Haider, AW; Kluft, C; Maseri, A; Thompson, GR | 1 |
Carter, AM; Grant, PJ; Mansfield, MW; Stickland, MH | 1 |
Elwood, P; Frankel, S; Smith, GD; Sweetnam, P; Yarnell, J | 1 |
Heikkilä, J; Kotamäki, M; Laustiola, K; Syvänne, M | 1 |
Cambien, F | 1 |
Iida, M; Iso, H; Koike, K; Komachi, Y; Sato, S; Shimamoto, T | 1 |
Fukuhara, S; Iwasaka, T; Karakawa, M; Kido, H; Komiyama, Y; Masuda, M; Murakami, T; Nomura, S; Takahashi, H | 1 |
N'Guyen, P; Pignon, B; Potron, G | 1 |
Athyros, VG; Boudoulas, H; Hatzikonstandinou, HA; Kontopoulos, AG; Mayroudi, MC; Papageorgiou, AA | 1 |
Jousilahti, P; Puska, P; Tuomilehto, J; Vartiainen, E | 1 |
Berebi, A; Caspi, A; Gorinstein, S; Kleipfish, A; Libman, I; Lichman, I; Trakhtenberg, S; Zemser, M | 1 |
Armitage, JM; Collins, R; Lawson, A; Meade, TW; Mitropoulos, KA; Peto, R; Reeves, BE; Wallendszus, KR; Wilson, SS | 1 |
McCredie, RM; Wang, J; Wang, XL; Wilcken, DE | 1 |
Braun, P; Merz, M; Park, JW | 1 |
Beacon, H; Beeso, J; Brown, AS; de Belder, A; Edmonds, M; Erusalimsky, JD; Hong, Y; Martin, JF; Sherwood, R | 1 |
de Maat, MP; Kluft, C; Kofflard, M; Pietersma, A; Sluiter, W | 1 |
Grzywacz, M; Kawalec, E; Musiał, J; Pajak, A; Pazucha, T; Szczeklik, A; Topór-Madry, R; Undas, A | 1 |
Bambauer, R; Klinkmann, J; Latza, R; Schiel, R | 1 |
Bambauer, R; Keller, HE; Klinkmann, J; Latza, R; Schiel, R | 1 |
Aro, A; Myllylä, G; Rasi, V; Salminen, I; Salomaa, VV; Vahtera, E | 1 |
Jerling, JC; Nair, CH; Oosthuizen, W; Veldman, FJ; Venter, CS; Vermaak, WJ; Vorster, HH | 1 |
Bouchard, C; Chagnon, M; Gagnon, J; Penttilä, I; Pérusse, L; Rankinen, T; Rauramaa, R; Väisänen, S | 1 |
Liu, SX; Wang, XL; Wilcken, DE | 1 |
Eberbach, A; Gardemann, A; Haberbosch, W; Hehrlein, FW; Katz, N; Schwartz, O; Tillmanns, H; Waas, W; Weiss, T | 1 |
Giddings, JC | 1 |
Wray, R | 1 |
Dwidedi, S; Gupta, A; Madan, N; Rusia, U; Sharma, S; Sikka, M | 1 |
Cremer, P; Peter, R; Seidel, D; Siegrist, J | 1 |
Assmann, G; Heinrich, J; Junker, R; Schulte, H; van de Loo, J | 1 |
Axon, AT; Braunholtz, D; Grant, PJ; Moayyedi, P; Ossei-Gerning, N; Smith, S; Wilson, JI | 1 |
Davy, KP; DeSouza, CA; Jones, PP; Seals, DR; Stevenson, ET | 1 |
A'Brook, R; McCluskey, MK; Tavendale, R; Tunstall-Pedoe, H; Woodward, M | 1 |
Carter, AM; Grant, PJ; Ossei-Gerning, N; Wilson, IJ | 1 |
Butowski, PS; Clarke, D; Fox, K; Goodall, AH; Knight, CJ; Panesar, M; Patel, D; Patrineli, A; Wright, C | 1 |
Brandl, U; Brückner, W; Jaeger, BR; Kreuzer, E; Meiser, B; Nagel, D; Reichart, B; Seidel, D; Steinbeck, G; Thiery, J; Uberfuhr, P; von Scheidt, W | 1 |
Bach, D; Dieplinger, H; Grabensee, B; Koch, M; Kronenberg, F; Kutkuhn, B; Trenkwalder, E | 1 |
Grabensee, B; Gradaus, F; Heering, P; Ivens, K; Jax, TW; Leschke, M; Schoebel, FC; Strauer, BE | 1 |
Byrne, A; Crean, P; Fitzgerald, DJ; Maher, M; Moran, N; Walsh, N | 1 |
Carter, AM; Grant, PJ; Kohler, HP; Stickland, MH | 1 |
Heidland, UE; Heintzen, MP; Klimek, WJ; Michel, CJ; Strauer, BE; Willers, R | 1 |
Donner, MG; Klein, GK; Mathes, PB; Richter, WO; Schwandt, P | 1 |
Oliver, MF | 1 |
Lowe, GD; Rumley, A; Tunstall-Pedoe, H; Woodward, M | 1 |
Döring, A; Fröhlich, M; Hendricks, P; Hense, HW; Koenig, W; Riegger, GA; Schunkert, H; Tropitzsch, A | 1 |
Borkowski, U; Darius, H; Genth, S; Meyer, J; Nowak, B; Rupprecht, HJ; Voigtländer, T | 1 |
Fitzpatrick, LA; Holmes, DR; Mousa, SA; Reilly, TM; Schwartz, RS; Srivatsa, SS; Tsao, PW | 1 |
Channer, KS; English, KM; Jones, TH; Steeds, R | 1 |
Bonadonna, R; Bonora, E; Egger, G; Kiechl, S; Muggeo, M; Oberhollenzer, F; Willeit, J | 1 |
Danesh, J; Peto, R | 1 |
Grant, PJ; Ossei-Gerning, N; Wilson, IJ | 1 |
Dhanjil, S; Diamond, JR; Elkeles, RS; Feher, MD; Mahmood, S; Mather, H; Nicolaides, AN; Poulter, C; Richmond, W; Sharp, P | 1 |
Anderson, TJ; Ganz, P; Meckel, CR; Mitchell, RN; Mudge, GH; Selwyn, AP; Simon, DI; Yeung, AC | 1 |
Carantoni, M; Fellin, R; Mezzetti, A; Palmieri, E; Vergnani, L; Volpato, S; Zuliani, G | 1 |
Appleby, P; Collins, R; Danesh, J; Peto, R | 1 |
Rosenson, RS; Tangney, CC | 1 |
Arnett, DK; Eckfeldt, JH; Folsom, AR; Garg, UC; Province, MA; Williams, RR | 1 |
Danielsen, R; Morrissey, JH; Onundarson, PT; Thors, H; Vidarsson, B | 1 |
Bordia, A; Srivastava, KC; Verma, SK | 1 |
Colman, T; Delgado-Rodriguez, M; Garcia-Fuentes, M; Garcia-Ribes, M; Gonzalez-Lamuño, D; Hernandez-Estefania, R; Pocovi, M; Revuelta, JM | 1 |
De Lorenzo, F; Kadziola, Z; Kakkar, VV; Mukherjee, M | 1 |
Archer, SL; Chamberlain, M; Dyer, AR; Green, D; Liu, K | 1 |
Goldschmidt-Clermont, P; Kiefe, CI; Kulkarni, K; Markovitz, JH; Nanda, N; Rustagi, P; Sekar, P | 1 |
Choussat, R; Collet, JP; Montalescot, G; Thomas, D | 1 |
Cui, X; Labhasetwar, V; Levy, RJ; Song, C; Underwood, T | 1 |
Habon, L; Juricskay, I; Kesmarky, G; Toth, K; Vajda, G | 1 |
Lewandowski, M; Mamont, B; Sadowski, Z | 1 |
Wanner, C; Zimmermann, J | 1 |
Sussekov, AV | 1 |
Assmann, G; Cullen, P; Schulte, H | 1 |
Dickfeld, T; Gawaz, M; Neumann, FJ; Pogátsa-Murray, G; Ruf, A; Schömig, A; Zohlnhöfer, D | 1 |
Born, GV; Cardona-Sanclemente, LE; Medina, R; Shafi, S | 1 |
Egberg, N; Eriksson, M; Mittleman, MA; Orth-Gomér, K; Schenck-Gustafsson, K; Wamala, S | 1 |
Bode, G; Brenner, H; Hoffmeister, A; Koenig, W; Rothenbacher, D; Wanner, P | 1 |
Jousilahti, P; Rasi, V; Salomaa, V; Vahtera, E | 1 |
Belichard, P; Bontemps, L; de Lorgeril, M; Geyssant, A; Itti, R; Salen, P | 1 |
Behar, S | 1 |
Seidel, D; Thiery, J | 1 |
Davis, MC | 1 |
Davis, MC; Swan, PD | 1 |
Fowkes, FG; Lee, AJ; Lowe, GD; Mowbray, PI; Price, JF; Rumley, A | 1 |
Hong, SH; Kim, JQ; Lee, DH; Min, WK; Song, J | 1 |
Bourke, C; Hedley, AJ; Janus, ED; Lam, TH; Liu, LJ | 1 |
Carter, AM; Catto, AJ; Grant, PJ | 1 |
Bittner, M; Breddin, HK; Kirchmaier, CM; Krzywanek, HJ; Lippold, R; Michaelis, J | 1 |
Assmann, G; Bobak, M; Bui, M; Fobker, M; Gostomzyk, J; Hense, HW; Junker, R; Kark, J; Kuch, B; Marmot, M; Schulte, H; Sinnreich, R; Vojtisek, P; von Eckardstein, A | 1 |
Holmes, MB; Howard, DB; Schneider, DJ; Sobel, BE | 1 |
Bingham, SA; Cummings, JH; Loktionov, A; Nell, T; O'Neill, IK; Runswick, SA; Vorster, H | 1 |
Hamann, GF; Jaeger, BR; Knüppel, HP; Pfefferkorn, TK; Thiery, J | 1 |
Montgomery, H; Woods, D | 1 |
Chyou, PH; Curb, JD; Kodama, K; Kusumi, S; Rodriguez, BL; Sharp, DS; Shimizu, Y; Tracy, RP; Yano, K | 1 |
Kang, JY; Kim, SB; Park, JH; Park, JS; Park, SJ; Park, SW; Yang, WS | 1 |
Cloutier, G; Genest, J; Weng, X | 1 |
Asano, H; Suzuki, M; Tanaka, H; Usuda, S | 1 |
Bremner, WF; Connors, ES; Dawson, S; Kanabrocki, EL; McCormick, JB; Nemchausky, BM; Olwin, JH; Rothschild, R; Ryan, M; Shirazi, P; Sothern, RB; Third, JL; Vahed, S | 1 |
Ridker, PM | 1 |
Castiñeiras, MJ; Fiol, C; Meco, JF; Pinto, X; Pujol, R; Quintana, E | 1 |
Abrignani, MG; Braschi, A; Braschi, GB; Caruso, R; Di Girolamo, A; Novo, G; Novo, S; Strano, A; Tantillo, R | 1 |
Chang, KH; Kang, DW; Lee, SH; Roh, JK; Yoon, BW | 1 |
Fitscha, P; Schweeger, I; Sinzinger, H | 1 |
Bray, PF; Goldschmidt-Clermont, PJ; Roos, C; Vijayan, KV | 1 |
Cyrowski, MS; Davidson, MH; Maki, A; Maki, KC; Marx, P | 1 |
Hedley, AJ; Janus, ED; Lam, TH; Lau, CP; Liu, LJ | 1 |
Bairey Merz, CN; Kaul, S; Paul-Labrador, MJ; Shah, PK; Shechter, M | 1 |
Boschetti, C; Cofrancesco, E; Cortellaro, F; Cortellaro, M; Mancini, M; Mariani, M; Paoletti, R | 1 |
Blazing, MA; Guyton, JR; Hagar, J; Kashyap, ML; Knopp, RH; McKenney, JM; Nash, DT; Nash, SD | 1 |
Kostis, JB; Lacy, CR | 1 |
Haberbosch, W; Jantos, C | 1 |
Kaftan, AH; Kaftan, O | 1 |
Kremastinos, DT; Kyriakides, ZS; Melissari, E; Sbarouni, E | 1 |
Astrup, A; Marckmann, P; Raben, A | 1 |
Marckmann, P | 1 |
Brancati, FL; Chambless, LE; Duncan, BB; Folsom, AR; McGovern, PG; Saito, I | 1 |
Badenhorst, CJ; Bourne, LT; Jerling, JC; Jooste, PL; Slazus, W; Steyn, K; Venter, CS; Vorster, HH | 1 |
Bielak, LF; Klee, GG; Peyser, PA; Schwartz, RS; Sheedy, PF; Turner, ST | 1 |
Iida, M; Imano, H; Iso, H; Kitamura, A; Kiyama, M; Komachi, Y; Naito, Y; Nakagawa, Y; Nakamura, M; Okamura, T; Sato, S; Shimamoto, T | 1 |
Crawford, VL; Stout, RW | 1 |
Lindahl, B; Siegbahn, A; Toss, H; Venge, P; Wallentin, L | 1 |
Caslake, MJ; Cooney, J; Ford, I; Krishna, M; Lowe, GD; Macphee, CH; McMahon, AD; O'Reilly, DS; Packard, CJ; Rumley, A; Suckling, KE; Wilkinson, FE | 1 |
Adamus, J; Gil, M; Olszewski, R; Zarebiński, M | 1 |
Barzegar, S; Bauer, KA; Cooper, JA; Howarth, DJ; Meade, TW; Miller, GJ; Mitchell, JP; Morrissey, JH; Rosenberg, RD | 1 |
Aston, CE; Kamboh, MI; Low, PS; Saha, N | 1 |
Darko, D; Kirk, G; McLaren, M; Sands, RH; Seed, M | 1 |
Borkenstein, M; Gallistl, S; Muntean, W; Sudi, KM; Troebinger, M; Weinhandl, G | 1 |
Ishida, M; Komori, K; Kume, M; Matsumoto, T; Ohta, S; Onohara, T; Sugimachi, K; Takeuchi, K | 1 |
Droullé, C; Garnotel, R; Hézard, N; Metz, D; Nguyen, P; Potron, G | 1 |
Basili, S; Cordova, C; Ferroni, P; Gazzaniga, PP | 1 |
Rosenson, RS; Schaefer, EJ; Tangney, CC | 1 |
Ahn, C; Aleksic, N; Boerwinkle, E; Folsom, AR; Wu, KK | 1 |
Fudal, M; Michalska-Małecka, K; Szczurek-Katański, K; Szyguła, J; Słowińska, L; Turczyński, B; Wilczewski, P; Wodniecki, J | 1 |
Halinen, M; Kemppainen, A; Koukkunen, H; Penttila, I; Penttilä, K; Pyörälä, K; Rantanen, T | 1 |
Borkenstein, M; Cvirn, G; Gallistl, S; Muntean, W; Sudi, KM | 1 |
Booyse, FM; Sell, SM; Song, C | 1 |
Alpsoy, S; Ata, N; Cavusoglu, Y; Gorenek, B; Timuralp, B; Unalir, A | 1 |
Holmes, MB; Kabbani, SS; Schneider, DJ; Sobel, BE; Terrien, CM; Watkins, MW | 1 |
Jousilahti, P; Palosuo, T; Rasi, V; Salomaa, V; Vahtera, E | 1 |
Campeau, L; Forman, S; Fox, NL; Herd, JA; Hickey, A; Hoogwerf, BJ; Hoppensteadt, D; Hunninghake, DB; Pifarré, R; Probstfield, JL; Terrin, ML; Walenga, JM | 1 |
Böke, E; Erbaş, T; Güvener, M; Güvener, N; Paşaoğlu, I; Tütüncü, NB; Tütüncü, T; Yilmaz, M | 1 |
Best, JD; Cumpston, GN; Dragicevic, G; Giles, GG; Herbert, KE; O'Dea, K; Stoney, RM | 1 |
Boura, J; Chandra, HR; Choudhary, N; O'Neill, C; O'Neill, WW; Timmis, GC | 1 |
Alfieri, O; Benussi, S; Casati, V; D'Angelo, A; Franco, A; Gerli, C; Torri, G | 1 |
Kannel, WB | 4 |
Heng, CK; Hong, S; Liu, Y; Low, PS; Saha, N | 1 |
Hergenç, G; Keleş, I; Onat, A; Sansoy, V; Uysal, O; Yildirim, B | 1 |
Beevers, DG; Lip, GY; Spencer, CG | 1 |
Colas, JL; Montalescot, G; Tribouilloy, C | 1 |
Ehnholm, C; Jauhiainen, M; Kulathinal, S; Pekkanen, J; Rasi, V; Salomaa, V; Vahtera, E | 1 |
Acevedo, M; Foody, JM; Pearce, GL; Sprecher, DL | 1 |
Capel, P; De Backer, G; De Bacquer, D; Delanghe, JR; Langlois, MR; Mak, R; Van Renterghem, L | 1 |
Erkelens, DW; Roeters van Lennep, JE; van der Wall, EE; Westerveld, HT | 1 |
Acevedo, M; Cross, JA; Foody, JM; Frolkis, JP; Hoogwerf, BJ; Pashkow, FJ; Pearce, GL; Robinson, K; Sprecher, DL; Vidt, DG | 1 |
Aggarwal, A; DiBattiste, PM; Kabbani, SS; Schneider, DJ; Sobel, BE; Terrien, EF | 1 |
Arber, N; Avitzour, D; Berliner, S; Elishkevitz, K; Fusman, R; Koffler, M; Rotstein, R; Shapira, I; Zeltser, D | 1 |
Russo, C | 1 |
Rosenson, RS; Shott, S; Tangney, CC | 1 |
Blumenthal, RS; Braunstein, JB; Bray, P; Gerstenblith, G; Kershner, DW; Post, WS; Schulman, SP | 1 |
Bergeron, J; Bogaty, P; Cantin, B; Dagenais, GR; Després, JP; Lamarche, B; Lupien, PJ; Moorjani, S | 1 |
Basso, F; Humphries, SE; Lowe, GD; McMahon, AD; Rumley, A | 1 |
Grant, PJ; Mansfield, MW; Mills, JD | 1 |
Blix, GG; Chan, J; Fraser, GE; Knutsen, SF; Lee, JW | 1 |
Barsotti, A; Brunelli, C; Ghigliotti, G; Leslie, S; Olivotti, L; Rossettin, P; Spallarossa, P | 1 |
Abramson, JL; Vaccarino, V | 1 |
Bail, D; Helber, U; Heller, W; Hoffmeister, HM; Walter, T | 1 |
Leonhardt, H; Uthoff, A; Uthoff, C | 1 |
Fulton, WF; Summer, DJ | 1 |
Girolami, A; Massa, G; Patrassi, GM; Schivazappa, L; Toffanin, F | 1 |
Ito, T; Matsui, E; Niwa, T; Sassa, H | 1 |
Niţă, I; Papilian, M | 2 |
Andreenko, GV; Liutova, LV | 1 |
Dudaev, VA; Evdokimov, VV | 1 |
Botti, C; Brunetti, A; Chioin, R; Dalla Volta, S; De Zio, A; Girolami, A; Salmaso, L; Schivazappa, L; Valsecchi, A | 1 |
Enger, SC; Johnsen, V; Laws, EA; Samuelsen, A | 1 |
Chakrabarti, R; Haines, AP; Meade, TW; North, WR; Stirling, Y | 2 |
Jerse, M; Keber, D; Keber, I; Stegnar, M | 1 |
Barillari, C; Bianchi, V; Parenti, M; Pasquali, R; Vezzadini, P | 1 |
Belousov, IuB; Liusov, VA; Panchenko, EP; Savenkov, MP; Sidorskiĭ, AL | 1 |
Davies, MJ; Fulton, WF; Robertson, WB | 1 |
Fedorishko, SS; Palamarchuk, VI; Revutskiĭ, EL; Vendt, VP | 1 |
Fedorishko, SS; Palamarchuk, VI | 2 |
Abazova, FI; Belousov, IuB; Savenkov, MP; Sidorskiĭ, AL | 1 |
Di Perri, T; Forconi, S; Guerrini, M; Pecchi, S; Rossi, C | 1 |
Rath, NF; Wuppermann, T | 1 |
Chernysheva, LN; Urbaniuk, KG | 1 |
Govseeva, NN; Kondrat'eva, LG; Solovtsova, KM; Vendt, VP | 1 |
Andreenko, GV; Lisina, AN; Liutova, LV; Panchenko, VM | 1 |
Cajozzo, A; Di Marco, P; Perricone, R | 1 |
Fukuda, I; Kawasaki, T; Kiso, T; Konishi, S; Mozai, T; Yoritsune, H; Yoshida, T | 1 |
Izuchi, Y; Kusunose, K; Miyanishi, E; Yamada, S | 2 |
Chowdhury, P; Moschos, CB | 1 |
Boisseau, M; Bouloumie, J; Bricaud, H; Broustet, JP; Emeriau, JP | 1 |
Harker, LA; Ritchie, JL | 1 |
Chubukova, AL; Iliushina, IP; Lukiianova, LE; Metelitsa, VI; Ostrovskaia, TP | 1 |
Lee, J; Oliver, GC; Salimi, A; Sherman, LA | 1 |
Dintenfass, L; Lake, B | 1 |
Aleksandrov, AA; Chubukova, AL; Kokurina, EV; Metelitsa, VI | 1 |
Erhardt, LR; Sjögren, A | 1 |
Haider, B; Moschos, CB; Oldewurtel, HA; Regan, TJ | 1 |
Fulton, WF; Sumner, DG | 1 |
Bol'shakova, RM; Dukhina, MA; Furkalo, NK; SolovtsovA, KM | 1 |
Belousov, IuB; Dudaev, VA; Liusov, VA; Shmushkovich, BI | 1 |
Eger, H; Fiehring, H; Reichelt, D; Reimann, G; Schilling, B; Sedlarik, K; Vollmar, F; Wilde, J | 1 |
Baroncini, S; Coccheri, S; De Rosa, V; Donato, S; Pretolani, E; Zoli, I | 1 |
Dormandy, JA; Postlethwaite, JC | 1 |
Dreiling, DA; Tuzhilin, DA | 1 |
Coleman, RE; Harwig, JF; Harwig, SS; Sherman, LA; Welch, MJ | 1 |
Maurer, B; Wray, R | 1 |
Hosokawa, T; Ikematsu, S; Itoh, O; Samori, T | 1 |
Dosková, M; Jezková, Z; Pokorný, J | 1 |
Boman, G; Erhardt, LR; Unge, G | 1 |
Barsamian, EM; Frisbie, JH; Parisi, AF; Sasahara, AA; Tow, DE | 1 |
Andersen, P | 1 |
Arrol, S; Bhatnagar, D; Durrington, PN; Ishola, M; Mackness, M; Mbewu, AD; Winocour, PH | 1 |
Belanger, AJ; D'Agostino, RB; Kannel, WB | 1 |
Pekkanen, J; Rasi, V; Salomaa, V | 1 |
Blombäck, B; Blombäck, M; Fatah, K; Hamsten, A | 1 |
Connelly, JB; Cooper, JA; Meade, TW | 1 |
Davies, SW; Gutteridge, CN; Marchant, B; Ranjadayalan, K; Stevenson, R; Syndercombe-Court, D; Timmis, AD; Umachandran, V | 1 |
Allardyce, W; Ballantyne, D; Tansey, P; Wosornu, D | 1 |
Arnesen, H; Eritsland, J; Seljeflot, I; Smith, P; Westvik, AB | 1 |
Cazenave, JP; Grunebaum, L; Mossard, JM; Sacrez, A; Wiesel, ML | 1 |
Erhart, R; Kemmler, G; Kunz, F; Pechlaner, C; Zwierzina, WD | 1 |
Eber, B; Gasser, R; Klein, W; Luha, O; Schumacher, M; Tiran, A; Toplak, H | 1 |
Berg, J; Berge, SR; Bjerkedal, T; Brudal, S; Høstmark, AT; Kierulf, P | 1 |
Sueishi, K; Tanaka, K | 1 |
Gliksman, M; Wilson, A | 1 |
Edmondson, SJ; Görög, P; Kovacs, IB; Ratnatunga, CP; Rees, GM; Ridler, CD | 1 |
Willich, SN | 1 |
Berg, K; Kierulf, P; Malinow, MR; Upson, B | 1 |
Hjemdahl, P; Larsson, PT; Olsson, G; Teger-Nilsson, AC | 1 |
Blanke, H; Höffken, H; Leschke, M; Motz, W; Schöbel, F; Strauer, BE | 1 |
Barbagallo, M; Catalano, I; Daví, G; Giammarresi, C; Nicolosi, G; Notarbartolo, A; Putignano, E; Violi, F | 1 |
Conlan, MG; Davis, CE; Folsom, AR; Sorlie, PD; Szklo, M; Wu, KK | 1 |
Jancsó, T; Mihai, K | 1 |
Engelberg, H | 1 |
Hennekens, CH; Ridker, PM | 1 |
Bainton, D; Baker, IA; Elwood, PC; O'Brien, JR; Sweetnam, PM; Whitehead, PJ; Yarnell, JW | 1 |
Alexander, HM; Dobson, AJ; Heller, RF; Lloyd, DM | 1 |
MacDonald, G; Nicolaides, AN; Salmasi, AM; Salmasi, S | 1 |
Kleophas, W; Leschke, M; Reinauer, H; Saddig, C; Strauer, BE; Toeller, M | 1 |
Dykun, IaV; Malaia, LT; Shuliak, LN; Topchiĭ, II; Volkov, VI | 1 |
Broadhurst, P; Hughes, L; Imeson, JD; Kelleher, C; Raftery, EB | 1 |
Banerjee, D; Blombäck, B; Carlsson, K; Hamsten, A; Hessel, B; Procyk, R; Silveira, A; Zacharski, L | 1 |
Konen, JC; McCormick, CP; Shihabi, ZK | 1 |
Jávor, T; Juricskay, I; Mezey, B; Simor, T; Tóth, K | 1 |
Lee, AJ; Lowe, GD; Smith, WC; Tunstall-Pedoe, H | 1 |
Bykova, MIu; Garganeeva, NP; Kanskaia, NV; Karpov, RS; Krasheninina, TV; Mikhaĭlova, VM; Roman'ko, OIu | 1 |
Jávor, T; Juricskay, I; Mezey, B; Tóth, K | 1 |
Gries, FA; Kleophas, W; Leschke, M; Martin, J; Schauseil, S; Schottenfeld, Y; Strauer, BE; Tschöpe, D | 1 |
Dyer, S; Howarth, DJ; Imeson, JD; Meade, TW; Stirling, Y | 1 |
Jespersen, J; Munkvad, S; Nieuwenhuizen, W | 1 |
Aoyama, T; Hattori, R; Kawai, C; Sakaguchi, K; Susawa, T; Takahashi, M; Takatsu, Y; Yui, N; Yui, Y | 1 |
Beattie, JM; Forbes, CD; Hutton, I; Lorimer, AR; Lowe, GD; Small, M | 1 |
Sonoki, H; Sugimoto, T; Tomaru, T; Tsukamoto, M; Uchida, Y | 1 |
Armstrong, VW; Eisenhauer, T; Janning, G; Schuff-Werner, P; Schütz, E; Seidel, D; Seyde, WC | 1 |
Harrison, MJ; Hurst, C; Meade, TW; Schneidau, A; Wilkes, HC | 1 |
Bareiss, P; Cazenave, JP; Drawin, T; Grunebaum, L; Kieny, JR; Mossard, JM; Roul, G; Sacrez, A; Wiesel, ML | 1 |
Belousov, IuB; Parfenov, AS | 1 |
Cucchi, G; Ferrara, E; Sardeo, C | 1 |
Green, F; Humphries, S | 1 |
Swahn, E; von Schenck, H; Wallentin, L | 1 |
Blanke, H; Egbring, R; Höffken, H; Joseph, K; Leschke, M; Schmidtsdorff, A; Strauer, BE | 1 |
Fratino, P; Grignani, G; Pacchiarini, L; Salerno, JA; Storti, C; Zucchella, M | 1 |
Gram, J; Jespersen, J; Munkvad, S | 1 |
Allison, JV; Cruickshank, JK; Ellis, LJ; Fox, TE; Miller, GJ; Mitropoulos, KA; Stirling, Y; Thompson, RL; Walker, AO; Wilkes, HC | 1 |
Ma, XL; Wang, YM; Zang, YM; Zhu, MZ | 1 |
De Leeuw, I; Rademakers, F; Rillaerts, E; Van Camp, K; Vandewoude, MF | 1 |
Green, KG; Heady, A; Oliver, MF | 1 |
Tulchinsky, M; Wilensky, RL; Wish, M; Zeller, JA | 1 |
Hahn, R; Heimburg, P; Hubert, H; Jöckel, KH; Müller-Seydlitz, PM | 1 |
Brozovic, M; Chakrabarti, RR; Haines, AP; Imeson, JD; Meade, TW; Mellows, S; Miller, GJ; North, WR; Stirling, Y; Thompson, SG | 1 |
Imeson, J; Meade, TW; Stirling, Y | 1 |
Blombäck, M; de Faire, U; Hamsten, A; Iselius, L | 1 |
Hessel, LW; Kluft, C | 1 |
Aĭngorn, ED; Andreenko, GV; Belokon', NA; Karabasova, MA; Zabotina, ON | 1 |
Brezinski, ME; Darius, H; Hock, CE; Lefer, AM; Yanagisawa, A | 1 |
Ajdukiewicz, AB; Davidson, JF; Douglas, AS; Meade, TW; Stewart, G; Stirling, Y; Thompson, SG; Vickers, MV; Walker, ID; Woolf, L | 1 |
Bonnet, JL; Bory, M; Bouvier, JL; Camilleri, JF; Djiane, P; Levy, G; Serradimigni, A | 1 |
Sonoki, H; Sugimoto, T; Tomaru, T; Uchida, Y | 1 |
Fan, JJ; Ma, XL; Zang, YM; Zhu, MZ | 1 |
Hayashi, M; Hayashida, K; Kihara, K; Kitoh, Y; Matsuo, H; Nishimura, T; Oka, H; Park, YD; Shimonagata, T; Uehara, T | 1 |
Denchev, S; Ivanova, R; Kamenov, V; Tomov, I | 1 |
Fincke, U; Flohé, L; Friderichs, E; Giertz, H; Schneider, J | 1 |
Bara, L; Bonithon-Kopp, C; Castanier, M; Jacqueson, A; Roger, M; Scarabin, PY | 1 |
Gurewich, V; Kosowsky, BD; Lipinska, I; Losordo, D; Meriam, CM; Philbin, E; Ramaswamy, K | 1 |
Smith, EB | 1 |
Banga, JD; Sixma, JJ | 1 |
Al'-Murabak, M; Andreev, EF; Borodkin, VV; Diukov, IV; Dudaev, VA | 1 |
Chen, D; Lou, FQ; Zhu, SM | 1 |
Eisenberg, PR; Jaffe, AS; Sherman, LA | 1 |
Agmon, J; Aronson, M; Berliner, S; Fuchs, J; Hazaz, B; Kariv, N; Pinkhas, J; Rotenberg, Z; Seligsohn, U; Weinberger, I | 1 |
Bogár, L; Tekeres, M; Tóth, K | 1 |
Eroshina, VA; Goliakov, VN; Semiletova, VI; Zimin, IuV | 1 |
Eisenberg, PR; Geltman, EM; Jaffe, AS; Rich, M; Schechtman, K; Schwartz, D; Sherman, L; Sobel, BE | 1 |
Singer, A | 1 |
Cristal, N; Shainkin-Kestenbaum, R; Winikoff, Y | 1 |
Borodkin, VV; Diukov, IV; Dudaev, VA | 1 |
Leschke, M; Motz, W; Strauer, BE | 1 |
Bhattacharya, SK; Dube, B; Dube, RK; Somani, PN; Tripathi, GK | 1 |
Fenwick, GR; Hanley, AB | 1 |
Haines, AP; Meade, TW; Miller, GJ; Stirling, Y; Thompson, SG; Vickers, MV | 1 |
Bulpitt, CJ; Markowe, HL; Marmot, MG; Meade, TW; Semmence, A; Shipley, MJ; Stirling, Y; Vickers, MV | 1 |
Baumann, M; Ernst, E; Matrai, A | 1 |
Gangadharan, V; Gordon, S; Hauser, AM; Mammen, EF; Ramos, RG; Stewart, JR; Timmis, GC; Westveer, DC | 1 |
Eisenberg, PR; Jaffe, AS; Perez, J; Schectman, K; Sherman, LA; Sobel, BE | 1 |
Eastham, R; Elwood, PC; Etherington, MD; Gilmour, RA; O'Brien, JR; Sweetnam, PM; Yarnell, JW | 1 |
Bachmann, F; Grbic, M; Sigwart, U | 1 |
Al-Yusuf, AR; Bhatnagar, SK; Hudak, A | 1 |
Katyshkina, NI; Liusov, VA; Soboleva, VN | 1 |
Filippova, SB; Ikonnikova, EI; Khalfen, ESh; Voronkova, LI | 1 |
Stone, MC; Thorp, JM | 1 |
Pliutto, AM | 1 |
Guniia, SS; Kiseleva, LN | 1 |
Attwell, TN; Chakrabarti, R; Fearnley, GR; Hocking, ED; Jackson, D; Mann, RD | 1 |
Rex, J | 1 |
Brakman, P; Epstein, SE; Redwood, DR; Rosing, DR | 1 |
Abildgaard, U; Fagerhol, MK; Refvem, O | 1 |
Gritsiuk, AI; Sopina, NV | 1 |
Andreenko, GV; Chazov, EI; Liutova, LV; Mazaev, AV; Sargin, KE | 1 |
Liapina, LA; Panchenko, VM | 1 |
Douglas, AS | 1 |
Pavlishchuk, SA; Petrova, TR | 1 |
Lahiri, K; Manskopf, G; Moschos, CB; Oldewurtel, HA; Regan, TJ | 1 |
Brecher, AS; Burkholder, DE; Burkholder, JS; Howe, WF | 1 |
Davidson, JF; Lochhead, M; McDonald, GA; McNicol, GP | 1 |
Chandler, AB; Chapman, I; Erhardt, LR; Ness, PM; Roberts, WC; Schwartz, CJ; Sherry, S; Simon, TL; Sinapius, D; Spain, DM | 1 |
Afaunova, VI; Denisova, TP; Kratovskaia, OV; Lebedeva, SN; Zalaldinova, NB | 1 |
Andreenko, GV; Chazov, EI; Liutova, LV; Podol'skaia, LV; Sargin, KE | 1 |
Penner, JA; Schnetzer, GW | 1 |
Bolocan, T; Grecu, O; Păunescu-Podeanu, A | 1 |
Astrup, T; Brakman, P; Epstein, SE; Redwood, DR; Rosing, DR | 1 |
Scrobohaci, ML; Stăncioiu, N | 1 |
Gordon, RJ; Snyder, GK; Taylor, WJ; Tritel, H | 1 |
Chapman, I | 1 |
Erhardt, IR | 1 |
Dal Palù, C; Donadon, W; Ferrari, S; Girelli Bruni, E; Pagnan, A; Tonolli, E | 1 |
Mantovani, M; Prino, G | 1 |
Kushner, S | 1 |
Kudriashov, BA | 1 |
Izuchi, Y; Miyanishi, E; Yamada, S | 1 |
Grob, PJ; Scheitlin, W; Thöni, R | 1 |
Atanasov, K | 1 |
Gormsen, J | 1 |
Hart, HC | 1 |
Deriagina, GP; Ganelina, IE; Krivoruchenko, IV; Ryvkin, BA | 1 |
Drzewiecki, J; Lipiński, B; Nowak, A | 1 |
Korsan-Bengtsen, K; Tibblin, G; Wilhelmsen, L | 1 |
Cotton, RC | 1 |
Lee, KT | 1 |
Bisarya, BN; Mukerji, DP; Vasavada, PS | 1 |
Grigorov, YG; Korkuschko, OV; Nenova, LN | 1 |
Woolf, N | 1 |
Baklaja-Jevremović, R; Bosnjaković, V; Dordević, BS; Nastić, D | 1 |
Karppinen, K | 1 |
Gerhold, WM; Mandel, EE | 1 |
Del Pino, MC; Morelli, AC; Pollini, H | 1 |
Moe, N | 1 |
Panchenko, VM | 1 |
Benz, LL; DeWeese, JA; Izzo, MJ; Mahoney, EB; Perry, JM; Schwartz, SI; Spar, IL; Yu, PN | 1 |
Takamiya, T | 1 |
Burke, WM; Lehan, PH; Moschos, CB; Oldewurtel, HA; Regan, TJ | 1 |
Mrazek, SA | 1 |
Bridges, JM; Mayne, EE; Weaver, JA | 1 |
Akinyanju, PA; Naismith, DJ; Szanto, S; Yudkin, J | 1 |
Agarova, EN; Krutovskaia, OV; Mikhaĭlovskaia, EG | 1 |
Parkhotik, II; Sakharchuk, II | 1 |
Bobkova, VI; Ezhova, IS | 1 |
El'gort, PE; Orlova, NP | 1 |
Chernysheva, GV | 1 |
Hermann, B; Tornóczky, J | 1 |
Iutanova, II; Loginov, AS | 1 |
Medvedeva, ZF; Shishkova, TV; Vorob'ev, AI | 1 |
Burckhardt, D; LaDue, JS; Vera, CA | 1 |
Cotton, RC; Craven, JL | 1 |
Datsenko, EM; Muratov, VI | 1 |
Gurevich, MA; Levantovskaia, OM | 1 |
Feniuk, EV | 1 |
Pavlishchuk, SA; Petrova, TP | 1 |
Farbiszewski, R; Lipiński, B; Myśliwiec, M; Worowski, K | 1 |
Cucuianu, M; Hărăguş, S; Missits, P | 1 |
Belen'kiĭ, AI | 1 |
Fearnley, GR | 1 |
Khvatova, EA; Romanovskaia, VK | 1 |
Brandt, EN; Hampton, JW; Mantooth, J; Wolf, SG | 1 |
Mikhalev, ID | 1 |
Pakhomova, PV | 1 |
74 review(s) available for fibrinogen and Coronary Disease
Article | Year |
---|---|
The Northwick Park Heart Study: evidence from the laboratory.
Topics: Antigens; Atherosclerosis; Blood Coagulation; Coronary Disease; Disease Progression; Factor VII; Fibrinogen; Hemostasis; Humans; Inflammation; Phenotype; Prospective Studies; Risk Factors; Thrombosis | 2014 |
[Rheology and coronary heart disease].
Topics: Angina Pectoris; Blood Viscosity; Coronary Circulation; Coronary Disease; Coronary Stenosis; Erythrocyte Aggregation; Fibrinogen; Hemorheology; Humans; Syndrome; Urokinase-Type Plasminogen Activator; Vascular Resistance | 2008 |
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.
Topics: Alcohol Drinking; Biomarkers; Blood Pressure; Body Mass Index; C-Reactive Protein; Cholesterol; Coronary Disease; Databases, Factual; Diabetes Mellitus; Female; Fibrinogen; Humans; Interleukin-6; Leukocyte Count; Lung Diseases; Male; Middle Aged; Motor Activity; Neoplasms; Regression Analysis; Risk Assessment; Risk Factors; Serum Albumin; Sex Factors; Smoking; Stroke; Triglycerides | 2010 |
Statistical methods for the time-to-event analysis of individual participant data from multiple epidemiological studies.
Topics: Age Factors; Coronary Disease; Data Interpretation, Statistical; Epidemiologic Methods; Fibrinogen; Humans; Proportional Hazards Models; Risk Factors; Sex Factors; Smoking; Time Factors | 2010 |
Predicting the risk of coronary heart disease. II: the role of novel molecular biomarkers and genetics in estimating risk, and the future of risk prediction.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Apolipoprotein A-I; Apolipoproteins B; Apolipoproteins E; Biomarkers; C-Reactive Protein; Coronary Disease; Cystatin C; Fibrinogen; Homocysteine; Humans; Lipoproteins; Natriuretic Peptide, Brain; Risk; Risk Assessment; Risk Factors; Uric Acid | 2010 |
Fibrinogen and cardiovascular disease: genetics and biomarkers.
Topics: Animals; Coronary Disease; Fibrinogen; Humans; Myocardial Infarction; Polymorphism, Genetic | 2011 |
Depressive symptoms, health behaviors, and subsequent inflammation in patients with coronary heart disease: prospective findings from the heart and soul study.
Topics: Aged; Body Mass Index; C-Reactive Protein; Coronary Disease; Depressive Disorder; Exercise; Female; Fibrinogen; Follow-Up Studies; Health Behavior; Humans; Inflammation Mediators; Interleukin-6; Male; Middle Aged; Mind-Body Relations, Metaphysical; Prospective Studies; Risk Factors; Smoking | 2011 |
Hematological risk factors for coronary heart disease.
Topics: Antithrombins; Bacterial Infections; Coronary Disease; Factor V; Factor VIII; Fibrinogen; Homocysteine; Humans; Mutation; Plasminogen Activator Inhibitor 1; Protein C; Protein S; Prothrombin; Risk Factors | 2002 |
Fibrinogen, C-reactive protein and coronary heart disease: does Mendelian randomization suggest the associations are non-causal?
Topics: Biomarkers; C-Reactive Protein; Coronary Disease; Fibrinogen; Genetic Predisposition to Disease; Humans; Risk Factors | 2004 |
Obstructive sleep apnea and cardiovascular disease.
Topics: Arousal; Arrhythmias, Cardiac; Arteriosclerosis; C-Reactive Protein; Cardiovascular Diseases; Coronary Disease; Fatigue; Fibrinogen; Heart Failure; Humans; Hypertension; Hypertension, Pulmonary; Interleukin-6; Ischemic Attack, Transient; Oxyhemoglobins; Plasminogen Inactivators; Platelet Aggregation; Polysomnography; Prevalence; Risk Factors; Severity of Illness Index; Sleep Apnea, Obstructive; Stroke | 2004 |
[Fibrates: mechanism of action, effect on levels of lipids and risk of coronary events. II. Fenofibrate].
Topics: Adult; Aged; Cholesterol; Coronary Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fenofibrate; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Insulin Resistance; Lipids; Male; Middle Aged; Placebos; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Triglycerides | 2004 |
Development of glycoprotein IIb-IIIa antagonists: translation of pharmacodynamic effects into clinical benefit.
Topics: Binding Sites; Biological Availability; Coronary Disease; Female; Fibrinogen; Humans; Male; Maximum Tolerated Dose; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Sensitivity and Specificity | 2004 |
Plasma fibrinogen.
Topics: Biomarkers; Blood Coagulation; Blood Coagulation Tests; Cardiovascular Diseases; Coronary Disease; Fibrinogen; Humans; Immunoassay | 2004 |
A systematic comparison of the quality and volume of published data available on novel risk factors for stroke versus coronary heart disease.
Topics: Apolipoproteins; C-Reactive Protein; Case-Control Studies; Chlamydophila pneumoniae; Cohort Studies; Coronary Disease; Fibrin Fibrinogen Degradation Products; Fibrinogen; Helicobacter pylori; Humans; Periodicals as Topic; Risk Factors; Stroke | 2005 |
Does elevated plasma fibrinogen increase the risk of coronary heart disease? Evidence from a meta-analysis of genetic association studies.
Topics: Coronary Disease; Fibrinogen; Genetic Predisposition to Disease; Humans; Risk Factors; Thrombosis | 2005 |
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
Topics: Adult; Aged; Cause of Death; Coronary Disease; Fibrinogen; Humans; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Risk; Stroke; Vascular Diseases | 2005 |
Is there more than C-reactive protein and fibrinogen? The prognostic value of soluble CD40 ligand, interleukin-6 and oxidized low-density lipoprotein with respect to coronary and cerebral vascular disease.
Topics: C-Reactive Protein; CD40 Ligand; Coronary Disease; Coronary Vessels; Databases, Bibliographic; Fibrinogen; Humans; Interleukin-6; Lipoproteins, LDL; Models, Statistical; Prognosis; Risk Factors; Vascular Diseases | 2006 |
Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clinical and experimental evidence.
Topics: Animals; Atherosclerosis; C-Reactive Protein; Cholesterol, LDL; Coronary Disease; Endothelium, Vascular; Fibrinogen; Hepatocytes; Humans; Inflammation; Interleukin-6; Monocytes; NF-kappa B; Phosphorylation; PPAR alpha; Proto-Oncogene Proteins c-jun; Signal Transduction | 2006 |
Fibrinogen and coronary heart disease: test of causality by 'Mendelian randomization'.
Topics: Adult; Case-Control Studies; Coronary Disease; Fibrinogen; Genotype; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Polymorphism, Genetic; Recombination, Genetic; Retrospective Studies; Risk Assessment | 2006 |
Fat metabolism, the fibrinogen/fibrinolytic system and blood flow: new potentials for the pharmacological treatment of coronary heart disease.
Topics: Arteriosclerosis; Coronary Circulation; Coronary Disease; Fibrinogen; Fibrinolysis; Humans; Hypolipidemic Agents; Lipid Metabolism; Regional Blood Flow; Thrombosis | 1981 |
[Fibrinogen and coronary heart disease].
Topics: Coronary Angiography; Coronary Disease; Fibrinogen; Humans; Prognosis; Prospective Studies; Risk Factors; Survival Rate | 1995 |
Prevention and management of bleeding complications after thrombolysis.
Topics: Aprotinin; Clinical Trials as Topic; Coronary Angiography; Coronary Disease; Drug Interactions; Fibrinogen; Hemorrhage; Heparin; Humans; Incidence; Plasma; Risk Factors; Thrombolytic Therapy; Tranexamic Acid | 1993 |
Fibrinogen in ischaemic heart disease.
Topics: Blood Viscosity; Cholesterol; Coronary Artery Disease; Coronary Disease; Coronary Thrombosis; Fibrinogen; Humans; Myocardial Infarction; Platelet Aggregation; Prospective Studies; Recurrence; Risk Factors | 1995 |
Recent progress in the clinical aspects of fibrinogen.
Topics: Adult; Aged; Arteriosclerosis; Cardiovascular Diseases; Cerebral Infarction; Clinical Trials as Topic; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Risk Factors | 1995 |
Biochemistry and measurement of fibrinogen.
Topics: Cardiovascular Diseases; Chemical Precipitation; Coronary Disease; Fibrinogen; Humans; Immunoassay; Molecular Weight; Reference Values; Whole Blood Coagulation Time | 1995 |
Fibrinogen and cardiovascular disease in clinical practice.
Topics: Arteriosclerosis; Cardiovascular Diseases; Coronary Disease; Fibrinogen; Humans; Lipoproteins; Myocardial Infarction; Prospective Studies; Reference Values; Risk Factors | 1995 |
Established risk factors and coronary artery disease: the Framingham Study.
Topics: Alcohol Drinking; Blood Pressure; Coronary Disease; Diabetes Complications; Diet; Fibrinogen; Humans; Leukocyte Count; Life Style; Lipids; Longitudinal Studies; Obesity; Risk Factors; Smoking | 1994 |
Fibrinogen: its emerging role as a cardiovascular risk factor.
Topics: Adult; Aged; Arterial Occlusive Diseases; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Risk Factors; Smoking | 1994 |
Fibrinogen as a cardiovascular risk factor--interrelationship with infections and inflammation.
Topics: Acute-Phase Reaction; Adult; Aged; Arterial Occlusive Diseases; Arteriosclerosis; Biomarkers; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Humans; Infections; Inflammation; Male; Middle Aged; Prospective Studies; Risk Factors | 1993 |
Regular exercise reduces fibrinogen levels: a review of longitudinal studies.
Topics: Coronary Disease; Cross-Sectional Studies; Exercise; Fibrinogen; Humans; Longitudinal Studies; Risk Factors | 1993 |
Exercise and haemostatic function.
Topics: Coronary Disease; Exercise; Fibrinogen; Hemostasis; Humans; Risk Factors | 1995 |
Metabolic abnormalities in cardiac ischemia.
Topics: Coronary Disease; Factor VII; Factor VIII; Fibrinogen; Humans; Hypertension; Insulin; Lipids; Plasminogen; Platelet Aggregation | 1995 |
Hemostatic factors as triggers of cardiovascular events.
Topics: Blood Platelets; Cardiovascular Diseases; Circadian Rhythm; Coronary Disease; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Risk Factors | 1996 |
Insight into the genetic epidemiology of coronary heart disease.
Topics: Alcohol Drinking; Angiotensin II; Cholesterol, HDL; Coronary Disease; Fibrinogen; Humans; Polymorphism, Genetic; Risk Factors; Smoking | 1996 |
[Fibrinogen: a risk factor].
Topics: Arteries; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Fibrinogen; Humans; Risk Factors; Thrombosis | 1996 |
Testosterone and coronary heart disease: is there a link?
Topics: Coronary Disease; Female; Fibrinogen; Fibrinolysis; Humans; Hyperinsulinism; Male; Myocardial Infarction; Obesity; Risk Factors; Smoking; Testosterone | 1997 |
Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies.
Topics: Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Humans; Risk Factors | 1998 |
Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies.
Topics: C-Reactive Protein; Coronary Disease; Fibrinogen; Humans; Leukocyte Count; Prospective Studies; Risk Factors; Serum Albumin | 1998 |
Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.
Topics: Animals; Antithrombins; Cardiovascular Diseases; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Endothelium, Vascular; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Inflammation; Lovastatin; Muscle, Smooth, Vascular; Platelet Aggregation; Pravastatin; Simvastatin; Thromboplastin; Thrombosis | 1998 |
Fibrinogen as a risk factor for coronary heart disease.
Topics: Cholesterol; Coronary Artery Disease; Coronary Disease; Fibrinogen; Hemostasis; Humans; Risk Factors; Triglycerides | 1998 |
[Current opinions on the role of hemostatic factors in the pathogenesis of coronary artery disease].
Topics: Blood Coagulation Factors; Coronary Disease; Fibrinogen; Fibrinolysis; Humans | 1998 |
Causes of coronary heart disease in patients on renal replacement therapy.
Topics: Animals; Apolipoproteins B; Coronary Disease; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Kidney Failure, Chronic; Lipoprotein(a); Renal Dialysis; Risk Factors | 1998 |
[Factors affecting the trans-endothelial accumulation of atherogenic plasma proteins in artery walls].
Topics: Animals; Arteries; Arteriosclerosis; Blood Pressure; Blood Proteins; Coronary Disease; Endothelium, Vascular; Fibrinogen; Humans; Lipoproteins, LDL; Rats; Rats, Inbred SHR; Risk Factors | 1998 |
LDL-apheresis: clinical experience and indications in the treatment of severe hypercholesterolemia.
Topics: Adolescent; Adult; Blood Component Removal; Cholesterol, HDL; Cholesterol, LDL; Combined Modality Therapy; Coronary Disease; Female; Fibrinogen; Heart Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Lipoprotein(a); Middle Aged; Treatment Outcome | 1993 |
High intensity training and the heart.
Topics: Adult; Cardiomyopathy, Hypertrophic; Coronary Disease; Exercise; Fibrinogen; Humans; Inflammation; Middle Aged; Renin-Angiotensin System; Risk Assessment | 1999 |
Novel risk factors and markers for coronary disease.
Topics: Biomarkers; C-Reactive Protein; Coronary Disease; Fibrinogen; Fibrinolysis; Homocysteine; Humans; Hyperhomocysteinemia; Lipoprotein(a); Risk Factors; Thrombophilia; Vasculitis | 2000 |
Chlamydia pneumoniae infection is not an independent risk factor for arterial disease.
Topics: Animals; Arteriosclerosis; Cells, Cultured; Chlamydia Infections; Chlamydia trachomatis; Chlamydophila pneumoniae; Coronary Disease; Diabetes Complications; Female; Fibrinogen; Genotype; Humans; Hypercholesterolemia; Hypertension; Macrophages; Male; Mice; Middle Aged; Monocytes; Odds Ratio; Prospective Studies; Rabbits; Risk Factors | 2000 |
Dietary treatment of thrombogenic disorders related to the metabolic syndrome.
Topics: Coronary Disease; Cross-Sectional Studies; Diet, Fat-Restricted; Dietary Fiber; Factor VII; Fibrinogen; Humans; Insulin; Insulin Resistance; Obesity; Thrombosis; Triglycerides | 2000 |
Fibrinogen and coronary risk.
Topics: Biomarkers; Coronary Disease; Cytokines; Female; Fibrinogen; Humans; Male; Plasminogen; Risk Factors; Sex Factors | 1999 |
[Platelet-leukocyte interactions in coronary heart disease: pathophysiology, clinical relevance, pharmacological modulation].
Topics: Abciximab; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Blood Platelets; CD18 Antigens; Chemotaxis, Leukocyte; Coronary Artery Bypass; Coronary Disease; Cytokines; Fibrinogen; Heparin; Humans; Immunoglobulin Fab Fragments; Leukocytes; Ligands; Macrophage-1 Antigen; Membrane Glycoproteins; Models, Biological; Myocardial Infarction; Neutrophils; P-Selectin; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombospondins; Tirofiban; Tyrosine | 2000 |
Influence of multiple risk factors on the hazard of hypertension.
Topics: Animals; Coronary Disease; Exercise; Fibrinogen; Glucose Intolerance; Humans; Hypertension; Hypertrophy, Left Ventricular; Lipoproteins; Risk Factors; Smoking | 1990 |
Risk factors for coronary heart disease: implications of gender.
Topics: Aged; Bacterial Infections; Biomarkers; C-Reactive Protein; Coronary Disease; Diabetes Complications; Estrogens; Female; Fibrinogen; Homocysteine; Humans; Hypertension; Inflammation; Lipid Metabolism; Male; Middle Aged; Obesity; Psychosocial Deprivation; Risk Factors; Sex; Smoking; Triglycerides | 2002 |
[Role of hemostatic markers in the pathogenesis of coronary diseases].
Topics: Biomarkers; Coronary Disease; Factor VII; Fibrinogen; Hemostasis; Humans | 2002 |
Interaction of hemostatic genetics with hormone therapy: new insights to explain arterial thrombosis in postmenopausal women.
Topics: Blood Coagulation Factors; Blood Platelets; Coronary Disease; Estrogen Replacement Therapy; Factor V; Factor VII; Female; Fibrinogen; Genetic Predisposition to Disease; Hemostasis; Humans; Plasminogen Activator Inhibitor 1; Point Mutation; Polymorphism, Genetic; Postmenopause; Prothrombin; Thrombosis | 2002 |
Population-based distributions of haemostatic variables.
Topics: Adolescent; Adult; Age Factors; Blood Coagulation Factors; Blood Group Antigens; Coronary Disease; Demography; England; Female; Fibrinogen; Genetic Variation; Hemostasis; Humans; Male; Middle Aged; Prospective Studies; Reference Values | 1977 |
[Determination of fibrinogen].
Topics: Adult; Afibrinogenemia; Aged; Cerebrovascular Disorders; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Neoplasms | 1976 |
Hypercoagulability and reduced fibrinolysis in hyperlipidemia: relationship to the metabolic cardiovascular syndrome.
Topics: Blood Coagulation; Cardiovascular Diseases; Cholesterol; Coronary Disease; Fibrinogen; Fibrinolysis; Humans; Hyperlipidemias; Lipoproteins, LDL; Metabolic Diseases; Plasminogen Inactivators; Syndrome | 1992 |
[Coagulation factors, platelets and coronary heart disease].
Topics: Blood Coagulation Factors; Coronary Disease; Factor VII; Female; Fibrinogen; Humans; Male; Myocardial Infarction; Platelet Aggregation; Recurrence; Tissue Plasminogen Activator | 1991 |
[Classical and new hemostasis risk factors in coronary disease].
Topics: Adult; Blood Platelets; Blood Viscosity; Cholesterol; Clinical Trials as Topic; Coronary Disease; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Hypertension; Platelet Count; Risk Factors; Smoking | 1992 |
Fibrinogen and plasminogen activator inhibitor-1 levels in hypertension and coronary heart disease. Potential effects of beta-blockade.
Topics: Adrenergic beta-Antagonists; Animals; Coronary Disease; Fibrinogen; Fibrinolysis; Humans; Hypertension; Plasminogen Inactivators; Stress, Physiological | 1991 |
[Correlation between juvenile myocardial infarct in parents and plasma fibrinogen levels in their offspring].
Topics: Adolescent; Adult; Age Factors; Child; Child, Preschool; Coronary Disease; Female; Fibrinogen; Humans; Male; Myocardial Infarction; Risk Factors | 1991 |
[Hemorheologic parameters during the 6 months following myocardial infarct].
Topics: Blood Flow Velocity; Blood Viscosity; Blood Volume; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Hematocrit; Humans; Male; Middle Aged; Myocardial Infarction | 1990 |
Control of plasma fibrinogen levels.
Topics: Base Sequence; Coronary Disease; Fibrinogen; Humans; Molecular Sequence Data | 1989 |
Risks and mechanisms of cardiovascular events in users of oral contraceptives.
Topics: Antigens; Cardiovascular Diseases; Contraceptives, Oral, Hormonal; Coronary Disease; Dose-Response Relationship, Drug; Estrogens; Factor VII; Female; Fibrinogen; Humans; Male; Progestins; Risk Factors; Thromboembolism | 1988 |
Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis.
Topics: Animals; Arteriosclerosis; Coronary Disease; Disease Models, Animal; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Lipoproteins, LDL; Muscle, Smooth, Vascular; Risk; Thrombosis | 1986 |
Diabetes mellitus, vascular disease and thrombosis.
Topics: Blood Coagulation Factors; Blood Platelets; Blood Viscosity; Cholesterol, HDL; Coronary Disease; Diabetic Angiopathies; Erythrocyte Deformability; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Hypercholesterolemia; Hyperlipidemias; Platelet Adhesiveness | 1986 |
The genus Allium--Part 3.
Topics: Allium; Animals; Arteriosclerosis; Asthma; Bacteria; Blood Glucose; Blood Protein Electrophoresis; Cholesterol; Clofibrate; Coronary Disease; Dermatitis, Contact; Dietary Fats; Drug Interactions; Fibrinogen; Fibrinolysis; Fungi; Garlic; Humans; Hyperlipidemias; Insecta; Microbial Sensitivity Tests; Mutagenicity Tests; Neoplasms; Oils, Volatile; Patch Tests; Plant Extracts; Plants, Medicinal; Platelet Aggregation; Prothrombin Time; Rabbits; Whole Blood Coagulation Time | 1985 |
Management of thrombotic diseases.
Topics: Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Cerebrovascular Disorders; Coronary Disease; Coumarins; Dextrans; Dipyridamole; Drug Antagonism; Drug Hypersensitivity; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Heart Valve Prosthesis; Hemorrhage; Heparin; Histamine H1 Antagonists; Humans; Hydrocortisone; Indenes; Intracranial Embolism and Thrombosis; Iodine Isotopes; Platelet Adhesiveness; Prostaglandins; Reserpine; Rheumatic Heart Disease; Streptokinase; Sulfinpyrazone; Thrombosis | 1971 |
[Fibrinogen--interpretation of the test results].
Topics: Afibrinogenemia; Cerebrovascular Disorders; Coronary Disease; Fibrinogen; Fibrinolysis; Humans; Inflammation; Methods; Neoplasms | 1973 |
Coronary thrombosis in myocardial infarction. Report of a workshop on the role of coronary thrombosis in the pathogenesis of acute myocardial infarction.
Topics: Adult; Aged; Arteries; Arteriosclerosis; Coronary Disease; Coronary Vessels; Female; Fibrinogen; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Infarction; Necrosis; Thrombosis; Time Factors | 1974 |
[Hyperlipemia and hypofibrinolysis in arteriosclerotic disease].
Topics: Adult; Animals; Arteriosclerosis; Blood Coagulation Tests; Cholesterol; Coronary Disease; Diet; Diet, Atherogenic; Fats; Fats, Unsaturated; Female; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Hyperlipidemias; Iodine Isotopes; Lipoproteins; Male; Methods; Middle Aged; Rabbits; Rats; Tissue Extracts | 1967 |
Circulatory effects of estrogen.
Topics: Adult; Animals; Blood Coagulation Disorders; Blood Platelets; Cardiovascular Diseases; Cardiovascular System; Contraceptives, Oral; Coronary Disease; Dogs; Estrogens; Factor IX; Factor VII; Factor VIII; Factor X; Female; Fibrinogen; Humans; Pregnancy; Rats; Sheep; Thromboembolism; Thrombophlebitis; Veins | 1970 |
[Current status of the problem of the interrelations of the blood coagulation and anticoagulation system].
Topics: Animals; Anticoagulants; Antifibrinolytic Agents; Blood Coagulation; Blood Coagulation Factors; Coronary Disease; Fibrinogen; Heparin; Humans; Sympathetic Nervous System; Thyroxine | 1971 |
[Fibrinogen--how to read its figures].
Topics: Afibrinogenemia; Cerebral Arterial Diseases; Coronary Disease; Female; Fibrinogen; Humans; Male; Methods; Neoplasms | 1971 |
66 trial(s) available for fibrinogen and Coronary Disease
Article | Year |
---|---|
Antihypertensive pharmacogenetic effect of fibrinogen-beta variant -455G>A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT study.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Chlorthalidone; Coronary Disease; Diuretics; Fibrinogen; Genetic Variation; Genotype; Humans; Hypertension; Kidney Failure, Chronic; Lisinopril; Middle Aged; Stroke; Treatment Outcome | 2009 |
Static platelet adhesion, flow cytometry and serum TXB2 levels for monitoring platelet inhibiting treatment with ASA and clopidogrel in coronary artery disease: a randomised cross-over study.
Topics: Aged; Aspirin; Case-Control Studies; Clopidogrel; Coronary Disease; Cross-Over Studies; Female; Fibrinogen; Flow Cytometry; Health; Humans; Male; Middle Aged; P-Selectin; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Principal Component Analysis; Regression Analysis; Thromboxane B2; Ticlopidine | 2009 |
Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.
Topics: Adenosine Diphosphate; Aged; Aspirin; Atorvastatin; Clopidogrel; Comorbidity; Coronary Artery Bypass; Coronary Disease; Drug Therapy, Combination; Female; Fibrinogen; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipoproteins, LDL; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Prospective Studies; Pyrroles; Ticlopidine | 2010 |
Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Topics: Adult; Biomarkers; C-Reactive Protein; Coronary Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inflammation; Insulin; Insulin Resistance; Kaplan-Meier Estimate; Male; Metformin; Middle Aged; Myocardial Revascularization; Plasminogen Activator Inhibitor 1; Prognosis; Sulfonylurea Compounds; Thiazolidinediones; Thrombophilia; Tissue Plasminogen Activator | 2011 |
Non-surgical periodontal therapy reduces coronary heart disease risk markers: a randomized controlled trial.
Topics: Biomarkers; C-Reactive Protein; Coronary Disease; Dental Prophylaxis; Female; Fibrinogen; Humans; Intention to Treat Analysis; Leukocyte Count; Longitudinal Studies; Male; Middle Aged; Periodontitis; Single-Blind Method; Treatment Outcome | 2012 |
[Prognostic value of fibrinogen in patients admitted with suspected unstable angina and non-q-wave myocardial infarction].
Topics: Aged; Angina, Unstable; Biomarkers; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis | 2002 |
Preoperative C-reactive protein level and outcome following coronary surgery.
Topics: Aged; Analysis of Variance; Biomarkers; C-Reactive Protein; Chi-Square Distribution; Coronary Artery Bypass; Coronary Disease; Fibrinogen; Humans; International Normalized Ratio; Leukocyte Count; Middle Aged; Partial Thromboplastin Time; Plasminogen Activator Inhibitor 1; Platelet Count; Postoperative Period; Prognosis; Prospective Studies | 2002 |
Correlation between ST-T-segment changes with markers of hemostasis in patients with acute coronary syndromes.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Apolipoproteins; Biomarkers; C-Reactive Protein; Coronary Disease; Coronary Vessels; Electrocardiography; Female; Fibrinogen; Follow-Up Studies; Germany; Hemostasis; Humans; Intercellular Adhesion Molecule-1; Male; Middle Aged; Myocardial Infarction; Patient Admission; Predictive Value of Tests; Risk Factors; Serum Amyloid A Protein; Statistics as Topic; Survival Analysis; Syndrome; Tissue Plasminogen Activator; Vascular Cell Adhesion Molecule-1 | 2002 |
Effects of dietary alpha-linolenic acid from blended oils on biochemical indices of coronary heart disease in Indians.
Topics: Adult; alpha-Linolenic Acid; Apolipoproteins; Biomarkers; Blood Platelets; Coronary Disease; Cross-Over Studies; Female; Fibrinogen; Fish Oils; Humans; India; Lipids; Male; Middle Aged; Phospholipids; Plant Oils; Platelet Aggregation | 2002 |
Myocardial damage, inflammation and thrombin inhibition in unstable coronary artery disease.
Topics: Adult; Aged; Aged, 80 and over; Antithrombins; C-Reactive Protein; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Glycine; Humans; Male; Middle Aged; Myocardial Infarction; Myocarditis; Piperidines; Survival Analysis; Troponin T | 2003 |
High intakes of trans monounsaturated fatty acids taken for 2 weeks do not influence procoagulant and fibrinolytic risk markers for CHD in young healthy men.
Topics: Adolescent; Adult; Analysis of Variance; Apolipoproteins A; Apolipoproteins B; Biomarkers; Blood Coagulation; Cholesterol; Coronary Disease; Cross-Over Studies; Dietary Carbohydrates; Factor VII; Fatty Acids; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Oleic Acid; Plasminogen Activator Inhibitor 1; Postprandial Period; Risk Factors; Stereoisomerism; Tissue Plasminogen Activator | 2003 |
Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease.
Topics: Acute-Phase Reaction; C-Reactive Protein; Coronary Artery Bypass; Coronary Disease; Exercise; Female; Fibrinogen; Genetic Markers; Humans; Interleukin-6; Male; Middle Aged; Military Personnel; Polymorphism, Genetic; Postoperative Period; United Kingdom | 2003 |
Dynamics of interrelationships between the content of lipoprotein particles, fibrinogen, and leukocyte count in the plasma from patients with coronary heart disease treated with Kwai.
Topics: Adult; Cholesterol; Coronary Disease; Fibrinogen; Garlic; Humans; Leukocyte Count; Lipoproteins; Male; Middle Aged; Plant Extracts; Plasma; Statistics as Topic; Triglycerides | 2003 |
Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease.
Topics: Angioplasty, Balloon, Coronary; Biomarkers; Case-Control Studies; Coronary Disease; Factor VII; Factor XIIa; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Incidence; Inflammation; Interleukin-6; Male; Middle Aged; Monocytes; Myocardial Infarction; Myocardial Revascularization; Pravastatin; Predictive Value of Tests; Risk Factors; Scotland; Thrombophilia; Triglycerides | 2004 |
Fresh israeli jaffa sweetie juice consumption improves lipid metabolism and increases antioxidant capacity in hypercholesterolemic patients suffering from coronary artery disease: studies in vitro and in humans and positive changes in albumin and fibrinog
Topics: Adult; Aged; Antioxidants; Beverages; Citrus; Citrus paradisi; Coronary Disease; Fibrinogen; Free Radical Scavengers; Fruit; Humans; Hypercholesterolemia; Israel; Lipids; Middle Aged; Serum Albumin | 2004 |
Associations of plasma fibrinogen and factor VII clotting activity with coronary heart disease and stroke: prospective cohort study from the screening phase of the Thrombosis Prevention Trial.
Topics: Age Factors; Aged; Coronary Disease; Factor VII; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Stroke; Thrombosis | 2006 |
Normalization of platelet reactivity in clopidogrel-treated subjects.
Topics: Adenosine Diphosphate; Adult; Arachidonic Acid; Aspirin; Blood Platelets; Clopidogrel; Collagen; Coronary Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fibrinogen; Humans; Male; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Transfusion; Platelet-Rich Plasma; Postoperative Hemorrhage; Receptors, Thrombin; Recovery of Function; Reference Values; Ticlopidine; Time Factors | 2007 |
Hypertriglyceridaemia and hypercoagulability.
Topics: Adult; Antigens; Blood Coagulation; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Factor VII; Factor VIII; Factor X; Fibrinogen; Fibrinolysis; Humans; Hyperlipoproteinemias; Male; Middle Aged; Risk; Triglycerides | 1983 |
Effects of warfarin therapy on plasma fibrinogen, von Willebrand factor, and fibrin D-dimer in left ventricular dysfunction secondary to coronary artery disease with and without aneurysms.
Topics: Analysis of Variance; Coronary Disease; Cross-Sectional Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Aneurysm; Heart Ventricles; Humans; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Thromboembolism; Ventricular Dysfunction, Left; von Willebrand Factor; Warfarin | 1995 |
Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking.
Topics: 6-Ketoprostaglandin F1 alpha; Administration, Cutaneous; Adult; Aged; beta-Thromboglobulin; Blood Coagulation; Cell Adhesion Molecules; Coronary Disease; Eicosanoids; Factor VII; Fibrinogen; Humans; Leukocyte Count; Male; Middle Aged; Nicotine; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Factor 4; Platelet Membrane Glycoproteins; Risk Factors; Smoking; Smoking Cessation; Thromboxane A2; Thromboxane B2 | 1993 |
Plasma fibrinogen levels and their correlates in 6457 coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study.
Topics: Age Factors; Aged; Bezafibrate; Body Mass Index; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Diabetes Complications; Diabetes Mellitus; Female; Fibrinogen; Humans; Hypertension; Israel; Male; Middle Aged; Motor Activity; Multivariate Analysis; Myocardial Infarction; Risk Factors; Sex Factors; Smoking; Triglycerides | 1995 |
[Heparin-induced extracorporeal LDL precipitation (HELP): a new therapeutic intervention in cerebrovascular diseases and peripheral arterial occlusive disease].
Topics: Aged; Arterial Occlusive Diseases; Blood Flow Velocity; Blood Viscosity; Cerebrovascular Disorders; Chemical Precipitation; Cholesterol; Coronary Disease; Extracorporeal Circulation; Female; Fibrinogen; Heparin; Humans; Lipoproteins, LDL; Male; Middle Aged; Myocardial Infarction; Rheology; Triglycerides | 1993 |
Do risk factors change in men at high risk of coronary heart disease? Observations on the effect of health promotion in primary care.
Topics: Aged; Blood Pressure; Body Mass Index; Cholesterol; Coronary Disease; Fibrinogen; Health Behavior; Health Education; Humans; Male; Middle Aged; Primary Health Care; Prospective Studies; Risk Factors; Smoking | 1995 |
Association of sex hormones and adiposity with plasma levels of fibrinogen and PAI-1 in postmenopausal women.
Topics: Adipose Tissue; Aged; Aged, 80 and over; Androstenedione; Body Mass Index; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Fibrinogen; Gonadal Steroid Hormones; Humans; Linear Models; Multivariate Analysis; Plasminogen Activator Inhibitor 1; Postmenopause; Progestins; Prospective Studies; Testosterone | 1996 |
[Lactovegetarian diet: effect on changes in body weight, lipid status, fibrinogen and lipoprotein (a) in cardiovascular patients during inpatient rehabilitation treatment].
Topics: Adult; Aged; Body Weight; Cardiac Rehabilitation; Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; Combined Modality Therapy; Coronary Disease; Diet, Fat-Restricted; Diet, Reducing; Diet, Vegetarian; Female; Fibrinogen; Humans; Lipids; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Patient Admission; Rehabilitation Centers; Treatment Outcome; Uric Acid | 1996 |
Evidence for primary and secondary prevention of coronary artery disease in women taking oestrogen replacement therapy.
Topics: Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Female; Fibrinogen; Humans; Lipoproteins; Medroxyprogesterone Acetate; Progesterone; Progesterone Congeners; Retrospective Studies; Risk Factors | 1996 |
Effects of simvastatin and ciprofibrate alone and in combination on lipid profile, plasma fibrinogen and low density lipoprotein particle structure and distribution in patients with familial combined hyperlipidaemia and coronary artery disease.
Topics: Adult; Analysis of Variance; Clofibric Acid; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Female; Fibric Acids; Fibrinogen; Follow-Up Studies; Humans; Hyperlipidemia, Familial Combined; Hypolipidemic Agents; Lipids; Lipoproteins, LDL; Lovastatin; Male; Middle Aged; Morbidity; Prospective Studies; Safety; Simvastatin; Survival Rate; Treatment Outcome; Ultracentrifugation | 1996 |
Moderate beer consumption and the blood coagulation in patients with coronary artery disease.
Topics: Aged; Alcohol Drinking; Beer; Blood Coagulation; Blood Coagulation Factors; Coronary Disease; Ethanol; Factor VII; Fibrinogen; Humans; Male; Middle Aged; Plasminogen Activators; Prothrombin Time | 1997 |
Randomized placebo-controlled study of the effects of simvastatin on haemostatic variables, lipoproteins and free fatty acids. The Oxford Cholesterol Study Group.
Topics: Adult; Aged; Chromatography, Thin Layer; Coronary Disease; Enzyme-Linked Immunosorbent Assay; Factor VII; Factor XII; Fatty Acids, Nonesterified; Female; Fibrinogen; Follow-Up Studies; Hemostasis; Humans; Hydroxymethylglutaryl CoA Reductases; Hypercholesterolemia; Hypolipidemic Agents; Lipoproteins; Lovastatin; Male; Middle Aged; Prospective Studies; Prothrombin; Risk Factors; Simvastatin; Single-Blind Method | 1997 |
Thrombin generation markers and coronary heart disease risk factors in a Polish population sample.
Topics: Adult; Aged; Biomarkers; Coronary Disease; Factor VII; Female; Fibrinogen; Humans; Male; Middle Aged; Poland; Regression Analysis; Risk Factors; Rural Population; Sex Distribution; Thrombin | 1997 |
Treatment of severe hyperlipidemia: six years' experience with low-density lipoprotein apheresis.
Topics: Adsorption; Adult; Aged; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Dextran Sulfate; Female; Fibrinogen; Humans; Hyperlipoproteinemia Type II; Immunosorbents; Lipoprotein(a); Longitudinal Studies; Male; Middle Aged; Plasmapheresis; Triglycerides | 1996 |
Low-density lipoprotein apheresis in the treatment of two patients with coronary heart disease and extremely elevated lipoprotein (a) levels.
Topics: Adult; Chi-Square Distribution; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Fibrinogen; Humans; Hyperlipoproteinemia Type II; Immunosorbents; Lipoprotein(a); Longitudinal Studies; Male; Plasmapheresis; Triglycerides; White People | 1996 |
Dietary pectin influences fibrin network structure in hypercholesterolaemic subjects.
Topics: Adult; Cholesterol; Coronary Disease; Dietary Fiber; Double-Blind Method; Fibrin; Fibrinogen; Hemostasis; Humans; Hypercholesterolemia; Lipids; Male; Middle Aged; Molecular Structure; Pectins; Risk Factors | 1997 |
Continued thromboxane A2 formation despite administration of a platelet glycoprotein IIb/IIIa antagonist in patients undergoing coronary angioplasty.
Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Biphenyl Compounds; Bleeding Time; Cell Division; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Fibrinogen; Heparin; Humans; Infusions, Intravenous; Male; Middle Aged; Muscle, Smooth, Vascular; P-Selectin; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Thrombosis; Thromboxane A2; Thromboxane B2; Vasoconstriction | 1997 |
Comparison of antiplatelet effects of aspirin, ticlopidine, or their combination after stent implantation.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Coronary Disease; Drug Therapy, Combination; Fibrinogen; Humans; P-Selectin; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Ticlopidine; Time Factors | 1998 |
Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study.
Topics: Adult; Aged; Bezafibrate; Carotid Arteries; Cholesterol; Cholesterol, HDL; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Electrocardiography; Exercise Test; Female; Femoral Artery; Fibrinogen; Follow-Up Studies; Humans; Hypolipidemic Agents; Lipids; Lipoproteins; Male; Middle Aged; Placebos; Time Factors; Triglycerides; Ultrasonography | 1998 |
Activated and total coagulation factor VII, and fibrinogen in coronary artery disease.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Cardiac Catheterization; Cholesterol; Cholesterol, HDL; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Coronary Thrombosis; Disease Progression; Factor VII; Factor VIIa; Female; Fibrinogen; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Prospective Studies; Regression Analysis; Risk Assessment; Sex Characteristics; Triglycerides | 1998 |
Effect of garlic (Allium sativum) on blood lipids, blood sugar, fibrinogen and fibrinolytic activity in patients with coronary artery disease.
Topics: Allyl Compounds; Antihypertensive Agents; Arachidonic Acid; Blood Glucose; Calcimycin; Cholesterol; Cholesterol, HDL; Collagen; Coronary Disease; Disulfides; Dose-Response Relationship, Drug; Fibrinogen; Fibrinolysis; Garlic; Humans; Ionophores; Lipids; Plant Extracts; Plant Oils; Plants, Medicinal; Platelet Aggregation; Platelet Aggregation Inhibitors; Sulfides; Thromboxane B2; Triglycerides | 1998 |
Effects of lipid-lowering drugs on left ventricular function and exercise tolerance in dyslipidemic coronary patients.
Topics: Blood Pressure; Cholesterol, LDL; Coronary Disease; Double-Blind Method; Dyspepsia; Exercise Test; Female; Fenofibrate; Fibrinogen; Heart Rate; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Patient Dropouts; Physical Endurance; Simvastatin; Stroke Volume; Treatment Outcome; Triglycerides; Ventricular Dysfunction, Left; Ventricular Function, Left | 1999 |
Lowering fibrinogen levels: clinical update. BIP Study Group. Bezafibrate Infarction Prevention.
Topics: Aged; Bezafibrate; Coronary Disease; Female; Fibrinogen; Humans; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Treatment Outcome | 1999 |
Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study.
Topics: Aged; Arterial Occlusive Diseases; Biomarkers; Blood Pressure; Blood Viscosity; Cholesterol; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Humans; Lipoproteins; Male; Middle Aged; Peripheral Vascular Diseases; Prospective Studies; Risk Factors; Smoking; Surveys and Questionnaires; United Kingdom | 1999 |
Spontaneous platelet aggregation as a predictive risk factor for vascular occlusions in healthy volunteers? Results of the HAPARG Study. Haemostatic parameters as risk factors in healthy volunteers.
Topics: Adult; Age Distribution; Aged; Coronary Disease; Female; Fibrinogen; Germany; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Platelet Aggregation; Predictive Value of Tests; Prospective Studies; Reference Values; Risk Assessment; Risk Factors; Sex Distribution | 1999 |
[Efficacy of hygienic and dietary therapy in coronary patients with isolated hypoalphalipoproteinemia].
Topics: Adult; Aged; Cholesterol, HDL; Coronary Disease; Female; Fibrinogen; Humans; Hygiene; Life Style; Male; Middle Aged; Tangier Disease | 1999 |
Association between elevated plasma fibrinogen and the small, dense low-density lipoprotein phenotype among postmenopausal women.
Topics: Aged; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Female; Fibrinogen; Hormone Replacement Therapy; Humans; Middle Aged; Phenotype; Postmenopause; Prognosis; Risk Factors; Surveys and Questionnaires | 2000 |
Plasma apolipoprotein B levels predict platelet-dependent thrombosis in patients with coronary artery disease.
Topics: Aged; Aged, 80 and over; Apolipoproteins B; Biomarkers; Blood Glucose; Blood Platelets; Cholesterol; Coronary Disease; Female; Fibrinogen; Humans; Hypolipidemic Agents; Magnesium; Male; Middle Aged; Platelet Aggregation; Platelet Count; Prognosis; Prospective Studies; Risk Factors; Thrombosis | 1999 |
Effects of fluvastatin and bezafibrate combination on plasma fibrinogen, t-plasminogen activator inhibitor and C reactive protein levels in coronary artery disease patients with mixed hyperlipidaemia (FACT study). Fluvastatin Alone and in Combination Trea
Topics: Adult; Aged; Bezafibrate; C-Reactive Protein; Cholesterol, LDL; Coronary Disease; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fibrinogen; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemia, Familial Combined; Hyperlipoproteinemia Type II; Hypertriglyceridemia; Hypolipidemic Agents; Indoles; Male; Middle Aged; Tissue Plasminogen Activator; Treatment Outcome | 2000 |
Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group.
Topics: Adult; Aged; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Delayed-Action Preparations; Double-Blind Method; Female; Fibrinogen; Gemfibrozil; Humans; Hypolipidemic Agents; Male; Middle Aged; Niacin; Triglycerides | 2000 |
Effects of simvastatin or hormone replacement therapy, or both, on fibrinogen, factor VII, and plasminogen activator inhibitor levels in postmenopausal women with proven coronary artery disease.
Topics: Anticholesteremic Agents; Antigens; Biomarkers; Coronary Disease; Cross-Over Studies; Drug Therapy, Combination; Estrogens, Conjugated (USP); Factor VII; Female; Fibrinogen; Hormone Replacement Therapy; Humans; Hypercholesterolemia; Medroxyprogesterone; Middle Aged; Plasminogen Inactivators; Postmenopause; Progesterone Congeners; Simvastatin | 2000 |
Ad libitum intake of low-fat diets rich in either starchy foods or sucrose: effects on blood lipids, factor VII coagulant activity, and fibrinogen.
Topics: Adult; Cholesterol; Coronary Disease; Diet, Fat-Restricted; Eating; Factor VII; Female; Fibrinogen; Humans; Lipid Metabolism; Lipids; Risk Factors; Starch; Sucrose; Triglycerides | 2000 |
Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease.
Topics: Aged; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoprotein C-III; Apolipoproteins C; Bezafibrate; Cholesterol, HDL; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Humans; Hypolipidemic Agents; Lipoprotein Lipase; Male; Middle Aged; Survival Analysis; Treatment Outcome; Triglycerides | 2000 |
Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.
Topics: Age Factors; Angina, Unstable; Biomarkers; C-Reactive Protein; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Male; Multivariate Analysis; Myocardial Infarction; Risk Factors; Troponin T | 2000 |
[Fibrinogen serum levels in patients with stable coronary artery disease and acute coronary syndrome].
Topics: Aged; Angina, Unstable; Chi-Square Distribution; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Recurrence | 2000 |
The effect of hormone replacement therapy and route of administration on selected cardiovascular risk factors in post-menopausal women.
Topics: Cardiovascular Diseases; Coronary Disease; Estrogen Replacement Therapy; Estrogens; Factor VII; Female; Fibrinogen; Humans; Lipoproteins; Middle Aged; Progestins; Risk Factors | 2000 |
Comparative study of HMG-CoA reductase inhibitors on fibrinogen.
Topics: Adult; Aged; Aged, 80 and over; Atorvastatin; Coronary Disease; Cross-Over Studies; Fatty Acids, Monounsaturated; Female; Fibrinogen; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lovastatin; Male; Middle Aged; Pravastatin; Pyrroles; Simvastatin | 2001 |
[Viscosity of blood and plasma in patients with single- and multi-vascular coronary heart disease].
Topics: Aged; Blood Glucose; Blood Viscosity; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Disease; Female; Fibrinogen; Hemodynamics; Humans; Male; Middle Aged; Triglycerides | 2000 |
The hemostatic effects of warfarin titration in post CABG patients in comparison to placebo treatment.
Topics: Adult; Aged; Anticoagulants; Aspirin; Coronary Artery Bypass; Coronary Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Factor VII; Female; Fibrinogen; Graft Occlusion, Vascular; Humans; International Normalized Ratio; Male; Middle Aged; Peptide Fragments; Postoperative Complications; Postoperative Hemorrhage; Prothrombin; Recurrence; Saphenous Vein; Thrombosis; Tissue Plasminogen Activator; Treatment Outcome; von Willebrand Factor; Warfarin | 2001 |
Tranexamic acid in off-pump coronary surgery: a preliminary, randomized, double-blind, placebo-controlled study.
Topics: Aged; Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Disease; Double-Blind Method; Drug Administration Schedule; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis, Surgical; Humans; Infusions, Intravenous; Male; Middle Aged; Postoperative Hemorrhage; Premedication; Prospective Studies; Tranexamic Acid | 2001 |
Interleukin-6 -174G>C polymorphism and risk of coronary heart disease in West of Scotland coronary prevention study (WOSCOPS).
Topics: Anticholesteremic Agents; C-Reactive Protein; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Female; Fibrinogen; Homozygote; Humans; Hypercholesterolemia; Interleukin-6; Male; Middle Aged; Odds Ratio; Polymorphism, Genetic; Pravastatin | 2002 |
High doses of atorvastatin do not affect activity of prothrombinase in patients with acute coronary syndromes.
Topics: Acute Disease; Aged; Anticholesteremic Agents; Atorvastatin; Coronary Disease; Female; Fibrinogen; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Platelet Aggregation; Pyrroles; Thromboplastin; Thrombosis | 2002 |
Influence of ACE inhibition on myocardial damage, the Kallikrein-Kinin system and hemostasis during cardiopulmonary bypass surgery.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Coronary Artery Bypass; Coronary Disease; Double-Blind Method; Enalapril; Female; Fibrinogen; Heart; Hemostasis; Humans; Intraoperative Complications; Kallikrein-Kinin System; Male; Middle Aged; Myocardial Reperfusion Injury | 2002 |
The effect of clofibrate on glucose tolerance, insulin secretion, triglycerides and fibrinogen in patients with coronary heart disease.
Topics: Adult; Aged; Blood Glucose; Clinical Trials as Topic; Clofibrate; Coronary Disease; Fibrinogen; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Triglycerides | 1977 |
The influence of combined treatment with propranolol and acetylsalicylic acid on platelet aggregation in coronary heart disease.
Topics: Adult; Aspirin; Clinical Trials as Topic; Coronary Disease; Drug Interactions; Epinephrine; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation; Propranolol; Time Factors | 1979 |
Influence of power and aerobic exercise training on haemostatic factors after coronary artery surgery.
Topics: Adult; Aged; Coronary Disease; Exercise; Factor VII; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Myocardial Revascularization; Prospective Studies | 1992 |
Effects of long-term treatment with warfarin on fibrinogen, FPA, TAT, and D-dimer in patients with coronary artery disease.
Topics: Adult; Aged; Antithrombin III; Combined Modality Therapy; Coronary Artery Bypass; Coronary Disease; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Follow-Up Studies; Humans; Middle Aged; Peptide Hydrolases; Time Factors; Warfarin | 1992 |
Improvement of silent myocardial ischaemia and reduction of plasma fibrinogen during nisoldipine therapy in occult coronary arterial disease.
Topics: Adult; Aged; Coronary Disease; Double-Blind Method; Electrocardiography, Ambulatory; Exercise Test; Female; Fibrinogen; Humans; Male; Middle Aged; Nisoldipine | 1991 |
Fibrinolytic enhancement by stanozolol: a double blind trial.
Topics: Adult; Aged; Blood Coagulation; Blood Coagulation Tests; Clinical Trials as Topic; Coronary Disease; Electrocardiography; Fibrin; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Stanozolol | 1972 |
603 other study(ies) available for fibrinogen and Coronary Disease
Article | Year |
---|---|
Exercise modulation in inflammation and metabolic hormonal disorders of COVID-19 to decrease risk factors in coronary heart disease.
Topics: C-Reactive Protein; Cardiovascular Diseases; Coronary Disease; COVID-19; Exercise; Fibrinogen; Galectin 3; Humans; Inflammation; Insulin; Insulin Resistance; Leptin; Pandemics; Risk Factors | 2023 |
The effect of bivalirudin on coagulation function in male patients with coronary heart disease undergoing percutaneous coronary intervention.
Topics: Blood Coagulation; Coronary Disease; Fibrinogen; Fibrinolytic Agents; Hemostatics; Heparin; Humans; Male; Percutaneous Coronary Intervention | 2023 |
Uncovering the protective mechanism of Huoxue Anxin Recipe against coronary heart disease by network analysis and experimental validation.
Topics: Animals; Apolipoprotein A-I; Blood Coagulation; Collagen; Complement C3; Coronary Disease; Down-Regulation; Drugs, Chinese Herbal; Fibrinogen; Inflammation; Interleukin-16; Male; Myocardial Infarction; Myocardium; Protective Agents; Rats; Rats, Sprague-Dawley | 2020 |
Correlations of degree of coronary artery stenosis with blood lipid, CRP, Hcy, GGT, SCD36 and fibrinogen levels in elderly patients with coronary heart disease.
Topics: Aged; Aged, 80 and over; C-Reactive Protein; CD36 Antigens; Coronary Disease; Female; Fibrinogen; gamma-Glutamyltransferase; Homocysteine; Humans; Lipids; Male; Middle Aged | 2019 |
Preoperative plasma fibrinogen level and transfusion in cardiac surgery: a biphasic correlation.
Topics: Aged; Cardiac Surgical Procedures; Coronary Disease; Erythrocyte Transfusion; Female; Fibrinogen; Humans; Male; Middle Aged; Postoperative Hemorrhage; Retrospective Studies | 2020 |
Using Coexpression Protein Interaction Network Analysis to Identify Mechanisms of Danshensu Affecting Patients with Coronary Heart Disease.
Topics: Coronary Disease; Cyclooxygenase 2; Drugs, Chinese Herbal; Fibrinogen; Gene Ontology; Gene Regulatory Networks; Humans; Lactates; Peptide Fragments; Protein Interaction Maps; Salvia miltiorrhiza; Scavenger Receptors, Class E; Sodium-Hydrogen Exchanger 3; Transcriptome | 2017 |
Detecting small-study effects and funnel plot asymmetry in meta-analysis of survival data: A comparison of new and existing tests.
Topics: Algorithms; Computer Simulation; Coronary Disease; Fibrinogen; Humans; Meta-Analysis as Topic; Models, Statistical; Odds Ratio; Patient Dropouts; Patient Participation; Proportional Hazards Models; Publication Bias; Randomized Controlled Trials as Topic; Reproducibility of Results; Research Design; Risk; Sample Size; Survival Analysis; Treatment Outcome | 2018 |
Ideal Cardiovascular Health and Incident Cardiovascular Disease: Heterogeneity Across Event Subtypes and Mediating Effect of Blood Biomarkers: The PRIME Study.
Topics: Biomarkers; C-Reactive Protein; Case-Control Studies; Chi-Square Distribution; Coronary Disease; Fibrinogen; Follow-Up Studies; France; Health Status; Hemostasis; Humans; Incidence; Inflammation Mediators; Interleukin-6; Male; Middle Aged; Multivariate Analysis; Northern Ireland; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke; Time Factors | 2017 |
Mendelian randomization evaluation of causal effects of fibrinogen on incident coronary heart disease.
Topics: Alleles; Coronary Disease; Fibrinogen; Genetic Pleiotropy; Genetic Variation; Genome-Wide Association Study; Humans; Incidence; Mendelian Randomization Analysis; Models, Genetic; Multivariate Analysis; Myocardial Infarction; Odds Ratio | 2019 |
Exploring causal associations between alcohol and coronary heart disease risk factors: findings from a Mendelian randomization study in the Copenhagen General Population Study.
Topics: Alcohol Dehydrogenase; Alcohol Drinking; Blood Glucose; Blood Pressure; Body Mass Index; Cohort Studies; Coronary Disease; Denmark; Female; Fibrinogen; Genotype; Humans; Lipids; Male; Middle Aged; Risk Factors | 2013 |
[Correlation between lipoprotein(a) and fibrinogen in elderly patients with coronary heart disease].
Topics: Aged; Aged, 80 and over; Case-Control Studies; Coronary Disease; Female; Fibrinogen; Humans; Lipoprotein(a); Logistic Models; Male; Risk Factors | 2013 |
Gender differences in the prospective associations of self-reported sleep quality with biomarkers of systemic inflammation and coagulation: findings from the Heart and Soul Study.
Topics: Aged; Biomarkers; C-Reactive Protein; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Hospitals, Veterans; Humans; Inflammation; Interleukin-6; Longitudinal Studies; Male; Middle Aged; Retrospective Studies; Self Report; Sex Characteristics; Sleep Wake Disorders | 2013 |
Alcohol drinking patterns and biomarkers of coronary risk in the Spanish population.
Topics: Adult; Aged; Alcohol Drinking; Alcoholic Intoxication; Biomarkers; Blood Glucose; Cholesterol, HDL; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Glycated Hemoglobin; Homeostasis; Humans; Insulin Resistance; Leptin; Linear Models; Male; Middle Aged; Risk Factors; Spain; Young Adult | 2014 |
Effects of long-term developmental patterns of adiposity on levels of C-reactive protein and fibrinogen among North-American men and women: the Spokane Heart Study.
Topics: Adiposity; Adult; Biomarkers; Body Mass Index; Body Weight; C-Reactive Protein; Coronary Disease; Female; Fibrinogen; Humans; Inflammation; Linear Models; Longitudinal Studies; Male; Middle Aged; Obesity; Risk Factors; Washington | 2014 |
Effect of physical activity level on biomarkers of inflammation and insulin resistance over 5 years in outpatients with coronary heart disease (from the Heart and Soul Study).
Topics: Aged; Biomarkers; C-Reactive Protein; California; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Humans; Incidence; Inflammation; Insulin; Insulin Resistance; Interleukin-6; Male; Middle Aged; Motor Activity; Outpatients; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Factors; Time Factors | 2014 |
Mediators of the effect of body mass index on coronary heart disease: decomposing direct and indirect effects.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Body Mass Index; C-Reactive Protein; Cholesterol; Coronary Disease; Effect Modifier, Epidemiologic; Female; Fibrinogen; Follow-Up Studies; Humans; Hypertension; Linear Models; Male; Middle Aged; Obesity; Overweight; Risk Factors | 2015 |
Commentary: beyond vague causal effect estimation of obesity on health outcomes.
Topics: Blood Glucose; Body Mass Index; C-Reactive Protein; Cholesterol; Coronary Disease; Female; Fibrinogen; Humans; Hypertension; Male | 2015 |
Analysis of the role of interleukin 6 receptor haplotypes in the regulation of circulating levels of inflammatory biomarkers and risk of coronary heart disease.
Topics: Aged; Biomarkers; C-Reactive Protein; Case-Control Studies; Coronary Disease; Female; Fibrinogen; Haplotypes; Humans; Interleukin-8; Male; Middle Aged; Polymorphism, Single Nucleotide; Receptors, Interleukin-6; Tumor Necrosis Factor-alpha | 2015 |
Role of Endogenous Factors in Response of Erythrocyte Membrane in Patients with Cardiovascular Diseases under Conditions of Ischemic Exposure.
Topics: Adsorption; Adult; Angina, Stable; Arm; Blood Viscosity; Brachial Artery; Constriction; Coronary Disease; Erythrocyte Membrane; Fibrinogen; Hemoglobins; Humans; Ischemia; Lipids; Male; Malondialdehyde; Middle Aged; Nucleotides; Plasminogen; Platelet Adhesiveness; von Willebrand Factor | 2015 |
Inflammation and hemostasis in atrial fibrillation and coronary heart disease: The REasons for Geographic And Racial Differences in Stroke study.
Topics: Aged; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Coronary Disease; Ethnicity; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Geography; Hemostasis; Humans; Inflammation; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke | 2015 |
Hemorheological and Glycemic Parameters and HDL Cholesterol for the Prediction of Cardiovascular Events.
Topics: Aged; Biomarkers; Blood Glucose; Blood Sedimentation; Cardiovascular Diseases; Cholesterol, HDL; Coronary Disease; Female; Fibrinogen; Glycated Hemoglobin; Glycemic Index; Hemorheology; Humans; Male; Middle Aged; Outpatients; Predictive Value of Tests; Reproducibility of Results; Risk Factors; Statistics, Nonparametric | 2016 |
Correlation between the plasma fibrinogen concentration and coronary heart disease severity in Moroccan patients with type 2 diabetes. Prospective study.
Topics: Aged; Aged, 80 and over; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Male; Middle Aged; Morocco; Prospective Studies; Risk Factors; Severity of Illness Index | 2016 |
A graphical model approach to systematically missing data in meta-analysis of observational studies.
Topics: Asthma; Bias; Carotid Intima-Media Thickness; Coronary Disease; Depression; Fibrinogen; Humans; Meta-Analysis as Topic; Multivariate Analysis; Odds Ratio; Risk Assessment; Risk Factors | 2016 |
Association of major depressive disorder with serum myeloperoxidase and other markers of inflammation: a twin study.
Topics: Biomarkers; C-Reactive Protein; Coronary Disease; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Fibrinogen; Granulocyte Colony-Stimulating Factor; Humans; Inflammation; Interleukin-3; Interleukin-6; Leukocytes; Male; Middle Aged; Peroxidase; Prospective Studies; Recombinant Fusion Proteins; Recombinant Proteins; Risk Factors; Tumor Necrosis Factor-alpha; Twins | 2008 |
[Correlation between levels of fibrinogen, beta455 g/A fibrinogen gene polymorphism and chronic periodontitis].
Topics: Adult; Alleles; Case-Control Studies; Chronic Periodontitis; Coronary Disease; Female; Fibrinogen; Genotype; Humans; Male; Middle Aged; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length | 2008 |
Association of Interleukin-1 gene polymorphisms with central obesity and metabolic syndrome in a coronary heart disease population.
Topics: Adult; Alleles; Body Mass Index; Coronary Disease; Female; Fibrinogen; Genotype; Humans; Inflammation; Interleukin-1; Male; Metabolic Syndrome; Middle Aged; Obesity; Polymorphism, Single Nucleotide | 2008 |
Plasma phospholipid fatty acids and CHD in older men: Whitehall study of London civil servants.
Topics: Aged; Apolipoproteins B; Biomarkers; C-Reactive Protein; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Fatty Acids; Fatty Acids, Monounsaturated; Fatty Acids, Unsaturated; Fibrinogen; Follow-Up Studies; Health Surveys; Humans; London; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Phospholipids; Risk; Trans Fatty Acids | 2009 |
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies.
Topics: Cohort Studies; Computer Simulation; Coronary Disease; Data Interpretation, Statistical; Female; Fibrinogen; Humans; Male; Meta-Analysis as Topic; Models, Statistical | 2009 |
Inflammatory biomarkers, physical activity, waist circumference, and risk of future coronary heart disease in healthy men and women.
Topics: Adiponectin; Aged; Biomarkers; C-Reactive Protein; Case-Control Studies; Coronary Disease; Early Diagnosis; Exercise; Female; Fibrinogen; Humans; Male; Middle Aged; Obesity, Abdominal; Peroxidase; Phospholipases A2; Prospective Studies; Risk Factors; Waist Circumference | 2011 |
Kinetics and prognostic value of inflammatory-sensitive protein, IL-6, and white blood cell levels in patients undergoing coronary stent implantation.
Topics: Aged; Angioplasty; C-Reactive Protein; Coronary Disease; Female; Fibrinogen; Humans; Interleukin-6; Kinetics; Leukocyte Count; Male; Middle Aged; Prognosis; Prospective Studies; Stents | 2009 |
Integrated associations of genotypes with multiple blood biomarkers linked to coronary heart disease risk.
Topics: Apolipoprotein A-I; Apolipoproteins; Biomarkers; Blood Chemical Analysis; C-Reactive Protein; Cholesterol; Coronary Disease; Fibrinogen; Humans; Lipoprotein Lipase; Male; Middle Aged; Polymorphism, Single Nucleotide; Prospective Studies; Risk Factors; Triglycerides | 2009 |
G-455A polymorphism of beta-fibrinogen gene and the risk of premature myocardial infarction in Greece.
Topics: Adult; Age of Onset; Alleles; Coronary Disease; Female; Fibrinogen; Genotype; Greece; Humans; Male; Myocardial Infarction; Odds Ratio; Polymerase Chain Reaction; Polymorphism, Genetic; Risk; Risk Factors | 2010 |
Non-surgical periodontal therapy lowers serum inflammatory markers: a pilot study.
Topics: Acute-Phase Proteins; Adult; Biomarkers; C-Reactive Protein; Coronary Angiography; Coronary Disease; Dental Prophylaxis; Dental Scaling; Female; Fibrinogen; Follow-Up Studies; Gingival Hemorrhage; Humans; Hypertension; Leukocyte Count; Male; Middle Aged; Oral Hygiene; Periodontal Diseases; Periodontal Index; Periodontal Pocket; Pilot Projects; Risk Factors; Root Planing; Social Class; Subgingival Curettage | 2009 |
Hemostasis, inflammation, and fatal and nonfatal coronary heart disease: long-term follow-up of the atherosclerosis risk in communities (ARIC) cohort.
Topics: Aged; Atherosclerosis; Biomarkers; Cohort Studies; Coronary Disease; Death, Sudden, Cardiac; Factor VIII; Female; Fibrinogen; Follow-Up Studies; Hemostasis; Humans; Inflammation; Kaplan-Meier Estimate; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Risk Factors; Serum Albumin; Smoking; United States; von Willebrand Factor | 2009 |
Study on the changes of thrombosis-associated factors in patients with coronary heart disease of turbidity-phlegm blocking syndrome.
Topics: Case-Control Studies; Coronary Disease; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Thrombosis; von Willebrand Factor | 2009 |
Leukocyte count is associated with incidence of coronary events, but not with stroke: a prospective cohort study.
Topics: Adult; Cardiovascular Diseases; Coronary Disease; Female; Fibrinogen; Humans; Incidence; Leukocyte Count; Male; Middle Aged; Prospective Studies; Risk Factors; Sex Factors; Smoking; Stroke; Sweden | 2010 |
The associations of interleukin-6 (IL-6) and downstream inflammatory markers with risk of cardiovascular disease: the Caerphilly Study.
Topics: alpha-Macroglobulins; Biomarkers; Blood Viscosity; C-Reactive Protein; Coronary Disease; Fibrinogen; Humans; Inflammation; Interleukin-6; Leukocyte Count; Male; Middle Aged; Prospective Studies; Risk Factors; Smoking; Stroke; United Kingdom | 2010 |
Air temperature and inflammatory and coagulation responses in men with coronary or pulmonary disease during the winter season.
Topics: Aged; Biomarkers; Blood Coagulation; C-Reactive Protein; Coronary Disease; Diabetes Mellitus, Type 2; Fibrinogen; Germany; Health Status Indicators; Humans; Lung Diseases; Male; Middle Aged; Risk Factors; Seasons; Temperature | 2010 |
Homocysteine, fibrinogen and anti-ox-LDL antibody levels as markers of atherosclerosis in prepubertal obese children.
Topics: Atherosclerosis; Autoantibodies; Biomarkers; Child; Coronary Disease; Female; Fibrinogen; Glycated Hemoglobin; Homocysteine; Humans; Lipoproteins, LDL; Male; Obesity | 2009 |
Association between fibrinogen plasma levels and platelet counts in an outpatient population and in patients with coronary heart disease.
Topics: Adolescent; Adult; Age Factors; Coronary Disease; Female; Fibrinogen; Humans; Leukocyte Count; Male; Middle Aged; Platelet Count; Young Adult | 2010 |
Associations of toenail selenium levels with inflammatory biomarkers of fibrinogen, high-sensitivity c-reactive protein, and interleukin-6: The CARDIA Trace Element Study.
Topics: Adult; Biomarkers; C-Reactive Protein; Coronary Disease; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Logistic Models; Male; Multivariate Analysis; Nails; Prospective Studies; Selenium; Trace Elements; United States | 2010 |
Insulin resistance and acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Blood Pressure; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Female; Fibrinogen; Humans; Inflammation; Insulin Resistance; Male; Middle Aged; Obesity | 2010 |
C-reactive protein, interleukin 6, fibrinogen and risk of sudden death in European middle-aged men: the PRIME study.
Topics: Biomarkers; C-Reactive Protein; Case-Control Studies; Cohort Studies; Coronary Disease; Death, Sudden, Cardiac; Europe; Fibrinogen; Humans; Inflammation Mediators; Interleukin-6; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Factors | 2010 |
Commentary: like it and lump it? Meta-analysis using individual participant data.
Topics: Coronary Disease; Data Interpretation, Statistical; Fibrinogen; Humans; Meta-Analysis as Topic; Proportional Hazards Models; Risk Factors | 2010 |
Heart rate variability and biomarkers of systemic inflammation in patients with stable coronary heart disease: findings from the Heart and Soul Study.
Topics: Aged; Autonomic Nervous System; Biomarkers; C-Reactive Protein; Cohort Studies; Coronary Disease; Female; Fibrinogen; Heart Rate; Humans; Inflammation Mediators; Interleukin-6; Male; Middle Aged; Prospective Studies | 2011 |
Fibrinogen and associated risk factors in a high-risk population: urban Indigenous Australians, the DRUID Study.
Topics: Adolescent; Adult; Age Distribution; Age Factors; Aged; Alcohol Drinking; Biomarkers; Blood Pressure; Body Mass Index; C-Reactive Protein; Cohort Studies; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Glycated Hemoglobin; Heart Rate; Humans; Lipids; Male; Middle Aged; Northern Territory; Population Groups; Principal Component Analysis; Regression Analysis; Risk Assessment; Risk Factors; Sex Distribution; Sex Factors; Smoking; Up-Regulation; Urban Population; Waist Circumference; Waist-Hip Ratio; Young Adult | 2010 |
Mendelian randomisation: a tool for assessing causality in observational epidemiology.
Topics: Alcohol Drinking; Blood Pressure; Causality; Coronary Disease; Fibrinogen; Homocysteine; Humans; Mendelian Randomization Analysis; Molecular Epidemiology; Stroke | 2011 |
What is the role of alternative biomarkers for coronary heart disease?
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Biomarkers; C-Reactive Protein; Coronary Disease; Fibrinogen; Homocysteine; Humans; Lipoprotein(a); Predictive Value of Tests; Prognosis; Risk Assessment; Risk Factors | 2011 |
The effects of Buyang Huanwu Decoction on hemorheological disorders and energy metabolism in rats with coronary heart disease.
Topics: Animals; Biomarkers; Blood Glucose; Blood Viscosity; Body Weight; Cardiovascular Agents; Coronary Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Energy Metabolism; Female; Fibrinogen; Hemorheology; Male; Myocardium; Physical Endurance; Platelet Aggregation; Qi; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase; Swimming; Time Factors; Tongue | 2011 |
Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independent of coronary heart disease risk factors: a PreCIS database study.
Topics: Adult; Aged; Blood Pressure; Cohort Studies; Coronary Disease; Databases, Factual; Female; Fibrinogen; Humans; Hypothyroidism; Male; Middle Aged; Retrospective Studies; Risk Factors; Systole; Thyrotropin; Triglycerides | 2011 |
Atherothrombotic risk factors & premature coronary heart disease in India: a case-control study.
Topics: Adult; Atherosclerosis; Blood Pressure; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Eating; Female; Fibrinogen; Homocysteine; Humans; India; Logistic Models; Male; Middle Aged; Platelet Count; Risk Factors; Smoking; Thrombosis; Triglycerides | 2011 |
Missing data methods in Mendelian randomization studies with multiple instruments.
Topics: Bayes Theorem; C-Reactive Protein; Coronary Disease; Female; Fibrinogen; Genetic Association Studies; Haplotypes; Humans; Mendelian Randomization Analysis; Models, Genetic; Multivariate Analysis | 2011 |
The Northwick Park Heart Studies: contrasts between the two factor VII assays used.
Topics: Antigens; Coronary Disease; Female; Fibrinogen; Hemostasis; Humans; Male | 2012 |
Quantitative determination of fibrinogen of patients with coronary heart diseases through piezoelectric agglutination sensor.
Topics: Agglutination Tests; Biosensing Techniques; Coronary Disease; Female; Fibrinogen; Humans; Linear Models; Male; Middle Aged; Quartz | 2010 |
A genetic instrument for Mendelian randomization of fibrinogen.
Topics: Alleles; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Gene Frequency; Genetic Predisposition to Disease; Humans; Male; Mendelian Randomization Analysis; Middle Aged; Multigene Family; Polymorphism, Single Nucleotide; Prospective Studies; Survival Analysis; United Kingdom | 2012 |
[Study on the correlation between Chinese medicine syndrome types of the Uighur and Han people and levels of blood lipids and fibrinogen in premature coronary heart disease patients].
Topics: Aged; Asian People; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Female; Fibrinogen; Humans; Male; Medicine, Chinese Traditional; Middle Aged; Triglycerides | 2012 |
Prognostic markers in young patients with premature coronary heart disease.
Topics: Adult; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Prognosis; Recurrence; Regression Analysis; Risk Factors; Survival Analysis; von Willebrand Factor | 2012 |
Vessel wall--where coagulation meets cell biology and immunology.
Topics: Biomarkers; Blood Coagulation; C-Reactive Protein; Cerebrovascular Disorders; Chemokine CX3CL1; Coronary Disease; Endothelium, Vascular; Fibrinogen; Humans; Inflammation; Thrombophilia; Vasculitis | 2012 |
Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: the Tromsø study.
Topics: Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Coronary Disease; Electrocardiography; Female; Fibrinogen; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Multivariate Analysis; Norway; Osteoprotegerin; Proportional Hazards Models; Prospective Studies; Risk Factors; Sex Factors | 2012 |
Fibrinogen may mediate the association between long sleep duration and coronary heart disease.
Topics: Aged; Coronary Disease; Fibrinogen; Humans; Longitudinal Studies; Middle Aged; Odds Ratio; Postmenopause; Sleep; Time Factors; United States | 2013 |
[Inflammatory and fibrinolytic activation after coronary artery bypass with extracorporeal circulation].
Topics: Aged; Biomarkers; C-Reactive Protein; Coronary Artery Bypass; Coronary Disease; Coronary Vessels; Extracorporeal Circulation; Female; Fibrinogen; Fibrinolysis; Humans; Inflammation; Interleukin-6; Leukocyte Count; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Platelet Count; Prospective Studies; Prothrombin Time; Time Factors | 2002 |
Relationship of tissue plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen with coronary artery disease in South Indian male subjects.
Topics: Analysis of Variance; Coronary Disease; Developing Countries; Fibrinogen; Humans; India; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Risk Factors; Tissue Plasminogen Activator | 2002 |
Obesity, coronary heart disease risk factors and diabetes in Chinese: an approach to the criteria of obesity in the Chinese population.
Topics: Adult; Aged; Anthropometry; Asian People; Blood Glucose; Blood Pressure; China; Cholesterol, HDL; Coronary Disease; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hypertension; Hypertriglyceridemia; Male; Middle Aged; Obesity; Prevalence; Prospective Studies; Risk Factors; Sex Distribution; Triglycerides | 2002 |
Fibrinogen--the key to familial CHD or just another shadow in Plato's allegory?
Topics: Biomarkers; Coronary Disease; Fibrinogen; Genetic Predisposition to Disease; Humans; Prognosis; Risk Factors | 2002 |
Elevated fibrinogen in the healthy male relatives of patients with severe, premature coronary artery disease.
Topics: Adolescent; Adult; Age of Onset; Aged; Case-Control Studies; Coronary Disease; Factor VII; Fibrinogen; Genetic Predisposition to Disease; Humans; Linear Models; Male; Middle Aged; Risk Factors; von Willebrand Factor | 2002 |
Job strain and major risk factors for coronary heart disease among employed males and females in a Swedish study on work, lipids and fibrinogen.
Topics: Adolescent; Adult; Cholesterol; Coronary Disease; Cross-Sectional Studies; Employment; Female; Fibrinogen; Humans; Hypertension; Job Satisfaction; Male; Middle Aged; Occupational Health; Risk Factors; Stress, Psychological; Surveys and Questionnaires; Sweden | 2002 |
Soluble intercellular adhesion molecule-1 and risk of future ischemic stroke: a nested case-control study from the Bezafibrate Infarction Prevention (BIP) study cohort.
Topics: Bezafibrate; Biomarkers; Brain Ischemia; Case-Control Studies; Chronic Disease; Cohort Studies; Comorbidity; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Humans; Hypolipidemic Agents; Intercellular Adhesion Molecule-1; Israel; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Risk Factors; Stroke | 2002 |
Changes of coronary risk factors after eradication of Helicobacter pylori infection.
Topics: Adult; Aged; Arteriosclerosis; Blood Glucose; Coronary Disease; Female; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Humans; Lipids; Male; Middle Aged; Risk Factors | 2002 |
Job conditions and fibrinogen in 14226 Belgian workers: the Belstress study.
Topics: Adult; Alcohol Drinking; Belgium; Biomarkers; Cholesterol, HDL; Coronary Disease; Cross-Sectional Studies; Employment; Female; Fibrinogen; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Occupational Diseases; Prospective Studies; Sex Factors; Social Support; Stress, Psychological | 2002 |
Risk factors for coronary heart disease in 55- and 35-year-old men and women in Sweden and Estonia.
Topics: Adult; Blood Glucose; Cohort Studies; Coronary Disease; Estonia; Female; Fibrinogen; Humans; Life Style; Lipoproteins; Longitudinal Studies; Male; Mass Screening; Middle Aged; Prevalence; Random Allocation; Residence Characteristics; Risk Factors; Sensitivity and Specificity; Smoking; Sweden | 2002 |
Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France and Northern Ireland. The PRIME study.
Topics: Coronary Disease; Factor VII; Fibrinogen; Follow-Up Studies; France; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Northern Ireland; Prospective Studies; Risk Factors | 2003 |
Fibrinogen: intra-individual variability in patients with arterial disease and in patients with cardiac valve replacements.
Topics: Analysis of Variance; Coronary Disease; Fibrinogen; Heart Valve Prosthesis; Humans; Prospective Studies | 2002 |
Drink to your health?
Topics: Alcohol Drinking; Beer; Blood Coagulation; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Ethanol; Fibrinogen; Health Promotion; Humans; Insulin Resistance; Wine | 2003 |
[Increased sP-selectin and other cardiovascular risk factors: fibrinogen, tissue plasminogen activator (t-PA Ag) and acute phase proteins after kidney transplantation].
Topics: Acute-Phase Proteins; Coronary Disease; Female; Fibrinogen; Humans; Kidney Transplantation; Male; Middle Aged; P-Selectin; Plasminogen Activator Inhibitor 1; Risk Factors; Tissue Plasminogen Activator | 2002 |
[Aspirin and inflammatory markers in patients with coronary disease].
Topics: Aspirin; Biomarkers; C-Reactive Protein; Coronary Disease; Fibrinogen; Humans; Platelet Aggregation Inhibitors | 2003 |
[Hemostatic coronary risk factors in a healthy population of Maracaibo, Venezuela].
Topics: Adult; Aged; Collagen; Coronary Disease; Female; Fibrinogen; Hemostasis; Hemostatic Disorders; Humans; Male; Middle Aged; Platelet Aggregation; Risk Factors; Ristocetin; Venezuela; von Willebrand Factor | 2003 |
Effects of fibrinogen on lipid peroxidation in patients with coronary heart disease and in vitro.
Topics: Coronary Disease; Fibrinogen; Humans; Lipid Peroxidation; Lipid Peroxides; Oxidative Stress | 2003 |
Comparative effects of diet and simvastatin on markers of thrombogenicity in patients with coronary artery disease.
Topics: Anticholesteremic Agents; Antineoplastic Agents; Apolipoproteins; Biomarkers; C-Reactive Protein; Coronary Disease; Female; Fibrinogen; Hemostatics; Humans; Hyperlipidemias; Lipoproteins; Male; Matrix Metalloproteinase 9; Middle Aged; Placebo Effect; Protease Inhibitors; Simvastatin; Thromboplastin; Thrombosis; Tissue Inhibitor of Metalloproteinase-1; Tumor Necrosis Factor-alpha | 2003 |
Importance of LDL/HDL cholesterol ratio as a predictor for coronary heart disease events in patients with heterozygous familial hypercholesterolaemia: a 15-year follow-up (1987-2002).
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Humans; Hyperlipoproteinemia Type II; Hypertension; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Factors; Smoking | 2003 |
C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study.
Topics: Angina Pectoris; Biomarkers; C-Reactive Protein; Cohort Studies; Coronary Disease; Death, Sudden, Cardiac; Fibrinogen; France; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Myocardial Infarction; Northern Ireland; Prospective Studies; Risk Factors; Statistics, Nonparametric | 2003 |
Increased Interleukin-6 levels in pituitary-deficient patients are independently related to their carotid intima-media thickness.
Topics: Autoantigens; C-Reactive Protein; Carotid Arteries; Case-Control Studies; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Growth Hormone; Humans; Hypopituitarism; Interleukin-6; Male; Middle Aged; Multivariate Analysis; Plasminogen Activator Inhibitor 1; Risk Factors; Tissue Plasminogen Activator; Tunica Intima; Ultrasonography | 2003 |
Platelets' glycoproteins and their ligands in patients with intermittent claudication.
Topics: Adult; Aged; Biomarkers; Coronary Disease; Female; Fibrinogen; Humans; Intermittent Claudication; Ligands; Male; Middle Aged; Platelet Membrane Glycoproteins; Smoking; Statistics as Topic; Triglycerides; Uric Acid; von Willebrand Factor | 2003 |
A genome-wide search for genes affecting circulating fibrinogen levels in the Framingham Heart Study.
Topics: Adult; Arteriosclerosis; Chromosomes, Human, Pair 10; Chromosomes, Human, Pair 2; Chromosomes, Human, Pair 7; Cohort Studies; Coronary Disease; Diabetes Mellitus; Family Health; Female; Fibrinogen; Genetic Predisposition to Disease; Genome, Human; Genotype; Humans; Hypertension; Lod Score; Male; Middle Aged; Obesity; Polymorphism, Restriction Fragment Length; Risk Factors | 2003 |
A twin study of C-Reactive Protein compared to other risk factors for coronary heart disease.
Topics: Adult; Blood Pressure; Body Mass Index; C-Reactive Protein; Cholesterol, HDL; Coronary Disease; Female; Fibrinogen; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Triglycerides; Twins, Monozygotic | 2003 |
Soluble intercellular adhesion molecule 1 and flow-mediated dilatation are related to the estimated risk of coronary heart disease independently from each other.
Topics: Adolescent; Adult; Aged; Biomarkers; Blood Glucose; Blood Pressure; C-Reactive Protein; Cholesterol, LDL; Coronary Circulation; Coronary Disease; Diastole; Dilatation, Pathologic; Female; Fibrinogen; Humans; Intercellular Adhesion Molecule-1; Leukocyte Count; Male; Middle Aged; Netherlands; Risk Factors; Sex Factors; Smoking; Solubility; Statistics as Topic; Systole; Triglycerides; Vasodilation | 2003 |
Observations on the plasma fibrinogen content after myocardial infarction.
Topics: Coronary Disease; Fibrin; Fibrinogen; Humans; Myocardial Infarction; Plasma | 1952 |
[Plasma fibrinogen in acute coronary syndromes].
Topics: Acute Coronary Syndrome; Coronary Disease; Fibrinogen; Heart; Hematologic Diseases; Humans | 1957 |
Differences in cardiovascular disease risk factors between Japanese in Japan and Japanese-Americans in Hawaii: the INTERLIPID study.
Topics: Adult; Alcohol Drinking; Antihypertensive Agents; Asian; Asian People; Biomarkers; Blood Pressure; Body Mass Index; Coronary Disease; Diastole; Dietary Fats; Electrolytes; Female; Fibrinogen; Glycated Hemoglobin; Hawaii; Humans; Hypertension; Japan; Male; Middle Aged; Risk Factors; Smoking; Systole | 2003 |
[Changes of fibrinogenemia in myocardial infarct and coronary insufficiency].
Topics: Coronary Artery Disease; Coronary Disease; Fibrinogen; Hematologic Diseases; Humans; Myocardial Infarction | 1961 |
[Studies on fibrinolytic activity and fibrinogen in the blood in atherosclerosis of the coronary vessels, myocardial infarction and during seizures of stenocardia].
Topics: Angina Pectoris; Atherosclerosis; Coronary Disease; Coronary Vessels; Fibrinogen; Fibrinolysis; Humans; Myocardial Infarction; Seizures | 1961 |
[Electropherograms of the blood serum in combination with fibrinogen and amino acids in patients with chronic coronary insufficiency].
Topics: Amino Acids; Blood Protein Electrophoresis; Coagulants; Coronary Disease; Fibrinogen; Humans; Hypertension; Serum | 1963 |
[THE IMPORTANCE OF INDICES OF PROTEIN AND LIPID METABOLISM FOR THE DIFFERENTIAL DIAGNOSIS OF VARIOUS FORMS OF CORONARY INSUFFICIENCY].
Topics: Angina Pectoris; Blood Protein Electrophoresis; Cholesterol; Coronary Disease; Diagnosis, Differential; Fibrinogen; Glycoproteins; Humans; Lipid Metabolism; Lipids; Lipoproteins; Myocardial Infarction; Phospholipids | 1963 |
[THE USE OF HYDROXYCHLOROQUINE IN THE TREATMENT OF VASCULAR DISEASES].
Topics: Arteriosclerosis; Arteritis; Blood Proteins; Cholesterol; Coronary Disease; Fibrinogen; Humans; Hydroxychloroquine; Intracranial Embolism; Intracranial Embolism and Thrombosis; Lipoproteins; Thrombophlebitis; Thrombosis | 1963 |
PLASMA-FIBRINOGEN LEVELS IN CORONARY-ARTERY DISEASE.
Topics: Angina Pectoris; Anticoagulants; Arteries; Blood Coagulation Tests; Coronary Disease; Fibrinogen; Humans; Myocardial Infarction; Pulmonary Edema; Pulmonary Embolism; Thrombophlebitis | 1963 |
[COAGULATION AND ANTICOAGULATION FACTORS IN THE BLOOD AND THEIR ALTERATION IN DISORDERS OF CORONARY CIRCULATION].
Topics: Angina Pectoris; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Coronary Circulation; Coronary Disease; Fibrinogen; Fibrinolysin; Heparin; Humans; Myocardial Infarction; Niacin; Statistics as Topic | 1963 |
[COAGULATION AND ANTICOAGULATION SYSTEM OF THE BLOOD AND ITS REACTION TO CORONARY CIRCULATION DISORDERS].
Topics: Angina Pectoris; Anticoagulants; Blood Coagulation Disorders; Blood Coagulation Tests; Coronary Circulation; Coronary Disease; Drug Therapy; Factor VII; Fibrinogen; Fibrinolysis; Heparin; Myocardial Infarction; Niacin; Prothrombin Time; Toxicology | 1964 |
[DIAGNOSTIC VALUE OF EXAMINING THE ENZYME SYSTEMS AND BLOOD PROTEINS IN PATIENTS WITH CHRONIC CORONARY INSUFFICIENCY].
Topics: Aldehyde-Lyases; Aspartate Aminotransferases; Blood Proteins; Coagulants; Colorimetry; Coronary Disease; Fibrinogen; Geriatrics | 1963 |
TURNOVER AND DISTRIBUTION OF 131-IODINE-LABELLED HUMAN FIBRINOGEN.
Topics: Arteriosclerosis; Blood Coagulation Tests; Coronary Disease; Diabetes Mellitus; Fibrinogen; Geriatrics; Humans; Intervertebral Disc Displacement; Iodine; Iodine Isotopes; Liver Cirrhosis; Lung Neoplasms; Metabolism; Radiometry; Thrombophlebitis; Thrombosis | 1964 |
FIBRINOLYTIC ACTIVITY IN DIABETES MELLITUS.
Topics: Cholesterol; Coronary Disease; Diabetes Mellitus; Diabetic Angiopathies; Fibrinogen; Fibrinolysis; Humans; Thrombolytic Therapy | 1964 |
THROMBOCYTOPENIA SECONDARY TO INTRAVASCULAR THROMBOSIS.
Topics: Blood Platelets; Coronary Disease; Drug Therapy; Fibrinogen; Heparin; Humans; Megakaryocytes; Pathology; Thrombocytopenia; Thrombophlebitis | 1964 |
[DIAGNOSTIC VALUE OF THE DETERMINATION OF BLOOD FIBRINOGEN IN MYOCARDIAL INFARCTION AND ARTERIAL THROMBOSIS].
Topics: Cardiovascular Diseases; Coronary Disease; Fibrinogen; Humans; Myocardial Infarction; Thrombosis | 1964 |
RELATIONSHIP BETWEEN THE BLOOD LEVELS OF CHOLESTEROL, MUCOPROTEINS, AND FIBRINOGEN IN ISCHAEMIC HEART DISEASE.
Topics: Blood; Cholesterol; Coronary Artery Disease; Coronary Disease; Fibrinogen; Humans; Male; Middle Aged; Mucoproteins; Myocardial Ischemia | 1965 |
FIBRINOLYTIC EFFECT OF METFORMIN IN CORONARY-ARTERY DISEASE.
Topics: Arteries; Biomedical Research; Blood Coagulation Tests; Cholesterol; Coronary Artery Disease; Coronary Disease; Fibrinogen; Fibrinolysis; Humans; Intermittent Claudication; Metformin; Middle Aged; Placebos; Thrombolytic Therapy | 1965 |
THE EFFECT OF ATROMID AND ATROMID-S ON PLASMA FIBRINOGEN AND PLASMINOGEN LEVELS.
Topics: Androsterone; Anticholesteremic Agents; Biomedical Research; Butyrates; Clofibrate; Coronary Disease; Drug Therapy; Fibrinogen; Hemostatics; Humans; Hypercholesterolemia; Pharmacology; Plasma; Plasminogen | 1965 |
[Study of the behavior of C-reactive protein and fibrinogen in coronary diseases].
Topics: C-Reactive Protein; Coronary Disease; Eubacterium; Fibrinogen; Heart; Hematologic Diseases; Hemostatics; Humans | 1960 |
The role of inflammation markers in triggering acute coronary events.
Topics: Acute Disease; Acute-Phase Proteins; Acute-Phase Reaction; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Biomarkers; C-Reactive Protein; Coronary Disease; Cytokines; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Patient Selection; Prospective Studies | 2003 |
Preprocedural serum levels of acute-phase reactants and prognosis after percutaneous coronary intervention.
Topics: Acute-Phase Proteins; Aged; Angioplasty, Balloon, Coronary; Biomarkers; C-Reactive Protein; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Humans; Interleukin-6; Lipoprotein(a); Male; Middle Aged; Prognosis; Recurrence; Stents; Survival Rate | 2003 |
Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME).
Topics: Biomarkers; C-Reactive Protein; Case-Control Studies; Cohort Studies; Coronary Disease; Fibrinogen; France; Humans; Incidence; Interleukin-18; Interleukin-6; Male; Middle Aged; Northern Ireland; Odds Ratio; Predictive Value of Tests; Prospective Studies; Risk Assessment; Risk Factors | 2003 |
[Relationship between Chlamydia pneumoniae and classical risk factors of coronary heart disease].
Topics: Adult; Age Factors; Aged; Antibodies, Bacterial; Chlamydophila Infections; Chlamydophila pneumoniae; Cholesterol; Coronary Disease; Data Interpretation, Statistical; Female; Fibrinogen; Humans; Hypercholesterolemia; Immunoenzyme Techniques; Immunoglobulin A; Male; Middle Aged; Risk Factors; Smoking | 2003 |
Dental infections and serum inflammatory markers in patients with and without severe heart disease.
Topics: Antibodies, Bacterial; Biomarkers; Blood Sedimentation; C-Reactive Protein; Case-Control Studies; Chlamydia; Confidence Intervals; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Gingivitis; Helicobacter pylori; Humans; Inflammation Mediators; Male; Middle Aged; Mouth, Edentulous; Odds Ratio; Periodontal Diseases; Periodontal Pocket; Tooth Diseases | 2003 |
Plasma circulating fibrinogen stability and moderate beer consumption.
Topics: Adult; Aged; Antioxidants; Beer; Calorimetry, Differential Scanning; Coronary Artery Bypass; Coronary Disease; Drug Stability; Fibrinogen; Humans; Hydrogen Bonding; Lipids; Male; Middle Aged; Protein Denaturation; Spectrometry, Fluorescence; Thermodynamics | 2003 |
The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease.
Topics: Adult; Aged; Apolipoprotein A-I; Apolipoproteins B; C-Reactive Protein; Chronic Disease; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Glomerular Filtration Rate; Homocysteine; Humans; Kidney Diseases; Lipoprotein(a); Male; Middle Aged; Risk Factors | 2004 |
Summaries for patients. Associations of newer cardiac risk factors with chronic kidney disease.
Topics: Adult; Aged; Apolipoprotein A-I; Apolipoproteins B; C-Reactive Protein; Chronic Disease; Coronary Disease; Female; Fibrinogen; Homocysteine; Humans; Kidney Diseases; Lipoprotein(a); Male; Middle Aged; Risk Factors | 2004 |
Fibrinogen, social position, and risk of heart disease.
Topics: Causality; Coronary Disease; Fibrinogen; Humans; Reproducibility of Results; Risk Factors; Social Class | 2004 |
Poor oral health is associated with coronary heart disease and elevated systemic inflammatory and haemostatic factors.
Topics: Adult; Aged; Blood Coagulation Factors; C-Reactive Protein; Case-Control Studies; Cholesterol; Coronary Disease; Fibrinogen; Humans; Inflammation Mediators; Italy; Leukocyte Count; Male; Middle Aged; Peptide Fragments; Periodontal Diseases; Periodontal Index; Prothrombin; Radiography, Panoramic; Statistics, Nonparametric; Tooth Diseases; Triglycerides; von Willebrand Factor | 2004 |
Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Topics: Aged; Biomarkers; Clinical Trials as Topic; Coronary Disease; Cross-Sectional Studies; Endothelium, Vascular; Female; Fibrinogen; Homocysteine; Humans; Hypertension; Male; Middle Aged; Outcome Assessment, Health Care; P-Selectin; Platelet Activation; Risk Factors; Stroke; von Willebrand Factor | 2004 |
Helicobacter pylori infection and the risk for coronary artery disease.
Topics: Adolescent; Adult; Aged; Causality; Coronary Disease; Female; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Risk Factors | 2004 |
Increased plasma homocysteine concentrations in healthy people with hostile behavior: the ATTICA study.
Topics: Adult; Coronary Disease; Feeding Behavior; Female; Fibrinogen; Greece; Homocysteine; Hostility; Humans; Leukocyte Count; Life Style; Male; Middle Aged; Smoking | 2004 |
Plasma fibrinogen levels are associated with a strong family history of myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Apolipoprotein A-I; Case-Control Studies; Comorbidity; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Genetic Predisposition to Disease; Germany; Humans; Male; Middle Aged; Myocardial Infarction; Parents; Risk Factors; Sampling Studies; Siblings | 2004 |
Education, socioeconomic and lifestyle factors, and risk of coronary heart disease: the PRIME Study.
Topics: Alcohol Drinking; Coronary Disease; Educational Status; Fibrinogen; Follow-Up Studies; France; Humans; Hypertension; Male; Middle Aged; Northern Ireland; Risk Factors; Smoking; Socioeconomic Factors; Systole; Unemployment | 2005 |
Fibrinogen, social position, and "Mendelian randomisation".
Topics: Coronary Disease; Fibrinogen; Humans; Risk Factors; Social Class; Socioeconomic Factors | 2004 |
Cross-sectional study of complement C3 as a coronary risk factor among men and women.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cholesterol; Cohort Studies; Complement C3; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Humans; Insulin; Male; Metabolic Syndrome; Middle Aged; Obesity; Odds Ratio; Risk Factors; Smoking; Triglycerides | 2005 |
The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study).
Topics: Aged; Analysis of Variance; Apolipoproteins E; C-Reactive Protein; Coronary Disease; Female; Fibrinogen; Homeostasis; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Odds Ratio; Polymorphism, Genetic; Predictive Value of Tests; Risk Factors | 2004 |
[Association of polymorphic marker G(-455)A of gene FGB with coronary artery disease].
Topics: Alleles; Coronary Disease; Female; Fibrinogen; Genetic Markers; Genetic Predisposition to Disease; Genotype; Humans; Male; Moscow; Myocardial Infarction; Polymorphism, Single Nucleotide | 2004 |
Constituents of red wine other than alcohol improve endothelial function in patients with coronary artery disease.
Topics: Antioxidants; Coronary Disease; Endothelium, Vascular; Ethanol; Fibrinogen; Humans; Lipids; Male; Middle Aged; Postprandial Period; Regional Blood Flow; Vasodilation; Wine | 2004 |
Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: the MONICA Optional Haemostasis Study.
Topics: Biomarkers; Blood Specimen Collection; Coronary Disease; Europe; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Inflammation Mediators; Male; Middle Aged; Risk Factors; Thrombosis; von Willebrand Factor | 2005 |
Migraine and other headaches: associations with Rose angina and coronary heart disease.
Topics: Adult; Aged; Arteriosclerosis; Black or African American; Chest Pain; Cohort Studies; Comorbidity; Coronary Disease; Diabetes Mellitus; Female; Fibrinogen; Headache; Humans; Hypercholesterolemia; Hypertension; Income; Male; Middle Aged; Migraine with Aura; Migraine without Aura; Physical Exertion; Prevalence; Risk Factors; Sex Factors; Surveys and Questionnaires; United States; Vasoconstriction; White People | 2004 |
[The relationship between hyperfibrinogenemia and severity of coronary heart disease].
Topics: Adult; Aged; Aged, 80 and over; Cholesterol; Coronary Angiography; Coronary Disease; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Severity of Illness Index; Triglycerides | 2004 |
Factors related to exercise capacity in asymptomatic middle-aged type 2 diabetic patients.
Topics: Adult; Coronary Disease; Diabetes Mellitus, Type 2; Electrocardiography; Exercise; Exercise Test; Fasting; Female; Fibrinogen; Heart Rate; Homeostasis; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Obesity; Prospective Studies; Sex Characteristics; Smoking | 2005 |
Fibrinogen and other coronary risk factors.
Topics: Adult; Blood Glucose; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Cross-Sectional Studies; Denmark; Female; Fibrinogen; Humans; Lipids; Male; Middle Aged; Myocardial Infarction; Regression Analysis; Risk Factors; Socioeconomic Factors; Triglycerides | 2005 |
Periodontal health improves systemic inflammatory and haemostatic status in subjects with coronary heart disease.
Topics: Adult; Aged; Analysis of Variance; C-Reactive Protein; Coronary Disease; Dental Care; Fibrinogen; Humans; Inflammation; Leukocyte Count; Lipoproteins, LDL; Male; Middle Aged; Oral Health; Periodontal Diseases; von Willebrand Factor | 2005 |
[Relation between diabetes compensation, albuminuria and biochemical parameters and the results of stress myocardial SPECT in asymptomatic type 2 diabetics].
Topics: Albuminuria; C-Reactive Protein; Coronary Circulation; Coronary Disease; Diabetes Mellitus, Type 2; Exercise Test; Female; Fibrinogen; Homocysteine; Humans; Male; Middle Aged; Tomography, Emission-Computed, Single-Photon; Uric Acid | 2004 |
[Ferritin and other acute phase proteins in various forms of coronary heart disease].
Topics: Aged; Angina Pectoris; Angina, Unstable; Biomarkers; C-Reactive Protein; Case-Control Studies; Coronary Disease; Echocardiography; Female; Ferritins; Fibrinogen; Humans; Male; Middle Aged; Myocardial Ischemia; Risk Factors | 2005 |
Lipoprotein (a) and coronary heart disease among women: beyond a cholesterol carrier?
Topics: Adult; Aged; Biomarkers; Body Mass Index; C-Reactive Protein; Cholesterol; Coronary Disease; Epidemiologic Methods; Female; Fibrinogen; Humans; Lipoprotein(a); Middle Aged | 2005 |
Fibrinogen measurement to assess the risk of arterial thrombosis in individual patients: not yet.
Topics: Arteries; Blood Coagulation Tests; Coronary Disease; Coronary Thrombosis; Fibrinogen; Humans; Platelet Aggregation; Risk; Risk Factors | 2005 |
Fibrinogen measurement to assess the risk of arterial thrombosis in individual patients: yes.
Topics: Arteries; Blood Coagulation Tests; Coronary Disease; Coronary Thrombosis; Fibrinogen; Humans; Platelet Aggregation; Risk; Risk Factors | 2005 |
Associations of fibrinogen and C-reactive protein with prevalent and incident coronary heart disease are attenuated by adjustment for confounding factors. British Women's Heart and Health Study.
Topics: Age Factors; Aged; Arteriosclerosis; C-Reactive Protein; Confounding Factors, Epidemiologic; Coronary Artery Disease; Coronary Disease; Female; Fibrin; Fibrinogen; Humans; Inflammation; Middle Aged; Models, Statistical; Odds Ratio; Prospective Studies; Risk Factors; Social Class | 2005 |
Quest for genes regulating plasma fibrinogen concentration: still a long way to go.
Topics: Coronary Disease; Fibrinogen; Gene Expression Profiling; Gene Expression Regulation; Humans; Risk Factors | 2005 |
A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study.
Topics: Algorithms; Calibration; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Diabetes Complications; Fibrinogen; Humans; Male; Medical Records; Middle Aged; Predictive Value of Tests; Risk Assessment; ROC Curve | 2005 |
Risk factors for cardiovascular event recurrence in the Atherosclerosis Risk in Communities (ARIC) study.
Topics: Atherosclerosis; Blood Pressure; Carotid Arteries; Cholesterol; Coronary Disease; Creatinine; Female; Fibrinogen; Follow-Up Studies; Humans; Hypertension; Leukocyte Count; Lipoprotein(a); Male; Middle Aged; Recurrence; Risk Factors; Serum Albumin; Smoking; Stroke; Tunica Intima; Tunica Media; Ultrasonography; Waist-Hip Ratio | 2005 |
An acute inflammatory reaction induced by myocardial damage is superimposed on a chronic inflammation in unstable coronary artery disease.
Topics: Abciximab; Adult; Aged; Angina, Unstable; Antibodies, Monoclonal; Anticoagulants; Aspirin; C-Reactive Protein; Case-Control Studies; Cohort Studies; Coronary Disease; Dalteparin; Female; Fibrinogen; Humans; Immunoglobulin Fab Fragments; Inflammation Mediators; Interleukin-6; Kinetics; Male; Middle Aged; Multicenter Studies as Topic; Myocardium; Prospective Studies; Randomized Controlled Trials as Topic; Troponin T | 2005 |
Gelatinase B C(-1562)T polymorphism in relation to ischaemic heart disease.
Topics: Apolipoproteins B; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Fibrinogen; Genotype; Humans; Lipoprotein(a); Male; Matrix Metalloproteinase 9; Myocardial Infarction; Point Mutation; Polymorphism, Genetic; Risk Factors | 2005 |
[Explosion of cardiovascular risks in family practice].
Topics: Adolescent; Adult; Aged; Animals; Cardiovascular Diseases; Coronary Disease; Cross-Sectional Studies; Diabetes Mellitus; Diet; Erectile Dysfunction; Family Practice; Female; Fibrinogen; Fishes; Germany; Humans; Hyperlipidemias; Hypertension; Male; Meta-Analysis as Topic; Middle Aged; Prospective Studies; Risk Factors; Smoking | 2005 |
Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study.
Topics: Aged; Biomarkers; Coronary Disease; Factor VIII; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Myocardial Ischemia; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; Risk Factors; Stroke; Tissue Plasminogen Activator; United Kingdom; von Willebrand Factor | 2005 |
Prediction model of coronary heart disease in patients with chronic kidney disease: role of plasma fibrinogen as a new prognostic variable.
Topics: Aged; Biomarkers; Chronic Disease; Coronary Disease; Female; Fibrinogen; Humans; Kidney Diseases; Male; Middle Aged; Models, Statistical; Prognosis; Risk Factors; Sensitivity and Specificity | 2005 |
Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS).
Topics: Aged; Algorithms; C-Reactive Protein; Cardiomegaly; Cohort Studies; Coronary Disease; Echocardiography; Female; Fibrinogen; Follow-Up Studies; Heart Atria; Heart Failure; Humans; Indians, North American; Male; Middle Aged; Myocardial Infarction; Risk Factors; Sex Factors; Stroke; United States | 2006 |
Genetic influences on fibrinogen, tissue plasminogen activator-antigen and von Willebrand factor in males and females.
Topics: Adult; Biomarkers; Coronary Disease; Female; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Risk Factors; Sex Factors; Tissue Plasminogen Activator; Twins, Dizygotic; Twins, Monozygotic; von Willebrand Factor | 2006 |
Arterial calcium on mammograms is not associated with inflammatory markers for heart disease risk.
Topics: Aged; Arteries; Biomarkers; Breast; C-Reactive Protein; Calcinosis; Calcium; Coronary Disease; Female; Fibrinogen; Humans; Inflammation; Mammography; Middle Aged; Prospective Studies; Risk Factors | 2006 |
Relationship between Chlamydia pneumoniae infection, inflammatory markers, and coronary heart diseases.
Topics: Aged; C-Reactive Protein; Case-Control Studies; Chlamydia Infections; Chlamydophila pneumoniae; Coronary Disease; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Fluorescent Antibody Technique; Humans; Immunoglobulin A; Immunoglobulin G; Interleukin-7; Male; Middle Aged | 2006 |
[The meaning of the combination of fibrinogen, micro/macroalbuminuria and atheromatosis in the carotid bloodstream for the evaluation of the abnormal finding of the stress myocardial SPECT in the asymptomatic 2nd type diabetic patients].
Topics: Albuminuria; Atherosclerosis; Carotid Arteries; Carotid Artery Diseases; Coronary Circulation; Coronary Disease; Diabetes Mellitus, Type 2; Dipyridamole; Female; Fibrinogen; Heart Ventricles; Humans; Male; Middle Aged; Tomography, Emission-Computed, Single-Photon; Ultrasonography | 2006 |
Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
Topics: Adult; Aged; Coronary Disease; Depression; Fatigue; Fibrinogen; Humans; Male; Middle Aged; Multivariate Analysis; Plasminogen Activator Inhibitor 1; Psychiatric Status Rating Scales; Surveys and Questionnaires; Tissue Plasminogen Activator | 2006 |
[The predictive value of serum advanced fibrinogen and uric acid for acute coronary event risk].
Topics: Aged; Blood Glucose; Chronic Disease; Coronary Disease; Female; Fibrinogen; Humans; Lipids; Male; Middle Aged; Predictive Value of Tests; Risk Factors; Uric Acid | 2006 |
Commentary: fibrinogen and coronary heart disease--test of causality by 'Mendelian' randomization by Keavney et al.
Topics: Coronary Disease; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Meta-Analysis as Topic; Polymorphism, Genetic; Risk Assessment | 2006 |
Effects of atorvastatin on coagulation parameters and homocysteine in patients with primary hypercholesterolemia.
Topics: Adult; Aged; Atorvastatin; Biomarkers; Blood Coagulation; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Heptanoic Acids; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Prospective Studies; Pyrroles; Treatment Outcome | 2006 |
Risk factors for ischemic stroke subtypes: the Atherosclerosis Risk in Communities study.
Topics: Black or African American; Brain Ischemia; Comorbidity; Coronary Disease; Diabetes Mellitus; Educational Status; Female; Fibrinogen; Follow-Up Studies; Humans; Hypercholesterolemia; Hypertension; Hypertrophy, Left Ventricular; Incidence; Intracranial Embolism; Leukocyte Count; Lipoprotein(a); Male; Maryland; Middle Aged; Minnesota; Mississippi; Multivariate Analysis; North Carolina; Proportional Hazards Models; Prospective Studies; Risk Factors; Smoking; von Willebrand Factor; Waist-Hip Ratio; White People | 2006 |
Increase of plasma fibrinogen levels and variability with age in a sample of middle aged healthy men.
Topics: Aged; Aging; Cholesterol; Coronary Disease; Fibrinogen; Genetic Variation; Humans; Male; Middle Aged; Risk Factors; Smoking; Triglycerides | 2007 |
Usefulness of D-Dimers and fibrinogen plasma determination in patients with polyvascular disease.
Topics: Arterial Occlusive Diseases; Biomarkers; Coronary Disease; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Survival Rate | 2006 |
Long-term effects of hemostatic variables on fatal coronary heart disease: 30-year results from the first prospective Northwick Park Heart Study (NPHS-I).
Topics: Adolescent; Adult; Age Distribution; Age Factors; Aged; Aged, 80 and over; Antigens; Biomarkers; Coronary Disease; Factor VII; Female; Fibrinogen; Follow-Up Studies; Hemostasis; Humans; Kaplan-Meier Estimate; London; Male; Middle Aged; Mortality; Odds Ratio; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Risk Assessment; Sex Distribution; Sex Factors; Time Factors | 2007 |
[Association of fibrinogen B beta -1420G/A, -993C/T and -854G/A gene polymorphism with coronary heart disease].
Topics: Adult; Aged; Aged, 80 and over; Alleles; Base Sequence; Coronary Disease; DNA; Female; Fibrinogen; Gene Frequency; Genotype; Haplotypes; Humans; Male; Middle Aged; Molecular Sequence Data; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Sequence Analysis, DNA | 2006 |
Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis.
Topics: Aged; Biomarkers; C-Reactive Protein; Calcinosis; Coronary Artery Disease; Coronary Disease; Coronary Vessels; Female; Fibrinogen; Humans; Inflammation; Male; Metabolic Syndrome; Middle Aged; Risk Factors; Uric Acid | 2007 |
Fibrinogen and factor VIIc levels: independent risk factors or markers of coronary disease risk?
Topics: Antigens; Biomarkers; Coronary Disease; Factor VII; Female; Fibrinogen; Humans; Male; Predictive Value of Tests; Risk Assessment; Risk Factors | 2007 |
Fibrinogen gene haplotypes in relation to risk of coronary events and coronary and extracoronary atherosclerosis: the Rotterdam Study.
Topics: Aged; Aortic Diseases; Calcinosis; Carotid Artery Diseases; Cohort Studies; Coronary Artery Disease; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Male; Middle Aged; Netherlands; Odds Ratio; Polymorphism, Single Nucleotide; Proportional Hazards Models; Prospective Studies; Risk Factors; Time Factors | 2007 |
Heart rate variability and markers of inflammation and coagulation in depressed patients with coronary heart disease.
Topics: Aged; Autonomic Nervous System; C-Reactive Protein; Coronary Disease; Depression; Electrocardiography; Female; Fibrinogen; Heart Rate; Humans; Inflammation Mediators; Interleukin-6; Male; Middle Aged; Statistics as Topic; Tumor Necrosis Factor-alpha | 2007 |
Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome.
Topics: Aged; Atherosclerosis; Biomarkers; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Creatinine; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Humans; Italy; Male; Metabolic Syndrome; Middle Aged; Odds Ratio; Prevalence; Risk Assessment; Risk Factors; Serum Albumin; Uric Acid | 2008 |
Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul Study.
Topics: Aged; Biomarkers; C-Reactive Protein; CD40 Ligand; Chi-Square Distribution; Cohort Studies; Coronary Disease; Cross-Sectional Studies; Depressive Disorder, Major; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Leukocyte Count; Male; Middle Aged; Prospective Studies; Severity of Illness Index | 2007 |
Association of high levels of plasma free dopamine with future coronary events in patients with coronary artery disease.
Topics: Aged; C-Reactive Protein; Chromatography, High Pressure Liquid; Coronary Artery Disease; Coronary Disease; Dopamine; Female; Fibrinogen; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Natriuretic Peptide, Brain; Neurotransmitter Agents; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke Volume; Ventricular Function, Left | 2007 |
Coagulation factor VII and inflammatory markers in patients with coronary heart disease.
Topics: Alleles; Amino Acid Substitution; Biomarkers; C-Reactive Protein; Coronary Disease; Factor VIIa; Female; Fibrinogen; Humans; Inflammation; Inflammation Mediators; Interleukin-6; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Quantitative Trait Loci | 2007 |
Human serum albumin levels and cardiovascular risk factors in elderly Japanese-American men: the Honolulu Heart Program.
Topics: Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Fibrinogen; Hawaii; Humans; Male; Risk Factors; Serum Albumin | 2007 |
High-sensitivity C-reactive protein in children at risk for coronary artery disease.
Topics: Adolescent; Blood Glucose; Body Mass Index; C-Reactive Protein; Case-Control Studies; Child; Child, Preschool; Cholesterol, HDL; Coronary Disease; Female; Fibrinogen; Humans; Hypercholesterolemia; Hypertension; Male; Obesity; Reference Values; Risk Assessment; Risk Factors; Sensitivity and Specificity; Turkey | 2007 |
Association between heart rate recovery after exercise testing and plasminogen activator inhibitor 1, tissue plasminogen activator, and fibrinogen in apparently healthy men.
Topics: Adult; Coronary Disease; Exercise; Exercise Test; Fibrinogen; Heart Rate; Humans; Male; Middle Aged; Parasympathetic Nervous System; Plasminogen Activator Inhibitor 1; Regression Analysis; Risk Factors; Tissue Plasminogen Activator | 2008 |
Altered protein metabolism following coronary artery bypass graft (CABG) surgery.
Topics: Albumins; Coronary Artery Bypass; Coronary Artery Bypass, Off-Pump; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Muscle Proteins; Muscles; Phenylalanine; Plasma Volume; Postoperative Period; Protein Biosynthesis | 2008 |
Low hematocrit per blood viscosity ratio as a mortality risk factor in coronary heart disease.
Topics: Blood Viscosity; Cause of Death; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Hematocrit; Humans; Male; Middle Aged; Predictive Value of Tests; Risk Factors; ROC Curve; Survival Analysis; Survival Rate | 2008 |
Positive correlation of CRP and fibrinogen levels as cardiovascular risk factors in early stage of continuous ambulatory peritoneal dialysis patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Confidence Intervals; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Probability; Reference Values; Risk Factors; Severity of Illness Index; Statistics, Nonparametric | 2008 |
Association of fibrinogen and fibrinogen gene beta148 and beta854 polymorphisms with coronary heart disease.
Topics: Aged; China; Cohort Studies; Comorbidity; Coronary Disease; Female; Fibrinogen; Genotype; Humans; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Risk Factors; Sex Distribution | 2008 |
[Study on the relationship between passive smoking and blood lipids, fibrinogen and viscosity among women who never smoke].
Topics: Apolipoprotein A-I; Blood Viscosity; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Tobacco Smoke Pollution | 2007 |
Urokinase in pulmonary embolism.
Topics: Adult; Aged; Blood Coagulation Tests; Coronary Disease; Endometriosis; Fibrinogen; Fibrinolytic Agents; Humans; Hypertension; Infusions, Parenteral; Iodine Radioisotopes; Middle Aged; Pulmonary Embolism; Radiography; Radionuclide Imaging; Retinal Detachment; Rheumatic Heart Disease | 1967 |
Haemostatic function and cardiovascular death: early results of a prospective study.
Topics: Adult; Blood Coagulation Disorders; Blood Pressure; Cholesterol; Coronary Disease; Death, Sudden; Factor VII; Factor VIII; Fibrinogen; Humans; Male; Middle Aged; Prospective Studies; Risk | 1980 |
Is raised plasma fibrinopeptide A a marker of acute coronary insufficiency?
Topics: Acute Disease; Angina Pectoris, Variant; Coronary Disease; Fibrinogen; Fibrinopeptide A; Humans | 1980 |
Haemostatic factors and coronary heart disease.
Topics: Adult; Animals; Arteriosclerosis; Blood Coagulation Factors; Cholesterol; Coronary Disease; Factor VIII; Fibrinogen; Hemostasis; Humans; Male; Middle Aged | 1981 |
Fibrinogen, coronary heart disease and prospective studies.
Topics: Coronary Disease; Fibrinogen; Humans; Prospective Studies; Research Design | 1981 |
Coronary heart disease, fibrinogen, and plasma heparin neutralising activity.
Topics: Coronary Disease; Fibrinogen; Heparin; Humans; Platelet Factor 4 | 1981 |
Menopausal status and haemostatic variables.
Topics: Age Factors; Cholesterol; Contraceptives, Oral; Coronary Disease; Factor VII; Female; Fibrinogen; Hemostasis; Humans; Menopause; Middle Aged; Risk | 1983 |
Fibrinopeptide A and sudden coronary death.
Topics: Aged; Coronary Disease; Death, Sudden; Female; Fibrinogen; Fibrinopeptide A; Heart; Humans; Male; Massage; Middle Aged; Punctures; Resuscitation; Thrombin; Time Factors | 1984 |
Fibrinopeptide A, platelet factor 4, and beta-thromboglobulin levels in coronary heart disease.
Topics: Adult; Aged; Beta-Globulins; beta-Thromboglobulin; Blood Coagulation Factors; Blood Platelets; Coronary Angiography; Coronary Disease; Female; Fibrinogen; Fibrinopeptide A; Heart Aneurysm; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Factor 4 | 1982 |
Regional fibrinolytic study in coronary artery disease.
Topics: Adult; alpha 1-Antitrypsin; alpha-Macroglobulins; Antithrombins; Aorta, Thoracic; Blood Specimen Collection; Cardiac Catheterization; Coronary Disease; Female; Fibrinogen; Fibrinolysis; Heart Atria; Heart Ventricles; Humans; Male; Middle Aged; Plasminogen; Pulmonary Artery | 1982 |
Fibrinopeptide A and beta thromboglobulin in patients with angina pectoris and acute myocardial infarction.
Topics: Adult; Aged; Angina Pectoris; Beta-Globulins; beta-Thromboglobulin; Blood Platelets; Coronary Disease; Fibrinogen; Fibrinopeptide A; Humans; Middle Aged; Myocardial Infarction; Myocardium; Thrombin; Thrombophlebitis | 1984 |
[Comparison of 2 methods for determining fibrinogen in the blood plasma].
Topics: Aged; Coronary Disease; Fibrinogen; Humans; Methods; Middle Aged | 1984 |
Coagulopathy and platelet activation in Kawasaki syndrome: identification of patients at high risk for development of coronary artery aneurysms.
Topics: Aneurysm; Antithrombin III; beta-Thromboglobulin; Blood Platelet Disorders; Blood Platelets; Child, Preschool; Coronary Disease; Disseminated Intravascular Coagulation; Fibrinogen; Humans; Infant; Mucocutaneous Lymph Node Syndrome; Risk | 1984 |
[Relation between concentrations of lipids, carbohydrates, fibrinogen and thyroid hormone and insulin levels in the blood of patients with chronic forms of ischemic heart disease].
Topics: Adult; Aged; Blood Glucose; Cholesterol; Coronary Disease; Fibrinogen; Humans; Insulin; Lipoproteins; Male; Middle Aged; Thyroid Hormones; Thyroxine; Triglycerides; Triiodothyronine | 1984 |
Increased fibrinopeptide A formation and thromboxane A2 production in patients with ischemic heart disease: relationships to coronary pathoanatomy, risk factors, and clinical manifestations.
Topics: beta-Thromboglobulin; Blood Coagulation; Blood Platelets; Coronary Disease; Female; Fibrinogen; Fibrinopeptide A; Hemostasis; Humans; Male; Middle Aged; Platelet Aggregation; Risk; Thromboxane A2; Thromboxanes | 1981 |
[Hypercoagulation in fishermen with hypertension, hyperlipidemia and coronary heart disease].
Topics: Adolescent; Adult; Aged; Blood Coagulation; Coronary Disease; Female; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Occupations; Platelet Adhesiveness; Sex Factors | 1984 |
[Longitudinal studies on the prognostic significance of plasma fibrinogen in diabetes mellitus].
Topics: Coronary Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Hypertension; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Prognosis | 1984 |
[Prognostic significance of the state of the blood coagulation system for the development of myocardial infarction and sudden death in patients with ischemic heart disease].
Topics: Adult; Aged; Blood Coagulation; Blood Coagulation Disorders; Coronary Disease; Death, Sudden; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis | 1984 |
[Interrelation of diabetes mellitus, atherosclerosis and ischemic heart disease].
Topics: Adult; Aged; Arteriosclerosis; Cholesterol; Coronary Disease; Diabetes Complications; Diabetes Mellitus; Erythrocytes; Female; Fibrinogen; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Humans; Lipid Peroxides; Lipoproteins, HDL; Male; Middle Aged; Sterols | 1984 |
Coronary thrombolysis with recombinant human tissue-type plasminogen activator.
Topics: alpha-2-Antiplasmin; Animals; Coronary Angiography; Coronary Disease; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Fibrinogen; Fibrinolysis; Myocardial Infarction; Plasminogen; Plasminogen Activators | 1984 |
Hypercoagulability and coronary artery disease.
Topics: Adult; Angina Pectoris; Blood Coagulation Disorders; Blood Coagulation Factors; Coronary Disease; Fibrinogen; Fibrinolysis; Humans; Lipids; Male; Middle Aged; Plasminogen Activators; Risk | 1984 |
Clot-selective coronary thrombolysis with tissue-type plasminogen activator.
Topics: Animals; Coronary Disease; Dogs; Fibrinogen; Infusions, Parenteral; Injections; Plasminogen Activators; Streptokinase; Time Factors; Tomography, Emission-Computed | 1983 |
Haemorheological investigations in patients with chronic ischaemic heart disease and acute myocardial infarction.
Topics: Blood Proteins; Blood Viscosity; Coronary Disease; Female; Fibrinogen; Hematocrit; Humans; Male; Myocardial Infarction | 1983 |
[Informative analysis of components of the system of regulation of blood coagulation in chronic ischemic heart disease].
Topics: Aged; Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Coronary Disease; Female; Fibrinogen; Fibrinolysis; Heparin; Humans; Male; Middle Aged; Platelet Aggregation | 1983 |
[Various indices of blood lipid composition in patients with chronic ischemic heart disease].
Topics: Cholesterol; Chronic Disease; Coronary Disease; Female; Fibrinogen; Humans; Lipids; Male; Middle Aged; Triglycerides | 1983 |
[Sterol-fibrinogen blood complexes in patients with diabetes mellitus and associated ischemic heart disease].
Topics: Adult; Aged; Coronary Disease; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Fibrinogen; Humans; Middle Aged; Sterols | 1983 |
[Hemorrheological changes in ischemic heart disease].
Topics: Adult; Aged; Angina Pectoris; Blood Viscosity; Coronary Disease; Erythrocytes; Exercise Test; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Myocardial Infarction; Rheology | 1983 |
[Preliminary study on erythrocyte filterability and other hemorrheological parameters in arteriosclerotic vascular disease].
Topics: Aged; Arteriosclerosis; Coronary Disease; Erythrocytes; Fibrinogen; Humans; Intermittent Claudication; Intracranial Arteriosclerosis; Male; Middle Aged; Platelet Aggregation; Rheology; Ultrafiltration | 1983 |
Evaluation of the haemorheological determinants in coronary heart disease.
Topics: Blood Viscosity; Coronary Disease; Fibrinogen; Hematocrit; Humans; Myocardial Infarction; Physical Exertion | 1984 |
[Effect of emotional stress on the system of hemostasis in patients with coronary arteriosclerosis].
Topics: Adult; Blood Coagulation; Coronary Disease; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation; Stress, Psychological; Thrombosis | 1984 |
Relationship of triglyceride levels to thrombosis in patients with coronary artery disease.
Topics: Adult; Aged; Anticoagulants; Antithrombin III; Blood Coagulation Disorders; Coronary Disease; Female; Fibrinogen; Humans; Hyperlipidemias; Male; Middle Aged; Platelet Aggregation; Prospective Studies; Thromboplastin; Thrombosis; Triglycerides | 1983 |
Fibrinolytic effects of intracoronary streptokinase administration in patients with acute myocardial infarction and coronary insufficiency.
Topics: Adult; Aged; Coronary Disease; Female; Fibrinogen; Fibrinolysis; Humans; Infusions, Parenteral; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Plasminogen; Prothrombin Time; Streptokinase; Time Factors | 1983 |
The measurement of risk indicators for coronary heart disease in air traffic control officers: a screening study in a healthy population.
Topics: Adult; Aviation; Cholesterol; Cholesterol, HDL; Coronary Disease; Fibrinogen; Humans; Lipoproteins, HDL; Male; Middle Aged; Occupations; Physical Examination; Risk; United Kingdom | 1983 |
Morphological variants of acute myocardial necrosis and their relationship to coronary artery thrombosis.
Topics: Animals; Arteriosclerosis; Coronary Disease; Coronary Vessels; Fibrinogen; Humans; Isoproterenol; Myocardial Infarction; Myocardium; Necrosis; Rats | 1980 |
Plasma fibrinogen levels as an indicator of myocardial necrosis.
Topics: Adult; Aged; Coronary Disease; Diagnosis, Differential; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Necrosis | 1982 |
Haemostatic factors associated with ischaemic heart disease in men aged 45 to 64 years. The Speedwell study.
Topics: Blood Coagulation Tests; Blood Viscosity; Coronary Disease; England; Fibrinogen; Hematocrit; Hemostasis; Humans; Male; Middle Aged; Pilot Projects; Platelet Count | 1982 |
Hemorheological characteristics of blood in various disease: diabetes mellitus, hypertension, acute infection, ischaemic heart disease & attempted suicide.
Topics: Blood Circulation; Blood Sedimentation; Blood Viscosity; Coronary Disease; Diabetes Mellitus; Erythrocytes; Fibrinogen; Hematocrit; Humans; Hypertension; Infections; Rheology; Stress, Mechanical; Suicide, Attempted | 1982 |
[comparison of indices of the blood rheological status in chronic ischemic heart disease].
Topics: Blood Viscosity; Chronic Disease; Coronary Disease; Erythrocyte Aggregation; Female; Fibrin; Fibrinogen; Humans; In Vitro Techniques; Male; Rheology | 1982 |
Haemostatic factors and coronary heart disease.
Topics: Coronary Disease; Fibrin; Fibrinogen; Hemostasis; Humans; Thromboembolism | 1982 |
[Role of changes in the sterine-fibrinogen complexes in the development of arteriosclerosis].
Topics: Adult; Aged; Cholesterol Esters; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Protein Binding; Risk | 1981 |
[Blood fibrinolytic system in health subjects and elderly patients with ischemic heart disease].
Topics: Aged; Blood Coagulation Tests; Coronary Disease; Fibrinogen; Fibrinolysis; Humans; Middle Aged | 1980 |
Comparative effect of clofibrate, garlic and onion on alimentary hyperlipemia.
Topics: Adult; Arteriosclerosis; Clofibrate; Coronary Disease; Fibrinogen; Garlic; Humans; Hyperlipidemias; Lipids; Male; Plants, Medicinal; Vegetables; Whole Blood Coagulation Time | 1981 |
[Characteristics of the disseminated intravascular coagulation syndrome in ischemic heart disease patients with congestive circulatory failure].
Topics: Aged; Antithrombin III; Coronary Disease; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Failure; Humans; Male; Middle Aged; Syndrome; Thromboembolism | 1981 |
The long-term use of garlic in ischemic heart disease--an appraisal.
Topics: Adult; Blood Coagulation; Cholesterol; Coronary Disease; Female; Fibrinogen; Fibrinolysis; Garlic; Humans; Lipids; Lipoproteins, LDL; Male; Plants, Medicinal; Triglycerides | 1981 |
[Chronobiology of fibrinogenemia and of Howell's time in normal, coronaropathic and hypertensive subjects].
Topics: Coronary Disease; Fibrinogen; Humans; Hypertension; Male; Prothrombin Time | 1981 |
Relation between extent of coronary artery disease and blood viscosity.
Topics: Adult; Blood Viscosity; Coronary Disease; Fibrinogen; Hematocrit; Humans; Male; Middle Aged | 1980 |
Increased plasma fibrinogen and platelet-aggregates in type II hyperlipoproteinaemia.
Topics: Adolescent; Adult; Arteriosclerosis; Cholesterol; Coronary Disease; Female; Fibrinogen; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Platelet Aggregation; Thrombosis; Triglycerides | 1980 |
[Study of behaviour of fibrinogen and of some glycoproteins in arteriosclerotic clinical situations (author's transl)].
Topics: Acute Disease; Arteriosclerosis; Chronic Disease; Coronary Disease; Diabetic Angiopathies; Fibrinogen; Glycoproteins; Humans; Hyperlipoproteinemias; Myocardial Infarction | 1980 |
Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors.
Topics: Aged; C-Reactive Protein; Chlamydia Infections; Chlamydophila pneumoniae; Coronary Disease; Cross-Sectional Studies; Electrocardiography; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Humans; Leukocyte Count; London; Male; Middle Aged; Risk Factors | 1995 |
Is diastolic dysfunction associated with thrombogenesis? A study of circulating markers of a prothrombotic state in patients with coronary artery disease.
Topics: Analysis of Variance; Biomarkers; Case-Control Studies; Chi-Square Distribution; Coronary Disease; Cross-Sectional Studies; Diastole; Echocardiography, Doppler, Pulsed; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Aneurysm; Heart Ventricles; Humans; Male; Middle Aged; Observer Variation; Prospective Studies; Systole; Thromboembolism; von Willebrand Factor | 1995 |
Haemostatic factors and lipoprotein (a) in three geographical areas in Finland: the Finrisk Haemostasis Study.
Topics: Age Distribution; Antigens; Coronary Disease; Demography; Factor VII; Female; Fibrinogen; Finland; Hemostasis; Humans; Incidence; Lipoprotein(a); Male; Middle Aged; Plasminogen; Risk Factors; Sex Distribution; Survival Rate | 1994 |
Platelet size, fibrinogen and lipoprotein(a) in coronary heart disease.
Topics: Adult; Blood Platelets; Case-Control Studies; Cell Separation; Coronary Disease; Female; Fibrinogen; Flow Cytometry; Humans; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Platelet Function Tests; Risk Factors | 1995 |
Evaluation of neopterin as a marker for restenosis following percutaneous transluminal coronary angioplasty.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Biomarkers; Biopterins; Chromatography, High Pressure Liquid; Coronary Angiography; Coronary Disease; Fibrinogen; Follow-Up Studies; Humans; Lipids; Male; Middle Aged; Neopterin; Recurrence | 1995 |
Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain.
Topics: Acute-Phase Reaction; Arteriosclerosis; Biomarkers; Blood Coagulation; Blood Glucose; Blood Pressure; Blood Proteins; Body Mass Index; C-Reactive Protein; Coronary Disease; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Intracranial Arteriosclerosis; Lipids; Lipoproteins; Male; Middle Aged; Peripheral Vascular Diseases; Plasminogen Activator Inhibitor 1; Prospective Studies; Radiography; Risk Factors; Severity of Illness Index; Smoking | 1995 |
Regression of transplant coronary artery disease during chronic HELP therapy: a case study.
Topics: Arteriosclerosis; Chemical Precipitation; Cholesterol, LDL; Coronary Angiography; Coronary Disease; Extracorporeal Circulation; Fibrinogen; Follow-Up Studies; Heart Transplantation; Humans; Hypercholesterolemia; Lipoprotein(a); Male; Middle Aged; Pravastatin; Time Factors | 1995 |
Genetic and environmental sources of fibrinogen variability in Israeli families: the Kibbutzim Family Study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Coronary Disease; Female; Fibrinogen; Genetic Variation; Humans; Israel; Likelihood Functions; Male; Middle Aged; Models, Genetic; Nuclear Family; Prospective Studies; Regression Analysis | 1995 |
Polymorphisms of the beta fibrinogen gene and plasma fibrinogen concentration in Caucasian and Japanese population samples.
Topics: Aged; Alleles; Asian People; Base Sequence; Body Mass Index; Coronary Disease; Diet; Disease Susceptibility; Estrogen Replacement Therapy; Female; Fibrinogen; Gene Frequency; Genes; Genetic Predisposition to Disease; Genotype; Habits; Humans; Japan; Male; Menopause; Middle Aged; Molecular Sequence Data; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Reference Values; Risk Factors; Triglycerides; United States; White People | 1995 |
Impact of polymorphisms in the alpha- and beta-fibrinogen gene on plasma fibrinogen concentrations of coronary heart disease patients.
Topics: Alleles; Base Sequence; Coronary Disease; Fibrinogen; Gene Frequency; Genes; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Molecular Sequence Data; Polymorphism, Restriction Fragment Length | 1995 |
[The relationship of apolipoprotein A-I and B-100 to cardiovascular diseases in aging males].
Topics: Aged; Apolipoprotein A-I; Apolipoprotein B-100; Apolipoproteins B; Cholesterol; Coronary Disease; Fibrinogen; Humans; Hypertension; Male; Middle Aged | 1995 |
Fibrinogen after coronary angioplasty as a risk factor for restenosis.
Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Prospective Studies; Recurrence; Risk Factors; von Willebrand Factor | 1995 |
Haemostatic factors and prevalent coronary heart disease; the FINRISK Haemostasis Study.
Topics: Antigens; Blood Coagulation Factors; Cholesterol; Cholesterol, HDL; Coronary Disease; Cross-Sectional Studies; Factor VII; Female; Fibrinogen; Finland; Hemostasis; Humans; Lipoprotein(a); Male; Middle Aged; Plasminogen; Prevalence; Risk Factors | 1994 |
Hemostatic function and coronary artery disease.
Topics: Blood Coagulation Factors; Coronary Disease; Endothelium, Vascular; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Tissue Plasminogen Activator; von Willebrand Factor | 1995 |
Fibrinogen: a link between chronic infection and coronary heart disease.
Topics: Aged; Chlamydia Infections; Chlamydophila pneumoniae; Chronic Disease; Coronary Disease; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Risk Factors | 1994 |
Helicobacter pylori infection and coronary heart disease.
Topics: Coronary Disease; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Humans; Leukocytes, Mononuclear | 1994 |
[Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].
Topics: Aged; alpha-2-Antiplasmin; Coronary Disease; Diabetes Mellitus, Type 2; Female; Fibrinogen; Fibrinolysis; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Plasminogen; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Risk Factors; Survivors | 1994 |
Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Blood Viscosity; Coronary Disease; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Hematocrit; Humans; Intermittent Claudication; Leukocytes; Male; Middle Aged; Pancreatic Elastase; Risk Factors; von Willebrand Factor | 1993 |
Effects of age, lipoproteins, and hemostatic parameters on the role of homocyst(e)inemia as a cardiovascular risk factor in men.
Topics: Adult; Age Factors; Blood Viscosity; Coronary Disease; Fibrinogen; Homocysteine; Humans; Lipoproteins; Male; Middle Aged; Risk Factors | 1994 |
Hemostatic factors in the Coronary Artery Risk Development in Young Adults (CARDIA) Study.
Topics: Adolescent; Adult; Aged; Blood Coagulation Factors; Blood Group Antigens; Coronary Disease; Female; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Risk Factors; Sex Factors | 1994 |
Lowering the risk of coronary heart disease.
Topics: Coronary Disease; Fibrinogen; Fish Oils; Humans; Risk Factors | 1993 |
Serum ferritin, sex hormones, and cardiovascular risk factors in healthy women.
Topics: Adult; Aging; Blood Pressure; Body Mass Index; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Estradiol; Exercise; Female; Ferritins; Fibrinogen; Gonadal Steroid Hormones; Hematocrit; Humans; Menstrual Cycle; Middle Aged; Premenopause; Progesterone; Risk Factors; Smoking; Testosterone; Triglycerides; Women's Health | 1994 |
Close relation between lipoprotein (a) levels and atherothrombotic disease in Japanese subjects > 75 years of age.
Topics: Aged; Aged, 80 and over; Aging; Arteriosclerosis; Cerebral Infarction; Cholesterol; Cohort Studies; Coronary Disease; Factor VII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hypertension; Japan; Lipoprotein(a); Male; Middle Aged; N-Acetylneuraminic Acid; Risk Factors; Sialic Acids | 1994 |
Why fibrinogen should be measured as part of the coronary heart disease risk profile.
Topics: Adult; Aged; Coronary Disease; Fibrinogen; Humans; Male; Middle Aged; Risk Factors; Smoking | 1993 |
Endogenous testosterone, fibrinolysis, and coronary heart disease risk in hyperlipidemic men.
Topics: alpha-2-Antiplasmin; Apolipoprotein A-I; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Fibrinogen; Fibrinolysis; Humans; Hypercholesterolemia; Lipoprotein(a); Male; Middle Aged; Plasminogen; Plasminogen Inactivators; Risk Factors; Testosterone; Tissue Plasminogen Activator; Triglycerides | 1993 |
Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group.
Topics: Adult; Aged; Aging; Angina Pectoris; Body Mass Index; Coronary Disease; Factor VIII; Female; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Risk Factors; Triglycerides; von Willebrand Factor | 1993 |
Reduction by niceritrol treatment of serum lipoprotein(a) in normolipidemic patients with coronary artery disease.
Topics: Adult; Aged; Apolipoproteins; Apolipoproteins B; Cholesterol, LDL; Coronary Disease; Female; Fibrinogen; Humans; Hypolipidemic Agents; Lipoprotein(a); Male; Middle Aged; Niceritrol; Regression Analysis | 1993 |
Gender and employment grade differences in blood cholesterol, apolipoproteins and haemostatic factors in the Whitehall II study.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins; Apolipoproteins B; Cholesterol; Coronary Disease; Factor VII; Female; Fibrinogen; Health Behavior; Hemostasis; Humans; London; Male; Menopause; Middle Aged; Occupations; Risk Factors; Sex Factors; Social Class | 1993 |
Fish consumption, omega-3 fatty acids and the Mediterranean diet.
Topics: Animals; Coronary Disease; Denmark; Diet; Diet Surveys; Eicosanoids; Fatty Acids, Omega-3; Fibrinogen; Fibrinolysis; Fishes; Humans; Italy; Life Style; Lipoproteins; Meat; Norway; Population Surveillance; Risk Factors; Spain; Yugoslavia | 1993 |
Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men.
Topics: Adult; Age Factors; Aged; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Factor VII; Female; Fibrinogen; Germany; Humans; Logistic Models; Male; Middle Aged; Prospective Studies; Smoking | 1994 |
Interrelation between angiographic severity of coronary artery disease and plasma levels of insulin, C-peptide and plasminogen activator inhibitor-1.
Topics: Body Mass Index; C-Peptide; Cholesterol, HDL; Coronary Angiography; Coronary Disease; Fibrinogen; Humans; Insulin; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Reference Values; Triglycerides | 1993 |
[Biochemical-physical and rheologic changes in the blood of patients with angina pectoris].
Topics: Adult; Aged; Angina Pectoris; Animals; Blood Viscosity; Coronary Disease; Cricetinae; Erythrocyte Deformability; Female; Fibrinogen; Hematocrit; Humans; Intermittent Claudication; Male; Middle Aged | 1993 |
Moderate to high intensity conditioning leisure time physical activity and high cardiorespiratory fitness are associated with reduced plasma fibrinogen in eastern Finnish men.
Topics: Adult; Analgesics; Arthritis, Rheumatoid; Body Mass Index; Cerebrovascular Disorders; Coffee; Comorbidity; Coronary Disease; Diabetes Mellitus; Diet; Energy Metabolism; Exercise; Fibrinogen; Finland; Humans; Leisure Activities; Male; Middle Aged; Multivariate Analysis; Oxygen Consumption; Physical Fitness; Population Surveillance; Risk Factors; Smoking; Socioeconomic Factors | 1993 |
[Factor VII and protein-C markers are no prognostic indicators in acute coronary heart disease].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Angina, Unstable; Antigens; Child; Coronary Disease; Factor VII; Fibrinogen; Humans; Middle Aged; Myocardial Infarction; Prognosis; Prospective Studies; Protein C | 1993 |
Relation of hemostatic risk factors to other risk factors for coronary heart disease and to sex hormones in men.
Topics: Adult; Aged; Coronary Disease; Estradiol; Factor VII; Fibrinogen; Gonadal Steroid Hormones; Hemostasis; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Risk Factors; Sex Hormone-Binding Globulin; Testosterone | 1993 |
Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study.
Topics: Adult; Angina Pectoris; Cerebrovascular Disorders; Coronary Disease; Cross-Sectional Studies; Diabetes Mellitus; Family; Female; Fibrinogen; Heart Diseases; Humans; Hypertension; Intermittent Claudication; Male; Middle Aged; Myocardial Infarction; Risk Factors; Sex Factors | 1993 |
Lipoprotein(a) concentrations are increased in patients with myocardial infarction and angiographically normal coronary arteries.
Topics: Apolipoprotein A-I; Apolipoproteins B; Cholesterol; Coronary Disease; Fibrinogen; Fibrinolysis; Humans; Lipids; Lipoprotein(a); Lipoproteins, HDL; Myocardial Infarction; Risk Factors; Triglycerides | 1993 |
Relation of fibrinogen to presence and severity of coronary artery disease is independent of other coexisting heart disease. The ECAT Angina Pectoris Study Group.
Topics: Coronary Angiography; Coronary Artery Disease; Coronary Disease; Female; Fibrinogen; Heart Diseases; Humans; Male; Middle Aged; Prospective Studies | 1993 |
Plasma fibrinogen and its correlates in Japanese and US population samples.
Topics: Asian People; Black People; Coronary Disease; Female; Fibrinogen; Humans; Japan; Male; Middle Aged; Risk Factors; Smoking; United States; White People | 1993 |
Reduction of plasma cold agglutinin titers by means of plasmapheresis to prepare a patient for coronary bypass surgery.
Topics: Agglutinins; Coronary Artery Bypass; Coronary Disease; Cryoglobulins; Fibrinogen; Hemoglobinometry; Humans; Isoantibodies; Leukocyte Count; Male; Middle Aged; Plasma Exchange; Plasmapheresis; Platelet Count; Preoperative Care; Prothrombin Time | 1993 |
Physiologic benefits of a stress reduction program for healthy middle-aged Army officers.
Topics: Adult; Arousal; Behavior Therapy; Coronary Disease; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Fibrinogen; Humans; Hydrocortisone; Leukocyte Count; Life Style; Lipids; Male; Middle Aged; Military Personnel; Psychophysiologic Disorders; Recurrence; Stress, Psychological; Testosterone; Type A Personality | 1993 |
Hemostatic risk factors of coronary artery disease in the Chinese.
Topics: Adult; Aged; Aged, 80 and over; Antithrombin III; Blood Glucose; Case-Control Studies; China; Cholesterol; Coronary Angiography; Coronary Disease; Diabetes Mellitus; Factor VII; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Platelet Count; Risk Factors; Serine Proteinase Inhibitors; Taiwan; Triglycerides | 1995 |
Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary Palmaz-Schatz stenting.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anticoagulants; Aspirin; Blood Platelets; Coronary Disease; Coronary Thrombosis; Female; Fibrinogen; Heparin; Humans; Logistic Models; Male; Middle Aged; Partial Thromboplastin Time; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Risk Factors; Stents; Treatment Outcome | 1996 |
Circulating factors of the haemostatic systems as indicators of increased or reduced coronary risk.
Topics: Angina Pectoris; Blood Coagulation Factors; C-Reactive Protein; Cholesterol; Coronary Disease; Fibrinogen; Follow-Up Studies; Humans; Risk Factors; Tissue Plasminogen Activator; von Willebrand Factor | 1995 |
Association between serum fibrinogen concentrations and HDL and LDL subfraction phenotypes in healthy men.
Topics: Aging; Apolipoproteins B; Body Mass Index; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Fibrinogen; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Male; Phenotype; Regression Analysis; Risk Factors; Triglycerides | 1996 |
Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde.
Topics: Adult; Alleles; Base Sequence; Coronary Angiography; Coronary Disease; Fibrinogen; Genetic Linkage; Genotype; Humans; Male; Middle Aged; Molecular Sequence Data; Multivariate Analysis; Myocardial Infarction; Polymorphism, Genetic; Smoking | 1996 |
Plasma fibrinogen and coronary heart disease in elderly Japanese-American men.
Topics: Age Distribution; Aged; Aged, 80 and over; Coronary Disease; Cross-Sectional Studies; Fibrinogen; Humans; Japan; Longitudinal Studies; Male; Multivariate Analysis; Prevalence; Risk Factors; United States | 1996 |
Fibrinogen is a predictor of mortality in coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study Group.
Topics: Aged; Coronary Disease; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Smoking | 1996 |
Coronary artery disease in IDDM. Gender differences in risk factors but not risk.
Topics: Adolescent; Adult; Age of Onset; Angina Pectoris; Body Constitution; Comorbidity; Coronary Disease; Depression; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Female; Fibrinogen; Follow-Up Studies; Humans; Hypertension; Hypertriglyceridemia; Lipids; Male; Motor Activity; Myocardial Infarction; Proportional Hazards Models; Risk; Risk Factors; Sex Factors; Smoking | 1996 |
Fibrinogen, coronary heart disease and mortality from all causes in smokers and nonsmokers. The study of men born in 1933.
Topics: Cause of Death; Coronary Disease; Fibrinogen; Humans; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk; Risk Factors; Smoking; Sweden | 1996 |
Lipid peroxidation, antioxidant defences and red-cell membrane changes in relation to coronary risk index and symptomatic coronary heart disease.
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Erythrocyte Membrane; Female; Fibrinogen; Free Radical Scavengers; Humans; India; Lipid Peroxidation; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Platelet Count; Reference Values; Sterol Esterase | 1995 |
Diabetes and coronary heart disease in American Indians: The Strong Heart Study.
Topics: Adult; Aged; Coronary Disease; Diabetes Mellitus; Female; Fibrinogen; Humans; Indians, North American; Lipoproteins; Male; Middle Aged; Nicotiana; Obesity; Odds Ratio; Plants, Toxic; Regression Analysis; Risk Factors; Smoking; Socioeconomic Factors | 1996 |
Fibrinogen in the offspring of men with premature coronary artery disease.
Topics: Adolescent; Adult; Age Factors; Child; Coronary Disease; Female; Fibrinogen; Genetic Markers; Humans; Hyperlipidemias; Lipids; Male; Middle Aged; Risk Factors | 1995 |
A variant of beta fibrinogen is a genetic risk factor for coronary artery disease and myocardial infarction.
Topics: Adult; Aged; Alleles; Case-Control Studies; Chromosomes, Human, Pair 4; Coronary Disease; Coronary Thrombosis; Female; Fibrinogen; Gene Frequency; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; Peptide Fragments; Risk Factors | 1996 |
Association of conventional and exertional coronary heart disease risk factors in 5,000 apparently healthy men.
Topics: Adult; Aged; Coronary Disease; Electrocardiography; Exercise Test; Fibrinogen; Humans; Incidence; Lipids; Male; Mass Screening; Middle Aged; Physical Exertion; Predictive Value of Tests; Prospective Studies; Risk Factors; United Kingdom | 1996 |
Fibrinogen and factor VIIag in healthy adolescents: the Floren-teen (Florence teenager) Study.
Topics: Adolescent; Age Factors; Blood Coagulation; Coronary Disease; Factor VIIa; Female; Fibrinogen; Humans; Male; Prospective Studies; Risk Factors; Sex Factors | 1996 |
Chronic-intermittent urokinase therapy in patients with end-stage coronary artery disease and refractory angina pectoris--a pilot study.
Topics: Aged; Angina Pectoris; Blood Viscosity; Coronary Disease; Drug Administration Schedule; Drug Resistance; Exercise Tolerance; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Pilot Projects; Plasminogen Activators; Urokinase-Type Plasminogen Activator | 1996 |
Lipoprotein(a) and its correlates in Japanese and U.S. population samples.
Topics: Aged; Alcohol Drinking; Analysis of Variance; Asian People; Chi-Square Distribution; Cholesterol; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Humans; Japan; Lipoproteins; Male; Middle Aged; Sampling Studies; Sex Distribution; United States; White People | 1996 |
Serum lipoprotein(a) level is related to thrombin generation and spontaneous intermittent coronary occlusion in patients with acute myocardial infarction.
Topics: Acute Disease; Adult; Aged; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Electrocardiography; Female; Fibrinogen; Fibrinolysin; Hemostasis; Humans; Lipids; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Plasminogen Activators; Thrombin; Time Factors; Tissue Plasminogen Activator; Triglycerides; von Willebrand Factor | 1996 |
Beta-fibrinogen gene-455 G/A polymorphism and fibrinogen levels. Risk factors for coronary artery disease in subjects with NIDDM.
Topics: Adenine; Aged; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Genotype; Guanine; Humans; Hypertension; Male; Middle Aged; Polymorphism, Genetic; Risk Factors | 1996 |
Birthweight, body-mass index in middle age, and incident coronary heart disease.
Topics: Birth Weight; Body Mass Index; Cholesterol; Coronary Disease; Fibrinogen; Humans; Incidence; Infant, Newborn; Logistic Models; Male; Middle Aged; Risk Factors; Smoking; Socioeconomic Factors | 1996 |
Influence of continued smoking and some biological risk factors on restenosis after percutaneous transluminal coronary angioplasty.
Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Endothelins; Epinephrine; Female; Fibrinogen; Humans; Linear Models; Lipids; Logistic Models; Male; Multivariate Analysis; Predictive Value of Tests; Prospective Studies; Recurrence; Risk Factors; Smoking; Tissue Plasminogen Activator | 1996 |
Passive smoking and plasma fibrinogen concentrations.
Topics: Aged; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Humans; Middle Aged; Rural Population; Tobacco Smoke Pollution | 1996 |
Flow cytometric analysis of platelet activation markers CD62P and CD63 in patients with coronary artery disease.
Topics: Adult; Aged; Angiography; Antigens, CD; Biomarkers; Blood Platelets; Cell Adhesion Molecules; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Female; Fibrinogen; Flow Cytometry; Humans; Male; Middle Aged; Platelet Activation; Platelet Membrane Glycoproteins; Tetraspanin 30 | 1996 |
Occupation, fibrinogen, and heart disease.
Topics: Agricultural Workers' Diseases; Coronary Disease; Female; Fibrinogen; Finland; Humans; Male; Middle Aged; Occupational Exposure; Occupations; Risk Factors | 1997 |
Polymorphisms of factor V, factor VII, and fibrinogen genes. Relevance to severity of coronary artery disease.
Topics: Aged; Coronary Disease; Factor V; Factor VII; Female; Fibrinogen; Genes; Genotype; Humans; Male; Polymorphism, Genetic | 1997 |
Regression of transplant coronary artery disease during chronic low-density lipoprotein-apheresis.
Topics: Blood Component Removal; Cholesterol, LDL; Coronary Angiography; Coronary Disease; Coronary Vessels; Fibrinogen; Heart Transplantation; Humans; Lipoprotein(a); Lipoproteins, LDL; Male; Middle Aged; Postoperative Complications; Risk Factors; Treatment Outcome | 1997 |
Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis.
Topics: Aged; Arteriosclerosis; Blood Platelets; Bone Marrow; Coronary Disease; Diabetes Mellitus; Female; Fibrinogen; Flow Cytometry; Humans; Interleukin-6; Male; Megakaryocytes; Middle Aged; Ploidies | 1997 |
Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markers.
Topics: Acute-Phase Reaction; Biomarkers; C-Reactive Protein; Coronary Angiography; Coronary Disease; Cytokines; Female; Fibrinogen; Humans; Immunoenzyme Techniques; Liver; Male; Middle Aged; Risk Factors; Smoking | 1996 |
Association of the fatty acid composition of serum phospholipids with hemostatic factors.
Topics: 8,11,14-Eicosatrienoic Acid; Antigens; Coronary Disease; Factor VII; Fatty Acids; Female; Fibrinogen; Hemostasis; Humans; Linoleic Acid; Linoleic Acids; Lipoprotein(a); Male; Middle Aged; Palmitic Acid; Phospholipids; Plasminogen; Risk Factors | 1997 |
Variation in plasma fibrinogen over one year: relationships with genetic polymorphisms and non-genetic factors.
Topics: Biomarkers; Body Constitution; Cholesterol, HDL; Cohort Studies; Coronary Disease; Deoxyribonuclease HindIII; Deoxyribonucleases, Type II Site-Specific; Energy Metabolism; Fibrinogen; Finland; Humans; Leukocyte Count; Longitudinal Studies; Male; Middle Aged; Oxygen Consumption; Polymorphism, Restriction Fragment Length; Random Allocation; Risk Factors; Time Factors | 1997 |
Circulating transforming growth factor beta 1 and coronary artery disease.
Topics: Aged; Biomarkers; Blood Glucose; Coronary Angiography; Coronary Disease; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Male; Middle Aged; Smoking; Transforming Growth Factor beta | 1997 |
Positive association of the beta fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction.
Topics: Acute-Phase Reaction; Alleles; Biomarkers; Coronary Disease; Fibrinogen; Homozygote; Humans; Male; Myocardial Infarction | 1997 |
Lipid metabolism.
Topics: Adult; Aged; Apolipoprotein E4; Apolipoproteins E; Cerebrovascular Disorders; Child; Cholesterol; Coronary Disease; Exercise; Fibrinogen; Humans; Lipid Metabolism | 1997 |
Hyperlipidaemia and cardiovascular disease.
Topics: Coronary Disease; Fibrinogen; Humans; Hyperlipidemias; Hypolipidemic Agents; Rehabilitation | 1997 |
Haemostatic function in coronary artery disease (CAD).
Topics: Adult; Aged; Bleeding Time; Blood Platelets; Coronary Disease; Female; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Partial Thromboplastin Time; Platelet Adhesiveness; Platelet Aggregation; Platelet Count; Prothrombin Time; Thrombin Time | 1997 |
Chronic work stress is associated with atherogenic lipids and elevated fibrinogen in middle-aged men.
Topics: Adult; Cholesterol, LDL; Coronary Disease; Cross-Sectional Studies; Employment; Fibrinogen; Germany; Humans; Internal-External Control; Logistic Models; Male; Middle Aged; Odds Ratio; Prevalence; Risk Factors; Stress, Psychological; Surveys and Questionnaires | 1997 |
Coagulation factor VII and the risk of coronary heart disease in healthy men.
Topics: Adult; Aged; Body Mass Index; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Diastole; Factor VII; Female; Fibrinogen; Follow-Up Studies; Germany, West; Humans; Incidence; Logistic Models; Male; Middle Aged; Regression Analysis; Risk Factors; Systole; Triglycerides | 1997 |
Helicobacter pylori infection is related to atheroma in patients undergoing coronary angiography.
Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis; Coronary Angiography; Coronary Disease; Coronary Vessels; Factor VII; Female; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; von Willebrand Factor | 1997 |
Plasma fibrinogen levels in healthy postmenopausal women: physical activity and hormone replacement status.
Topics: Aged; Coronary Disease; Estrogen Replacement Therapy; Exercise; Female; Fibrinogen; Humans; Middle Aged; Postmenopause; Risk Factors | 1997 |
Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish Heart Health Study: cohort study.
Topics: Adult; Age Factors; Blood Glucose; Blood Pressure; Body Height; Body Mass Index; Body Weight; Cause of Death; Cholesterol; Cohort Studies; Coronary Disease; Female; Fibrinogen; Humans; Life Style; Male; Middle Aged; Physical Fitness; Potassium; Proportional Hazards Models; Risk Factors; Scotland; Smoking; Sodium; Vitamins | 1997 |
Association of the platelet Pl(A) polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bbeta 448 polymorphism with myocardial infarction and extent of coronary artery disease.
Topics: Cardiovascular Diseases; Coronary Angiography; Coronary Disease; Female; Fibrinogen; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Count; Platelet Glycoprotein GPIb-IX Complex; Polymorphism, Genetic; Risk Factors | 1997 |
Altered platelet function detected by flow cytometry. Effects of coronary artery disease and age.
Topics: Adult; Age Factors; Aged; Blood Platelets; Coronary Disease; Female; Fibrinogen; Flow Cytometry; Humans; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Smoking | 1997 |
Aggressive lowering of fibrinogen and cholesterol in the prevention of graft vessel disease after heart transplantation.
Topics: Adult; Aged; Anticholesteremic Agents; Blood Component Removal; Cholesterol; Coronary Disease; Female; Fibrinogen; Heart Transplantation; Humans; Male; Middle Aged; Simvastatin | 1997 |
Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients.
Topics: Adult; Aged; Apolipoproteins B; Austria; Cholesterol, HDL; Comorbidity; Coronary Disease; Cross-Sectional Studies; Diabetes Mellitus; Female; Fibrinogen; Humans; Hypertension; Kidney Failure, Chronic; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Phenotype; Prevalence; Renal Dialysis; Risk Factors; Smoking | 1997 |
Restenosis after elective coronary balloon angioplasty in patients with end stage renal disease: a case-control study using quantitative coronary angiography.
Topics: Angioplasty, Balloon, Coronary; Case-Control Studies; Cholesterol; Cholesterol, HDL; Coronary Angiography; Coronary Disease; Fibrinogen; Humans; Kidney Failure, Chronic; Male; Middle Aged; Recurrence; Retrospective Studies; Triglycerides | 1997 |
Levels of activated FXII in survivors of myocardial infarction--association with circulating risk factors and extent of coronary artery disease.
Topics: Case-Control Studies; Cholesterol; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Factor VII; Factor XIIa; Female; Fibrinogen; Humans; Insulin; Male; Myocardial Infarction; Risk Factors; Survivors; Tissue Plasminogen Activator; Triglycerides | 1998 |
[Acute coronary vessel occlusion after PTCA--possibility of risk stratification using quantitative coronary angiography, clinical determinants and laboratory chemistry parameters].
Topics: Aged; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Coronary Thrombosis; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prognosis; Retrospective Studies; Risk Factors | 1997 |
Plasma total homocysteine levels in patients with early-onset coronary heart disease and a low cardiovascular risk profile.
Topics: Adult; Body Constitution; Body Mass Index; Cholesterol, HDL; Coronary Disease; Cysteine; Female; Fibrinogen; Glutathione; Homocysteine; Humans; Lipoproteins; Lipoproteins, VLDL; Male; Middle Aged; Risk Factors; Sex Characteristics; Triglycerides; Uric Acid | 1998 |
Fibrinogen and coronary heart disease--what does it mean?
Topics: Arteriosclerosis; Biomarkers; Coronary Disease; Female; Fibrinogen; Humans; Male; Risk Factors | 1998 |
Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women. The Scottish Heart Health Study.
Topics: Adult; Biomarkers; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Mortality; Predictive Value of Tests; Proportional Hazards Models; Risk Factors; Smoking | 1998 |
Effects of hormone replacement therapies on fibrinogen and plasma viscosity in postmenopausal women.
Topics: Aged; Blood Viscosity; Coronary Disease; Drug Combinations; Estrogen Replacement Therapy; Estrogens; Female; Fibrinogen; Humans; Middle Aged; Multivariate Analysis; Progesterone | 1998 |
Selective alpha v beta 3 integrin blockade potently limits neointimal hyperplasia and lumen stenosis following deep coronary arterial stent injury: evidence for the functional importance of integrin alpha v beta 3 and osteopontin expression during neointi
Topics: Animals; Cell Adhesion; Cell Movement; Coronary Disease; Coronary Vessels; Endothelium, Vascular; Fibrinogen; Osteopontin; Peptides, Cyclic; Protein Binding; Receptors, Vitronectin; Recurrence; Sialoglycoproteins; Stents; Swine; Vitronectin | 1997 |
U-shaped and J-shaped relationships between serum insulin and coronary heart disease in the general population. The Bruneck Study.
Topics: Adult; Age Factors; Aged; Analysis of Variance; Antithrombin III; Apolipoprotein A-I; Blood Glucose; Body Mass Index; Cholesterol, HDL; Coronary Disease; Cross-Sectional Studies; Electrocardiography; Fasting; Female; Fibrinogen; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hypertension; Insulin; Italy; Male; Middle Aged; Models, Statistical; Risk Factors; Sex Factors; Triglycerides | 1998 |
Sex differences in coagulation and fibrinolysis in subjects with coronary artery disease.
Topics: Antigens; Arteriosclerosis; Blood Coagulation; Chest Pain; Comorbidity; Coronary Angiography; Coronary Disease; Diabetes Mellitus; England; Factor VII; Female; Fibrinogen; Fibrinolysis; Humans; Hypertension; Lipids; Male; Middle Aged; Obesity; Plasminogen Activator Inhibitor 1; Retrospective Studies; Risk Factors; Sex Factors; Smoking; von Willebrand Factor | 1998 |
Hemostatic/fibrinolytic predictors of allograft coronary artery disease after cardiac transplantation.
Topics: Adult; Arteriosclerosis; Biomarkers; Coronary Angiography; Coronary Disease; Female; Fibrinogen; Fibrinolysis; Heart Transplantation; Hemostasis; Humans; Male; Middle Aged; Risk Factors; Thrombosis | 1997 |
Relationships between fasting plasma insulin, anthropometrics, and metabolic parameters in a very old healthy population. Associazione Medica Sabin.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Anthropometry; Apolipoprotein A-I; Biomarkers; Blood Glucose; Body Constitution; Body Mass Index; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Factor VII; Fasting; Female; Fibrinogen; Humans; Insulin; Male; Multivariate Analysis; Obesity; Plasminogen Activator Inhibitor 1; Regression Analysis; Risk Factors; Sex Factors; Triglycerides | 1998 |
Lack of association between platelet glycoprotein IIb/IIIa receptor PlA polymorphism and coronary artery disease or carotid intima-media thickness.
Topics: Adult; Antigens, Human Platelet; Binding Sites; Blood Platelets; Carotid Arteries; Coronary Disease; DNA; DNA Primers; Fibrinogen; Humans; Integrin beta3; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Polymerase Chain Reaction; Polymorphism, Genetic; Ultrasonography; von Willebrand Factor | 1998 |
Polymorphism of the platelet glycoprotein IIIa gene in patients with coronary stenosis.
Topics: Aged; Alcohol Drinking; Alleles; Angioplasty, Balloon, Coronary; Combined Modality Therapy; Comorbidity; Coronary Disease; Diabetes Mellitus; Female; Fibrinogen; Gene Frequency; Genotype; Humans; Hypertension; Lipids; Male; Middle Aged; Platelet Glycoprotein GPIIb-IIIa Complex; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Prevalence; Risk Factors; Smoking; Stents | 1998 |
Association of DEXA-assessed total body fat mass with serum lipids and haemostatic variables.
Topics: Absorptiometry, Photon; Adipose Tissue; Adult; Antigens; Body Composition; Coronary Disease; Factor VII; Female; Fibrinogen; Hemostasis; Humans; Lipids; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Risk Factors; Tissue Plasminogen Activator | 1998 |
Association of dietary fish and n-3 fatty acid intake with hemostatic factors in the coronary artery risk development in young adults (CARDIA) study.
Topics: Adult; Animals; Black People; Coronary Disease; Diet; Dietary Fats, Unsaturated; Factor VII; Factor VIII; Fatty Acids, Omega-3; Female; Fibrinogen; Fishes; Hemostasis; Humans; Male; Prospective Studies; Risk Factors; von Willebrand Factor; White People | 1998 |
Increased platelet activation and fibrinogen in Asian Indians. Potential implications for coronary risk.
Topics: Adult; Coronary Disease; Cross-Cultural Comparison; Female; Fibrinogen; Humans; India; Male; Middle Aged; Platelet Activation; Risk Factors | 1998 |
Arterial uptake of biodegradable nanoparticles for intravascular local drug delivery: results with an acute dog model.
Topics: Angioplasty, Balloon; Animals; Arteries; Biocompatible Materials; Biodegradation, Environmental; Chromones; Coronary Disease; Disease Models, Animal; Dogs; Drug Delivery Systems; Endothelium, Vascular; Fibrinogen; Fibrinolytic Agents; Heparin; Infusions, Intra-Arterial; Lactic Acid; Male; Morpholines; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Postoperative Complications | 1998 |
Hemorheological parameters in coronary artery disease.
Topics: Adult; Blood Viscosity; Coronary Angiography; Coronary Disease; Fibrinogen; Hemodynamics; Humans; Middle Aged; Risk Factors | 1998 |
Hyperlipidaemia and cardiovascular disease.
Topics: Coronary Disease; Exercise; Female; Fibrinogen; Humans; Hyperlipidemias; Male; Risk Factors; Smoking Cessation | 1998 |
Smoking, lipoproteins and coronary heart disease risk. Data from the Münster Heart Study (PROCAM).
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Coronary Disease; Female; Fibrinogen; Germany; Humans; Lipoproteins; Logistic Models; Male; Prospective Studies; Risk Factors; Smoking | 1998 |
Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement.
Topics: Abciximab; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Binding Sites; Blood Platelets; Coronary Disease; Drug Therapy, Combination; Female; Fibrinogen; Gene Expression Regulation; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Ligands; Male; Middle Aged; Myocardial Ischemia; P-Selectin; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoproteins; Stents; Thrombocytopenia; Ticlopidine | 1998 |
Relationship between plasma fibrinogen and coronary heart disease in women.
Topics: Adult; Aged; Angina Pectoris; Body Mass Index; C-Reactive Protein; Case-Control Studies; Coronary Disease; Female; Fibrinogen; Hospitalization; Humans; Lipids; Logistic Models; Menopause; Middle Aged; Myocardial Infarction; Reference Values; Risk Factors; Smoking | 1999 |
Cytomegalovirus infection and coronary heart disease: results of a german case-control study.
Topics: Adult; Age Factors; Aged; Antibodies, Viral; Biomarkers; Blood Viscosity; C-Reactive Protein; Case-Control Studies; Confidence Intervals; Coronary Disease; Cytomegalovirus Infections; Female; Fibrinogen; Germany; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Leukocyte Count; Male; Middle Aged; Odds Ratio | 1999 |
Symptoms of chronic bronchitis, haemostatic factors, and coronary heart disease risk.
Topics: Blood Coagulation Factors; Body Mass Index; Bronchitis; Chronic Disease; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Finland; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Plasminogen; Retrospective Studies; Risk Factors; Smoking; Surveys and Questionnaires | 1999 |
Oral contraceptive use and hemodynamic, lipid, and fibrinogen responses to smoking and stress in women.
Topics: Adolescent; Adult; Contraceptives, Oral; Coronary Disease; Female; Fibrinogen; Humans; Lipids; Risk Factors; Smoking; Stress, Psychological | 1999 |
Association of negative and positive social ties with fibrinogen levels in young women.
Topics: Adult; Arousal; Coronary Disease; Female; Fibrinogen; Hemostasis; Humans; Personality Assessment; Risk Factors; Social Support | 1999 |
Fibrinogen gene polymorphism in a non-Caucasian population.
Topics: Aged; Alleles; Asian People; Body Mass Index; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Deoxyribonucleases, Type II Site-Specific; Female; Fibrinogen; Gene Frequency; Humans; Korea; Male; Middle Aged; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Triglycerides | 1999 |
The relationship between fibrinogen and other coronary heart disease risk factors in a Chinese population.
Topics: Adult; Age Distribution; Aged; Analysis of Variance; Case-Control Studies; China; Comorbidity; Coronary Disease; Cross-Sectional Studies; Data Collection; Diabetes Mellitus; Female; Fibrinogen; Humans; Hypertension; Incidence; Linear Models; Male; Middle Aged; Obesity; Random Allocation; Risk Assessment; Risk Factors; Sampling Studies; Sex Distribution; Smoking | 1999 |
Association of the alpha-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation.
Topics: Amino Acid Substitution; Atrial Fibrillation; Brain Ischemia; Comorbidity; Coronary Disease; Diabetes Mellitus; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Hypertension; Male; Point Mutation; Polymorphism, Genetic; Risk; Risk Factors; Smoking; Survival Analysis; Thromboembolism; Thrombophilia; Transglutaminases | 1999 |
An ecological study of determinants of coronary heart disease rates: a comparison of Czech, Bavarian and Israeli men.
Topics: Aged; Blood Glucose; Blood Pressure; Coronary Disease; Czechoslovakia; Fibrinogen; Germany; Homocysteine; Humans; Israel; Lipoproteins; Male; Middle Aged; Prevalence; Risk Factors; Triglycerides | 1999 |
Differences between activation thresholds for platelet P-selectin glycoprotein IIb-IIIa expression and their clinical implications.
Topics: Aspirin; Blood Platelets; Coronary Disease; Fibrinogen; Humans; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding | 1999 |
Apolipoprotein E and methylenetetrahydrofolate reductase genetic polymorphisms in relation to other risk factors for cardiovascular disease in UK Caucasians and Black South Africans.
Topics: Alleles; Apolipoproteins E; Black People; Blood Pressure; Coronary Disease; Fibrinogen; Genotype; Humans; Lipids; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Risk Factors; South Africa; United Kingdom; White People | 1999 |
Increased cerebral CO(2) reactivity after heparin-mediated extracorporal LDL precipitation (HELP) in patients with coronary heart disease and hyperlipidemia.
Topics: Aged; Anticoagulants; Blood Component Removal; Blood Viscosity; Carbon Dioxide; Cerebral Arteries; Cerebrovascular Circulation; Chemical Precipitation; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Extracorporeal Circulation; Fibrinogen; Heparin; Humans; Hyperlipidemias; Lipoprotein(a); Middle Aged; Prospective Studies; Triglycerides; Ultrasonography, Doppler, Transcranial | 1999 |
Plasma fibrinogen and its correlates in elderly Japanese men living in Japan and Hawaii.
Topics: Aged; Aged, 80 and over; Asian; California; Cholesterol, HDL; Coronary Disease; Cross-Sectional Studies; Fibrinogen; Hawaii; Hematocrit; Humans; Japan; Leukocyte Count; Life Style; Male; Middle Aged; Prevalence; Retrospective Studies; Risk Factors; Stroke; Triglycerides | 1999 |
Hyperfibrinogenemia is an independent risk factor for atherosclerotic renal artery stenosis.
Topics: Aged; Arteriosclerosis; Blood Coagulation Disorders; Coronary Angiography; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Renal Artery Obstruction; Retrospective Studies; Risk Factors; Severity of Illness Index | 1999 |
Contribution of the -455G/A polymorphism at the beta-fibrinogen gene to erythrocyte aggregation in patients with coronary artery disease.
Topics: 5' Untranslated Regions; Adult; Comorbidity; Coronary Disease; Erythrocyte Aggregation; Female; Fibrinogen; Gene Expression Regulation; Genetic Markers; Genetic Predisposition to Disease; Genotype; Humans; Linkage Disequilibrium; Male; Middle Aged; Point Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Quebec; Smoking | 1999 |
Development and evaluation of a new canine myocardial infarction model using a closed-chest injection of thrombogenic material.
Topics: Animals; Aspartate Aminotransferases; Blood Pressure; Blood Transfusion, Autologous; Coronary Disease; Coronary Thrombosis; Creatine Kinase; Disease Models, Animal; Dogs; Electrocardiography; Fibrinogen; Heart Rate; Hydroxybutyrate Dehydrogenase; Injections, Intra-Arterial; Isoenzymes; Myocardial Infarction; Organ Size; Pulmonary Wedge Pressure; Stroke Volume; Thrombin; Vascular Patency | 1999 |
Relation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men.
Topics: Aged; Biomarkers; Blood Platelets; Cholesterol, HDL; Cholesterol, LDL; Circadian Rhythm; Coronary Disease; Fibrinogen; Humans; Lipoprotein(a); Male; Middle Aged; Platelet Count; Prognosis; Reproducibility of Results; Retrospective Studies; Triglycerides | 2000 |
Increased plasma levels of fibrinogen in acute and chronic ischemic coronary syndromes.
Topics: Acute Disease; Aged; Analysis of Variance; Angina, Unstable; Chronic Disease; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Risk Factors; Syndrome; Time Factors | 1999 |
Significance of acute multiple brain infarction on diffusion-weighted imaging.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Arteriosclerosis; Brain; Cerebral Infarction; Coronary Disease; Diffusion; Embolism; Female; Fibrinogen; Hematocrit; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Middle Aged | 2000 |
Successful eradication of Helicobacter pylori as determined by ((13))C-urea breath test does not alter fibrinogen and acute phase response markers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute-Phase Reaction; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Biomarkers; Breath Tests; Cholesterol, HDL; Cholesterol, LDL; Clarithromycin; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Sulfoxides; Treatment Outcome; Triglycerides; Urea | 2000 |
The Pl(A2) polymorphism of integrin beta(3) enhances outside-in signaling and adhesive functions.
Topics: Actins; Alleles; Amino Acid Substitution; Animals; Antigens, Human Platelet; Biopolymers; Cell Adhesion Molecules; Cell Line; Cell Size; CHO Cells; Clot Retraction; Coronary Disease; Cricetinae; Cricetulus; Cytochalasin D; Cytoskeleton; Female; Fibrinogen; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Genetic Predisposition to Disease; Humans; Kidney; Male; Phosphorylation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Point Mutation; Polymorphism, Genetic; Protein Isoforms; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Risk Factors; Signal Transduction | 2000 |
Fibrinogen, angina and coronary heart disease in a Chinese population.
Topics: Adult; Age Distribution; Aged; Aging; Analysis of Variance; Angina Pectoris; Asian People; China; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Hong Kong; Humans; Incidence; Linear Models; Male; Middle Aged; Multivariate Analysis; Population Surveillance; Risk Factors; Sex Distribution; Survival Rate | 2000 |
Hemostatic function and coronary artery disease.
Topics: Coronary Disease; Fibrinogen; Hemostasis; Humans | 2000 |
Coronary artery disease and infection with chlamydia pneumonia.
Topics: Antibodies; C-Reactive Protein; Case-Control Studies; Chlamydia Infections; Coronary Disease; Female; Fibrinogen; Humans; Immunoglobulin G; Lipids; Male; Middle Aged; Pneumonia; Prospective Studies | 2000 |
Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study.
Topics: Apolipoproteins; Body Constitution; Cholesterol, HDL; Coronary Disease; Diabetes Mellitus, Type 2; Factor VIII; Female; Fibrinogen; Follow-Up Studies; Humans; Incidence; Leukocyte Count; Male; Middle Aged; Prospective Studies; Risk Factors; Serum Albumin; von Willebrand Factor | 2000 |
Plasma fibrinogen of black South Africans: the BRISK study.
Topics: Adolescent; Adult; Age Factors; Black People; Body Mass Index; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Health Surveys; Humans; Incidence; Male; Middle Aged; Regression Analysis; Risk Factors; Sex Factors; South Africa; Stroke | 1998 |
Association of fibrinogen with quantity of coronary artery calcification measured by electron beam computed tomography.
Topics: Adult; Aged; Aged, 80 and over; Calcinosis; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Tomography, X-Ray Computed | 2000 |
Plasma fibrinogen and coronary heart disease in urban Japanese.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Coronary Disease; Female; Fibrinogen; Humans; Incidence; Japan; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Risk Factors; Sex Factors; Urban Population | 2000 |
Seasonal variations in coronary heart disease.
Topics: Coronary Disease; Fibrinogen; Humans; Incidence; Respiratory Tract Infections; Seasons | 2000 |
Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Anticholesteremic Agents; Biomarkers; C-Reactive Protein; Case-Control Studies; Cholesterol; Coronary Disease; Fibrinogen; Humans; Hypercholesterolemia; Inflammation; Leukocyte Count; Logistic Models; Male; Middle Aged; Myocardial Infarction; Phospholipases A; Phospholipases A2; Pravastatin; Risk Factors; Triglycerides | 2000 |
Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease.
Topics: Biomarkers; Blood Coagulation Factors; Coronary Disease; Factor IXa; Factor VIIa; Factor Xa; Fibrinogen; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Regression Analysis; Risk Assessment; Risk Factors; ROC Curve | 2000 |
Racial and genetic determinants of plasma factor XIII activity.
Topics: Adult; Asian People; China; Coronary Disease; Factor XIII; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Plasminogen; Polymorphism, Genetic; Risk Assessment; White People | 2000 |
Determinants of haemostatic risk factors for coronary heart disease in obese children and adolescents.
Topics: Adolescent; Body Composition; Child; Child, Preschool; Coronary Disease; Factor VII; Female; Fibrinogen; Hemostasis; Humans; Insulin; Male; Obesity; Physical Fitness; Plasminogen Inactivators; Risk Factors; Triglycerides | 2000 |
Increased plasma fibrinogen level and future risk of coronary artery disease after repair of abdominal aortic aneurysm.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Analysis of Variance; Aortic Aneurysm, Abdominal; Cardiovascular Diseases; Cause of Death; Cerebrovascular Disorders; Coronary Disease; Female; Fibrinogen; Humans; Incidence; Male; Middle Aged; Postoperative Complications; Prognosis; Proportional Hazards Models; Renal Insufficiency; Retrospective Studies; Risk Factors; Smoking; Survival Analysis | 2000 |
Rebuttal to circulating IL-6 levels in chronic obstructive pulmonary disease.
Topics: Coronary Disease; Fibrinogen; Humans; Interleukin-6; Lung Diseases, Obstructive; Risk Factors | 2001 |
Beta-fibrinogen gene -455G/A polymorphism and coronary heart disease incidence: the Atherosclerosis Risk in Communities (ARIC) Study.
Topics: Adenine; Alleles; Arteriosclerosis; Cohort Studies; Coronary Disease; Fibrinogen; Genotype; Guanine; Humans; Incidence; Male; Middle Aged; Polymorphism, Genetic; Prospective Studies; Risk Factors; United States | 2001 |
C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris.
Topics: Adult; Aged; Aged, 80 and over; Angina, Unstable; C-Reactive Protein; Coronary Disease; Factor Analysis, Statistical; Female; Fibrinogen; Humans; Interleukin-6; Male; Myocardial Infarction; Prognosis; Retrospective Studies; Risk Assessment; Syndrome; Tumor Necrosis Factor-alpha | 2001 |
Effects of short-term energy restriction and physical training on haemostatic risk factors for coronary heart disease in obese children and adolescents.
Topics: Adolescent; Antigens; Body Composition; Child; Coronary Disease; Diet, Reducing; Energy Intake; Exercise; Factor VII; Female; Fibrinogen; Homeostasis; Humans; Longitudinal Studies; Male; Obesity; P-Selectin; Risk Factors; von Willebrand Factor; Weight Loss; White People | 2001 |
PCR-RFLP genotyping assay for the Bcl I polymorphism of the beta-fibrinogen gene.
Topics: Alleles; Automation; Coronary Disease; Deoxyribonucleases, Type II Site-Specific; DNA Mutational Analysis; Fibrinogen; Genetic Testing; Genotype; Humans; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Time Factors | 2001 |
Evaluation of C-reactive protein, fibrinogen and antithrombin-III as risk factors for coronary artery disease.
Topics: Angina Pectoris; Antithrombin III; C-Reactive Protein; Coronary Angiography; Coronary Disease; Female; Fibrinogen; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Risk Factors; Serine Proteinase Inhibitors; Smoking | 2001 |
Quantification by flow cytometry of the efficacy of and interindividual variation of platelet inhibition induced by treatment with tirofiban and abciximab.
Topics: Abciximab; Adult; Aged; Antibodies, Monoclonal; Coronary Disease; Female; Fibrinogen; Flow Cytometry; Humans; Immunoglobulin Fab Fragments; Infusions, Intravenous; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Tirofiban; Tyrosine | 2001 |
The association of c-reactive protein, serum amyloid a and fibrinogen with prevalent coronary heart disease--baseline findings of the PAIS project.
Topics: Adult; Age Distribution; Aged; Apolipoproteins; Biomarkers; C-Reactive Protein; Comorbidity; Confidence Intervals; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Finland; Humans; Incidence; Inflammation Mediators; Male; Middle Aged; Obesity; Odds Ratio; Probability; Risk Assessment; Risk Factors; Sensitivity and Specificity; Serum Amyloid A Protein; Sex Distribution; Smoking | 2001 |
Chlamydia pneumonia seropositivity correlates with serum fibrinogen and lipoprotein a levels: any role in atherosclerosis?
Topics: Aged; Antibodies, Bacterial; Arteriosclerosis; C-Reactive Protein; Cardiovascular Diseases; Carotid Artery Diseases; Chlamydophila pneumoniae; Cholesterol, LDL; Coronary Disease; Diabetes Complications; Diabetes Mellitus; Female; Fibrinogen; Humans; Immunoglobulin G; Lipoprotein(a); Male; Middle Aged; Risk Factors; Sex Factors; Triglycerides | 2001 |
Insulin resistance as a major determinant of increased coronary heart disease risk in postmenopausal women with Type 2 diabetes mellitus.
Topics: Absorptiometry, Photon; Adipose Tissue; Aged; Albuminuria; Blood Glucose; Blood Pressure; Cholesterol; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Electrocardiography; Factor VII; Female; Fibrinogen; Homeostasis; Humans; Insulin; Insulin Resistance; Lipoproteins; Lipoproteins, LDL; Middle Aged; Models, Biological; Plasminogen Activator Inhibitor 1; Postmenopause; Proinsulin; Risk Factors; Triglycerides | 2001 |
Chlamydia pneumoniae exposure and inflammatory markers in acute coronary syndrome (CIMACS).
Topics: Acute Disease; Aged; Analysis of Variance; Angina, Unstable; Antibodies, Bacterial; Biomarkers; C-Reactive Protein; Chlamydophila Infections; Chlamydophila pneumoniae; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Humans; Immunoglobulin G; Leukocyte Count; Male; Middle Aged; Syndrome | 2001 |
Why do smokers have higher plasma fibrinogen levels than non-smokers?
Topics: Case-Control Studies; Coronary Disease; Cytokines; Dose-Response Relationship, Drug; Fibrinogen; Humans; Male; Smoking; Smoking Cessation | 2001 |
Fibrinogen genotypes (alpha and beta) are associated with plasma fibrinogen levels in Chinese.
Topics: Adult; Aged; Analysis of Variance; Asian People; China; Coronary Disease; Environment; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Linkage Disequilibrium; Male; Middle Aged; Polymorphism, Restriction Fragment Length; Risk Factors; Singapore; Smoking | 2001 |
C-reactive protein and coronary heart disease in western Turkey.
Topics: Adult; Age Distribution; Aged; Biomarkers; Body Mass Index; C-Reactive Protein; Cohort Studies; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Odds Ratio; Prevalence; Prospective Studies; Risk Factors; Surveys and Questionnaires; Turkey | 2001 |
Haemorheological, endothelial and platelet function in subjects with hypertension: relationship to cardiovascular risk and influence of antihypertensive treatment.
Topics: Antihypertensive Agents; Biomarkers; Blood Viscosity; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Hypertension; Male; P-Selectin; Risk Factors; Stroke; von Willebrand Factor | 2001 |
[Fibrinogen: a cardiovascular risk factor].
Topics: Adult; Aged; Aortic Diseases; Arteriosclerosis; Cardiovascular Diseases; Coronary Angiography; Coronary Disease; Female; Fibrinogen; Humans; Leg; Life Style; Male; Pregnancy; Prospective Studies; Risk; Risk Factors; Smoking; Stroke | 2000 |
Hemostatic factors as predictors of coronary events and total mortality: The FINRISK '92 Hemostasis Study.
Topics: Antigens; Biological Factors; Cholesterol; Cohort Studies; Coronary Disease; Factor VII; Female; Fibrinogen; Follow-Up Studies; Humans; Lipoprotein(a); Male; Middle Aged; Plasminogen; Predictive Value of Tests; Prospective Studies; Risk Factors; Survival Analysis; Survival Rate | 2002 |
Fibrinogen: associations with cardiovascular events in an outpatient clinic.
Topics: Biomarkers; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Prognosis; Regression Analysis | 2002 |
Discriminative value of serum amyloid A and other acute-phase proteins for coronary heart disease.
Topics: Acute-Phase Proteins; Adult; Antibodies, Bacterial; Antibodies, Viral; Body Mass Index; C-Reactive Protein; Chlamydophila pneumoniae; Coronary Disease; Cytomegalovirus; Fibrinogen; Haptoglobins; Helicobacter pylori; Humans; Inflammation; Male; Middle Aged; Risk Factors; Serum Amyloid A Protein | 2002 |
Blood glucose concentrations < or = 125 mg/dl and coronary heart disease risk.
Topics: Adult; Aged; Blood Glucose; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Homocysteine; Humans; Male; Middle Aged; Prediabetic State; Risk Factors | 2002 |
Suboptimal early inhibition of platelets by treatment with tirofiban and implications for coronary interventions.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Blood Coagulation Tests; Coronary Disease; Drug Therapy, Combination; Fibrinogen; Heparin; Humans; Immunoglobulin Fab Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Tirofiban; Tyrosine | 2002 |
Rheological determinants of red blood cell aggregation in diabetic patients in relation to their metabolic control.
Topics: Acute-Phase Proteins; Blood Glucose; Blood Sedimentation; C-Reactive Protein; Cell Adhesion; Cell Aggregation; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Erythrocytes; Female; Fibrinogen; Hemorheology; Humans; In Vitro Techniques; Leukocyte Count; Male; Sensitivity and Specificity; Triglycerides | 2002 |
Hypertriglyceridemia is associated with an elevated blood viscosity Rosenson: triglycerides and blood viscosity.
Topics: Adult; Aged; Blood Viscosity; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Humans; Hypertriglyceridemia; Male; Middle Aged; Probability; Regression Analysis; Sampling Studies; Sensitivity and Specificity; Triglycerides | 2002 |
Association of fibrinogen and lipoprotein(a) as a coronary heart disease risk factor in men (The Quebec Cardiovascular Study).
Topics: Adult; Age Factors; Biomarkers; Blood Pressure; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Fibrinogen; Follow-Up Studies; Humans; Lipoprotein(a); Male; Middle Aged; Prospective Studies; Quebec; Risk Factors; Smoking; Triglycerides | 2002 |
Tissue plasminogen activator, fibrin D-dimer, and insulin resistance in the relatives of patients with premature coronary artery disease.
Topics: Adult; Coronary Disease; Family; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Insulin Resistance; Male; Middle Aged; Regression Analysis; Tissue Plasminogen Activator | 2002 |
Water, other fluids, and fatal coronary heart disease: the Adventist Health Study.
Topics: Adult; Aged; Beverages; Blood Viscosity; California; Confounding Factors, Epidemiologic; Coronary Disease; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Risk Factors; Water | 2002 |
Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults.
Topics: Adult; C-Reactive Protein; Coronary Disease; Cross-Sectional Studies; Exercise; Female; Fibrinogen; Humans; Inflammation; Leukocyte Count; Logistic Models; Male; Middle Aged; Odds Ratio; Risk Factors; United States | 2002 |
[Whole blood- and plasma viscosity in the presence of coronary risk factors. Investigations concerning the characteristics of blood flow and viscosity-effective plasma components in patients with coronary risk factors and risk factor combinations (author'
Topics: alpha-Macroglobulins; Beta-Globulins; Blood Viscosity; Cholesterol; Coronary Disease; Female; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Immunoglobulin G; Immunoglobulin M; Lipoproteins, LDL; Male; Obesity; Smoking; Triglycerides | 1977 |
The great circulatory paradox.
Topics: Autoradiography; Coronary Disease; Fibrinogen; Humans; Iodine Radioisotopes; Isotope Labeling; Myocardial Infarction | 1977 |
Short heparin thrombin clotting time, increased fibrinogen and platelet aggregates count in coronary disease: a probable hypercoagulable state.
Topics: Adult; Aged; Blood Coagulation; Coronary Disease; Female; Fibrinogen; Heparin; Humans; Male; Middle Aged; Platelet Aggregation; Thrombin Time | 1979 |
Fibrinolysis in patients with ischemic heart disease (in relation to the etiologic factor of myocardial infarction).
Topics: Acute Disease; Angina Pectoris; Coronary Disease; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Lipids; Middle Aged; Myocardial Infarction; Plasminogen; Serum Globulins; Streptokinase | 1975 |
Investigations on the changes of the blood coagulation-fibrinolysis system as a risk factor for coronary heart disease. I. Prevalence of the changes in the blood coagulation-fibrinolysis system in a middle aged male population.
Topics: Adult; Age Factors; Blood Coagulation Disorders; Blood Platelets; Coronary Disease; Fibrinogen; Fibrinolysin; Humans; Male; Middle Aged; Platelet Adhesiveness; Platelet Factor 3; Risk; Romania | 1975 |
Investigations on the changes of the blood coagulation-fibrinolysis system as a risk factor of coronary heart disease. II. Changes of platelets, fibrinogen and antiplasmins in a group of 2,000 middle aged men (40-60 years) periodically followed up for thr
Topics: Adult; Age Factors; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelets; Coronary Disease; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Male; Middle Aged; Platelet Adhesiveness; Sex Factors | 1975 |
[Fibrinolytic activity of blood flowing through the heart ventricles and major vessels of rats under normal conditions and in experimental myocardial ischemia].
Topics: Animals; Blood Coagulation Tests; Coronary Disease; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Heart Ventricles; Jugular Veins; Male; Plasminogen Activators; Pulmonary Artery; Rats; Venae Cavae | 1977 |
[Blood viscosity in ischemic heart disease with different types of hyperlipoproteinemia].
Topics: Adult; Aged; Blood Viscosity; Coronary Disease; Female; Fibrinogen; Hematocrit; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Triglycerides | 1977 |
[Rheologic, coagulative parameters and study of fibrinolysis in patients with coronary heart disease before and after aorto-coronary by-pass (author's transl)].
Topics: Adult; Aged; Blood Coagulation; Blood Coagulation Tests; Blood Flow Velocity; Blood Viscosity; Complement C3; Complement C4; Coronary Artery Bypass; Coronary Disease; Female; Fibrinogen; Fibrinolysis; Hematocrit; Humans; Male; Middle Aged; Prothrombin Time | 1978 |
Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations.
Topics: Adolescent; Adult; Alcohol Drinking; Contraceptives, Oral; Coronary Disease; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Physical Exertion; Skinfold Thickness; Smoking; Social Class | 1979 |
[The clofibrate-dipyridamole combination in the treatment of athero-arteriosclerotic vasculopathy].
Topics: Adult; Aged; Arteriosclerosis; Clofibrate; Coronary Disease; Dipyridamole; Drug Combinations; Drug Evaluation; Female; Fibrinogen; Glucose Tolerance Test; Humans; Lipids; Male; Middle Aged; Platelet Aggregation; Prothrombin | 1979 |
[State of hemostasis and blood rheology in congestive circulatory insufficiency].
Topics: Blood Viscosity; Coronary Disease; Erythrocyte Aggregation; Fibrinogen; Heart Failure; Hematocrit; Hemostasis; Humans; Myocardial Infarction; Platelet Aggregation; Thromboembolism | 1979 |
The relation of coronary thrombosis to ischaemic myocardial necrosis.
Topics: Cardiomyopathies; Coronary Disease; Coronary Vessels; Death, Sudden; Fibrinogen; Humans; Myocardial Infarction; Necrosis; Radioisotopes | 1979 |
[The clinical significance of blood viscosity in degenerative angiopathies].
Topics: Blood Proteins; Blood Viscosity; Cholesterol; Coronary Disease; Female; Fibrinogen; Hematocrit; Humans; Lipids; Male; Myocardial Infarction; Vascular Diseases | 1979 |
[Blood sterol-fibrinogen complexes in chronic ischemic heart disease].
Topics: Adult; Aged; Angina Pectoris; Chronic Disease; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Protein Binding; Sterols | 1979 |
[Blood fibrinogen-bound sterols in ischemic heart disease].
Topics: Adult; Cholesterol; Chronic Disease; Coronary Disease; Female; Fibrinogen; Free Radicals; Humans; Lipids; Male; Middle Aged; Protein Binding; Sterols | 1979 |
[Fibrinogen metabolism in congestive circulatory insufficiency].
Topics: Aged; Arrhythmias, Cardiac; Body Fluid Compartments; Coronary Disease; Fibrinogen; Half-Life; Heart Failure; Humans; Iodine Radioisotopes; Middle Aged; Mitral Valve Insufficiency; Rheumatic Heart Disease | 1977 |
[Changes in systemic blood viscosity in subjects with regional chronic vasculopathies during spontaneous and induced ischemia].
Topics: Adult; Angina Pectoris; Arterial Occlusive Diseases; Blood Viscosity; Chronic Disease; Coronary Disease; Diabetic Angiopathies; Diabetic Retinopathy; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Myocardial Infarction; Osmotic Fragility | 1977 |
[Quantitative analysis of fibrinmonomer in Arwin-therapy (author's transl)].
Topics: Ancrod; Coronary Disease; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Humans | 1978 |
[Nonenzymatic fibrinolysis in ischemic heart disease].
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Epinephrine; Fibrinogen; Fibrinolysis; Heparin; Humans; Middle Aged; Myocardial Infarction | 1978 |
[Determination of the sterol content in fibrinogen as a method of diagnosing the progression of arteriosclerosis].
Topics: Adult; Coronary Disease; Fibrinogen; Humans; Hyperlipidemias; Male; Middle Aged; Sterols | 1978 |
[Characteristics of the indicators of the blood coagulation and fibrinolysis systems in the pre-clinical stage of ischemic heart disease].
Topics: Adult; Antithrombin III; Blood Coagulation; Coronary Disease; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Plasminogen Activators; Risk | 1978 |
[Survival of blood platelets and fibrinogen in patients with ischemic cardiopathy].
Topics: Aged; Blood Platelets; Cell Survival; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged | 1977 |
Studies on the hemorheological factors in ischemic heart disease and cerebrovascular disorders.
Topics: Blood Viscosity; Cerebrovascular Disorders; Coronary Disease; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Platelet Adhesiveness; Platelet Aggregation | 1978 |
Effects of experimental coronary thrombosis upon regional and systemic plasma chromatographic patterns.
Topics: Animals; Blood Protein Electrophoresis; Blood Proteins; Chromatography, Gel; Coronary Disease; Disease Models, Animal; Dogs; Fibrinogen; Immunodiffusion | 1975 |
[Influence of acute exertion and physical training on platelet function of the coronary patient].
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Coronary Disease; Fibrinogen; Humans; Lipids; Male; Middle Aged; Myocardial Infarction; Physical Exertion; Platelet Adhesiveness; Platelet Aggregation | 1976 |
Platelet and fibrinogen survival in coronary atherosclerosis. Response to medical and surgical therapy.
Topics: Adult; Aged; Aspirin; Blood Platelets; Cell Survival; Coronary Disease; Dipyridamole; Fibrinogen; Humans; Male; Middle Aged; Myocardial Revascularization | 1977 |
[Prevalence of ischemic heart disease depending on the extent of manifestation of certain risk factors].
Topics: Age Factors; Blood Glucose; Blood Pressure; Cholesterol; Coronary Disease; Fibrinogen; Humans; Male; Mathematics; Middle Aged; Moscow; Risk; Triglycerides | 1977 |
Continued incorporation of circulating radiolabeled fibrinogen into preformed coronary artery thrombi.
Topics: Albumins; Animals; Coronary Disease; Dogs; Electricity; Fibrinogen; Iodine Radioisotopes; Time Factors | 1977 |
Blood viscosity factors in evaluation of submaximal work output and cardiac activity in men.
Topics: Adult; Age Factors; Aged; Blood Viscosity; Body Height; Body Weight; Cholesterol; Coronary Disease; Electrocardiography; Exercise Test; Fibrinogen; Heart; Hematocrit; Humans; Male; Middle Aged; Physical Fitness | 1977 |
[Relationship between certain risk factors, age and ischemic heart disease according to simultaneous epidemiological study].
Topics: Age Factors; Blood Glucose; Blood Pressure; Coronary Disease; Epidemiologic Methods; Fibrinogen; Humans; Lipids; Male; Middle Aged; Risk | 1977 |
Attempted diagnosis of ventricular mural thrombi in acute mycardial infarction using 125I-labelled fibrinogen.
Topics: Acute Disease; Aged; Coronary Disease; Female; Fibrinogen; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Infarction; Pericarditis | 1976 |
Effect of coronary thrombus age on fibrinogen uptake.
Topics: Animals; Coronary Disease; Disease Models, Animal; Dogs; Fibrinogen; Male; Time Factors | 1976 |
Proceedings: I-Labelled fibrinogen, autoradiography, and stereoarteriography in identification of coronary thrombotic occlusion in fatal myocardial infarction.
Topics: Angiography; Autoradiography; Coronary Disease; Fibrinogen; Humans; Myocardial Infarction | 1976 |
[Intravascular disorders of microcirculation and microthrombus formation in patients with chronic ischemic disease of the heart].
Topics: Adult; Blood Coagulation; Coronary Disease; Erythrocyte Aggregation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Heparin; Humans; Hypertension; Kallikreins; Kininogens; Male; Microcirculation; Middle Aged; Myocardial Infarction; Thrombosis | 1976 |
[Circulation time of 125I-labeled fibrinogen in patients with ischemic heart disease with different types of hyperlipoproteinemia].
Topics: Adult; Aged; Blood Coagulation; Coronary Disease; Female; Fibrinogen; Half-Life; Humans; Hyperlipidemias; Iodine Radioisotopes; Isotope Labeling; Male; Middle Aged; Time Factors | 1976 |
[An experimental model of electrically-induced coronary thrombosis in the closed chest].
Topics: Animals; Aspartate Aminotransferases; Blood Gas Analysis; Blood Pressure; Coronary Disease; Coronary Vessels; Creatine Kinase; Disease Models, Animal; Dogs; Electric Injuries; Fibrinogen; Fibrinolysis; Myocardial Infarction; Myocardium; Platelet Count; Time Factors | 1975 |
[New therapeutic possibilities in the field of coronary disease].
Topics: Adult; Aged; Angina Pectoris; Benzofurans; Benzyl Alcohols; Blood Coagulation; Coronary Circulation; Coronary Disease; Female; Fibrinogen; Glycogen; Heart; Humans; Lipids; Male; Middle Aged; Myocardium; Oxygen Consumption; Vasodilator Agents; Water-Electrolyte Balance | 1975 |
Results of ankle ststolic pressure measurements in patients with intermittent claudication being treated with clofibrate.
Topics: Ankle; Blood Flow Velocity; Blood Pressure; Blood Pressure Determination; Blood Viscosity; Clofibrate; Coronary Disease; Female; Fibrinogen; Humans; Intermittent Claudication; Male; Middle Aged; Vascular Diseases | 1975 |
Cardiovascular lesions in pancreatitis.
Topics: Acute Disease; Adult; Amylases; Blood Coagulation; Blood Coagulation Tests; Capillary Permeability; Chronic Disease; Coronary Disease; Electrocardiography; Female; Fibrinogen; Fibrinolysis; Glucuronidase; Hemorrhage; Humans; Middle Aged; Pancreatic Elastase; Pancreatitis; Thrombelastography; Trypsin; Trypsin Inhibitors | 1975 |
Radioiodinated soluble canine fibrin. Preparation and evaluation as a thrombus localizing agent in the dog.
Topics: Animals; Coronary Disease; Disease Models, Animal; Dogs; Evaluation Studies as Topic; Fibrin; Fibrinogen; Half-Life; Iodine Radioisotopes; Isotope Labeling; Solubility; Thrombophlebitis; Thrombosis | 1975 |
Letter: Fibrinogen and mural thrombosis.
Topics: Coronary Disease; Fibrinogen; Humans | 1975 |
[A case of consumption coagulopathy due to atrial giant thrombus. Detection of thrombus by scintillation camera using fibrinogen labelled with 125I, 131I and warfarin-aspirin combination therapy (author's transl)].
Topics: Aspirin; Coronary Disease; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Female; Fibrinogen; Heart Atria; Humans; Iodine Radioisotopes; Middle Aged; Radionuclide Imaging; Thrombosis; Warfarin | 1975 |
[Antibodies and fibrinolysis in ischaemic heart disease (author's transl)].
Topics: Adult; Antibodies; Antibody Formation; Coronary Disease; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged | 1975 |
Formation of coronary arterial thrombi in relation to onset of necrosis in acute myocardial infarction in man. A clinical and autoradiographic study.
Topics: Aged; Coronary Disease; Female; Fibrinogen; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Infarction; Necrosis | 1976 |
Noninvasive detection of intracardiac thrombosis: 131-I fibrinogen cardiac survey.
Topics: Animals; Aortic Valve; Coronary Disease; Dogs; Fibrinogen; Heart Aneurysm; Heart Atria; Heart Valve Prosthesis; Humans; Iodine Radioisotopes; Male; Middle Aged; Mitral Valve Stenosis; Radionuclide Imaging | 1976 |
A cross-sectional evaluation of cardiovascular risk factors in coronary heart disease associated with type 1 (insulin-dependent) diabetes mellitus.
Topics: Adult; Albuminuria; Alcohol Drinking; Apolipoproteins A; Apolipoproteins B; Blood Glucose; Blood Pressure; C-Peptide; Cholesterol, HDL; Cholesterol, VLDL; Coronary Disease; Creatinine; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Fibrinogen; Humans; Lipoprotein(a); Lipoproteins, HDL; Lipoproteins, LDL; Middle Aged; Regression Analysis; Risk Factors; Smoking; Triglycerides | 1992 |
Update on fibrinogen as a cardiovascular risk factor.
Topics: Age Factors; Aged; Arteriosclerosis; Cardiovascular Diseases; Cerebrovascular Disorders; Cohort Studies; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Risk Factors; Sex Factors | 1992 |
Fibrin gel network characteristics and coronary heart disease: relations to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and coronary atherosclerosis.
Topics: Acute-Phase Proteins; Adult; Coronary Artery Disease; Coronary Disease; Fibrin; Fibrinogen; Gels; Humans; In Vitro Techniques; Lipoproteins; Male; Molecular Structure; Myocardial Infarction; Polymers | 1992 |
Strenuous exercise, plasma fibrinogen, and factor VII activity.
Topics: Aged; Blood Pressure; Cholesterol; Coronary Disease; Cross-Sectional Studies; Exercise; Factor VII; Fibrinogen; Humans; Male; Middle Aged; Risk Factors | 1992 |
Streptokinase induced defibrination assessed by thrombin time: effects on residual coronary stenosis and left ventricular ejection fraction.
Topics: Aged; Cardiac Catheterization; Coronary Disease; Female; Fibrin; Fibrinogen; Humans; Male; Middle Aged; Prospective Studies; Streptokinase; Stroke Volume; Thrombin Time; Thrombolytic Therapy; Ventricular Function, Left | 1992 |
[Variations of plasma Willebrand factor and fibrinogen in coronary pathology].
Topics: Angina Pectoris; Biomarkers; Coronary Disease; Fibrinogen; Humans; Middle Aged; Myocardial Infarction; von Willebrand Factor | 1992 |
Increased lipid binding to thrombi in coronary artery disease. Findings in patients without premedication in native (not anticoagulated) test systems.
Topics: Blood Coagulation; Blood Platelets; Coronary Disease; Female; Fibrinogen; Humans; Lipid Metabolism; Male; Thrombosis | 1992 |
Fibrinogen values in patients with and without restenosis following percutaneous transluminal coronary angiography.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Recurrence; Risk Factors | 1992 |
Involvement of plasma fibrinogen in coronary artery disease.
Topics: Coronary Disease; Fibrinogen; Humans; Research Design | 1992 |
Coronary risk factors in middle-aged men as related to smoking, coffee intake and physical activity.
Topics: Adult; Apolipoproteins B; Cholesterol, HDL; Coffee; Coronary Disease; Evaluation Studies as Topic; Exercise; Feeding Behavior; Fibrinogen; Humans; Linear Models; Male; Middle Aged; Norway; Risk Factors; Smoking; Triglycerides | 1992 |
Lessons in prevention of ischemic heart disease learned from pathological studies of coronary atherosclerosis.
Topics: Adolescent; Adult; Aorta; Cerebral Arteries; Child; Child, Preschool; Coronary Artery Disease; Coronary Disease; Coronary Vessels; Female; Fibrinogen; Humans; Incidence; Infant; Infant, Newborn; Japan; Male; Multivariate Analysis | 1992 |
Are hemostatic factors responsible for the paradoxical risk factors for coronary heart disease and stroke?
Topics: Blood Coagulation Factors; Cerebral Hemorrhage; Cerebrovascular Disorders; Coronary Disease; Fibrinogen; Forecasting; Hemostasis; Humans; Lipids; Prospective Studies; Risk Factors; Thromboembolism | 1992 |
Significance of plasma fibrinogen in coronary arterial disease: marker or causative risk factor for arterial thrombosis?
Topics: Blood Coagulation; Coronary Disease; Coronary Thrombosis; Female; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation; Risk Factors | 1992 |
Fibrinogen, viscosity, and white blood cell count.
Topics: Blood Viscosity; Coronary Disease; Fibrinogen; Humans; Leukocyte Count; Predictive Value of Tests | 1992 |
Population variation and genetics of plasma homocyst(e)ine level.
Topics: Adult; Analysis of Variance; Apolipoproteins; Coronary Disease; Female; Fibrinogen; Homocysteine; Homocystine; Humans; Lipids; Male; Middle Aged; Norway; Twins; Twins, Dizygotic; Twins, Monozygotic | 1992 |
[Chronic intermittent urokinase therapy in therapy-refractory angina pectoris].
Topics: Aged; Angina Pectoris; Blood Viscosity; Chronic Disease; Coronary Disease; Drug Evaluation; Exercise Test; Fibrinogen; Heart; Humans; Injections, Intravenous; Male; Middle Aged; Radionuclide Imaging; Thallium Radioisotopes; Time Factors; Urokinase-Type Plasminogen Activator | 1992 |
[When will fibrinogen screening become available?].
Topics: Animals; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol; Coronary Disease; Fibrinogen; Humans; Myocardial Infarction; Rabbits; Risk Factors | 1991 |
Increased plasminogen activator inhibitor antigen levels in diabetic patients with stable angina.
Topics: Adult; Aged; Angina Pectoris; Antithrombin III; Coronary Disease; Diabetes Mellitus, Type 2; Exercise Test; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Peptide Hydrolases; Plasminogen Inactivators; Tissue Plasminogen Activator | 1991 |
Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors.
Topics: Body Constitution; Cardiovascular Diseases; Coronary Disease; Factor VII; Female; Fibrinogen; Humans; Life Style; Lipids; Male; Middle Aged; Prospective Studies; Racial Groups; Risk Factors; Sex Factors; Smoking | 1991 |
Low-dose intermittent heparin therapy decreases plasma fibrinogen levels.
Topics: Coronary Disease; Depression, Chemical; Dietary Fats; Fibrinogen; Heparin; Humans; Injections, Subcutaneous; Interleukin-1; Thrombosis | 1991 |
Hemostatic risk factors for coronary heart disease.
Topics: Blood Viscosity; Cohort Studies; Coronary Disease; Factor VII; Fibrinogen; Humans; Leukocyte Count; Male; Risk Factors | 1991 |
Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies.
Topics: Blood Viscosity; Cohort Studies; Coronary Disease; England; Fibrinogen; Humans; Incidence; Leukocyte Count; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Risk Factors; Smoking; Wales | 1991 |
Passive smoking and the risk of heart attack or coronary death.
Topics: Adult; Aged; Australia; Case-Control Studies; Coronary Disease; Female; Fibrinogen; Heart Failure; Humans; Male; Middle Aged; Prevalence; Sex Factors; Tobacco Smoke Pollution | 1991 |
[Rheologic changes in the postprandial phase].
Topics: Adult; Blood Viscosity; Cholesterol; Coronary Disease; Dietary Fats; Erythrocyte Aggregation; Fibrinogen; Humans; Hyperlipidemias; Lipids; Retrospective Studies; Risk Factors; Triglycerides | 1990 |
[The content of fibronectin, fibrinogen, its degradation products and myoglobin in patients with ischemic heart disease].
Topics: Adult; Angina Pectoris; Coronary Disease; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibronectins; Humans; Male; Myocardial Infarction; Myoglobin; Physical Exertion; Thrombolytic Therapy; Time Factors | 1990 |
Fibrinogen, factor VII clotting activity and coronary artery disease severity.
Topics: Cholesterol; Coronary Angiography; Coronary Disease; Coronary Vessels; Factor VII; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Triglycerides | 1990 |
Native fibrin gel networks and factors influencing their formation in health and disease.
Topics: Adult; Afibrinogenemia; Blood Coagulation; Coronary Disease; Factor XIII; Fibrin; Fibrinogen; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent Dyes; Gels; Humans; Kinetics; Lasers; Microscopy; Nephelometry and Turbidimetry; Permeability; Reference Values; Thiocyanates; Thrombin | 1990 |
Plasma fibrinogen levels in type II diabetics.
Topics: Albuminuria; Blood Glucose; Cholesterol; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fibrinogen; Glycated Hemoglobin; Humans; Immunoassay; Risk Factors | 1990 |
CHD risk factors: a Framingham study update.
Topics: Aged; Cardiomegaly; Cohort Studies; Coronary Disease; Female; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Lipids; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Risk Factors | 1990 |
Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study.
Topics: Adult; Age Factors; Alcohol Drinking; Coronary Disease; Female; Fibrinogen; Humans; Life Style; Male; Middle Aged; Risk Factors; Sex Factors; Smoking; Social Class | 1990 |
[The characteristics of the interrelation between the hemostatic system and the fibronectin level in patients with ischemic heart disease].
Topics: Antigen-Antibody Complex; Autonomic Nervous System Diseases; Blood Donors; Complement C3c; Complement C4; Coronary Disease; Dystonia; Fibrinogen; Fibrinolysis; Fibronectins; Hemostasis; Humans; Male; Middle Aged; Vascular Diseases | 1990 |
Pattern recognition in evaluation of haemorheological and haemodynamical measurements in the cardiological diagnostics.
Topics: Acute Disease; Adult; Blood Viscosity; Cardiac Output; Cardiomyopathies; Coronary Disease; Diagnosis, Differential; Electrocardiography; Female; Fibrinogen; Hematocrit; Hemodynamics; Humans; Male; Middle Aged; Myocarditis; Reference Values | 1990 |
[Acute effects of extracorporeal LDL cholesterol and fibrinogen elimination on blood rheology and microcirculation].
Topics: Adult; Blood Gas Monitoring, Transcutaneous; Blood Viscosity; Cholesterol, LDL; Coronary Disease; Fibrinogen; Heparin; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Oxygen; Rheology | 1990 |
Antithrombin III and procoagulant activity: sex differences and effects of the menopause.
Topics: Adult; Aged; Aging; Antithrombin III; Coronary Disease; Factor VII; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Menopause; Middle Aged; Sex Factors | 1990 |
Plasma HMW fibrinogen in patients with ischaemic heart disease.
Topics: Aged; Aged, 80 and over; Coronary Disease; Fibrinogen; Humans; Middle Aged; Molecular Weight; Myocardial Infarction; Prospective Studies | 1990 |
Heparin requirement in tissue-type plasminogen activator-induced experimental coronary thrombolysis: comparison with urokinase-induced coronary thrombolysis.
Topics: alpha-2-Antiplasmin; Animals; Coronary Disease; Coronary Thrombosis; Coronary Vessels; Dogs; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fibrinogen; Heparin; Infusions, Intra-Arterial; Time Factors; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 1987 |
Severity of coronary artery disease and basal fibrinolysis.
Topics: Adult; alpha-2-Antiplasmin; alpha-Macroglobulins; Cholesterol; Coronary Disease; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Plasminogen; Plasminogen Activators; Severity of Illness Index; Triglycerides | 1987 |
The thrombolytic effects of native tissue-type plasminogen activator (AK-124) on experimental canine coronary thrombosis.
Topics: Animals; Coronary Disease; Coronary Thrombosis; Dogs; Fibrin; Fibrinogen; Humans; Platelet Aggregation; Recurrence; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 1989 |
Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (HELP).
Topics: Adult; Blood Viscosity; Chemical Precipitation; Coronary Disease; Erythrocyte Aggregation; Extracorporeal Circulation; Female; Fibrinogen; Heparin; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Male; Middle Aged; Muscles; Oxygen Consumption; Rheology | 1989 |
Arterial disease risk factors and angiographic evidence of atheroma of the carotid artery.
Topics: Aging; Angiography, Digital Subtraction; Arteriosclerosis; Carotid Artery Diseases; Cerebrovascular Disorders; Cholesterol; Coronary Disease; Factor VIII; Female; Fibrinogen; Hemoglobins; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Risk Factors; Smoking; Triglycerides; Uric Acid | 1989 |
[Relation of an increase of von Willebrand factor in the blood, acute myocardial infarction, unstable angina and coronary thrombosis].
Topics: Adult; Angina Pectoris; Angina, Unstable; Coronary Disease; Coronary Thrombosis; Creatine Kinase; Factor VII; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Inactivators; Tissue Plasminogen Activator; von Willebrand Factor | 1989 |
[Relation between disorders of the rheological properties of the blood and the system of hemostasis in patients with ischemic heart disease].
Topics: Adult; Aged; Blood Viscosity; Coronary Disease; Erythrocyte Aggregation; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Risk Factors | 1989 |
[Fibrinogen, a cardiovascular risk factor].
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Female; Fibrinogen; Humans; Italy; Male; Middle Aged; Myocardial Infarction; Risk Factors | 1989 |
[Effect of hypolipidemic agents on the content of sterol-fibrinogen complexes of the blood in patients with ischemic heart disease].
Topics: Angina Pectoris; Coronary Disease; Drug Evaluation; Drug Therapy, Combination; Female; Fibrinogen; Humans; Hypolipidemic Agents; Male; Middle Aged; Sterols; Time Factors | 1989 |
Plasma fibrinogen in unstable coronary artery disease.
Topics: Angina Pectoris; Angina, Unstable; Body Weight; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Orosomucoid; Smoking | 1989 |
[Effect of fenofibrate on fibrinogen concentration and blood viscosity. Consequences for myocardial microcirculation in coronary heart disease?].
Topics: Blood Viscosity; Coronary Circulation; Coronary Disease; Drug Evaluation; Erythrocyte Aggregation; Exercise Test; Fenofibrate; Fibrinogen; Heart; Humans; Lipids; Microcirculation; Myocardial Infarction; Propionates; Radionuclide Imaging; Thallium Radioisotopes | 1989 |
Fibrinopeptide A levels in patients with acute ischaemic heart disease.
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Fibrinogen; Fibrinopeptide A; Humans; Middle Aged; Myocardial Infarction | 1989 |
Elevated plasma concentrations of fibrinogen may cause an overestimation of functional plasminogen.
Topics: Coronary Disease; False Positive Reactions; Fibrinogen; Humans; Plasminogen | 1989 |
Fat consumption and factor VII coagulant activity in middle-aged men. An association between a dietary and thrombogenic coronary risk factor.
Topics: Adult; Alcohol Drinking; Antigens; Cholesterol, LDL; Coronary Disease; Dietary Carbohydrates; Dietary Fats; Dietary Proteins; Factor VII; Fibrinogen; Humans; Lipids; Male; Middle Aged; Risk Factors | 1989 |
[Effects of splenectomy on changes in hemorrheologic parameters following coronary occlusion in dogs].
Topics: Animals; Blood Viscosity; Coronary Disease; Dogs; Female; Fibrinogen; Hematocrit; Male; Postoperative Period; Rheology; Splenectomy | 1989 |
Blood viscosity parameters in coronary heart disease: effect of fish oil supplementation.
Topics: Aged; Blood Viscosity; Coronary Disease; Double-Blind Method; Erythrocyte Deformability; Fibrinogen; Fish Oils; Humans; Male; Middle Aged; Random Allocation | 1989 |
Blood pressure, cigarette smoking and heart attack in the WHO co-operative trial of clofibrate.
Topics: Bezafibrate; Clofibrate; Coronary Disease; Fibrinogen; Humans; Hypertension; Male; Smoking; World Health Organization | 1989 |
Urinary fibrinopeptide A levels in ischemic heart disease.
Topics: Angina Pectoris; Angina, Unstable; Coronary Disease; Female; Fibrinogen; Fibrinopeptide A; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies | 1989 |
Viscoelasticity and red blood cell aggregation in patients with coronary heart disease.
Topics: Blood Viscosity; Coronary Disease; Erythrocyte Aggregation; Fibrinogen; Hematocrit; Humans; Male | 1989 |
Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.
Topics: Adult; Blood Pressure; Cholesterol; Coronary Disease; Factor VII; Fibrinogen; Follow-Up Studies; Hemostasis; Humans; London; Male; Middle Aged; Prospective Studies; Regression Analysis; Risk; Time Factors; Triglycerides | 1986 |
Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease.
Topics: Age Factors; Coronary Disease; Cotinine; Cross-Sectional Studies; Factor VII; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Regression Analysis; Risk Factors; Smoking; Time Factors | 1987 |
Genetic and cultural inheritance of plasma fibrinogen concentration.
Topics: Adult; Child; Coronary Disease; Cultural Characteristics; Culture; Environmental Exposure; Female; Fibrinogen; Humans; Male; Middle Aged; Models, Theoretical; Obesity; Risk Factors; Smoking | 1987 |
Advances in clinical fibrinolysis.
Topics: Coronary Disease; Factor XII; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Glycoproteins; Humans; Plasminogen; Plasminogen Activators; Plasminogen Inactivators; Tissue Plasminogen Activator | 1986 |
[Characteristics of hemostasis, fibrinolysis and lipid indicators in children and their fathers with a history of myocardial infarction at a young age].
Topics: Adolescent; Adult; Antithrombin III Deficiency; Blood Coagulation; Child; Cholesterol; Cholesterol, HDL; Coronary Disease; Disease Susceptibility; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Plasminogen Activators; Triglycerides | 1986 |
Beneficial effects of tissue-type plasminogen activator in acute myocardial ischemia in cats.
Topics: Animals; Cats; Coronary Disease; Coronary Vessels; Creatine Kinase; Electrocardiography; Fibrinogen; Hemodynamics; Myocardium; Organ Size; Tissue Plasminogen Activator | 1986 |
An international and interregional comparison of haemostatic variables in the study of ischaemic heart disease. Report of a working group.
Topics: Adult; Cholesterol; Coronary Disease; Czechoslovakia; Factor VII; Factor VIII; Fibrinogen; Fibrinolysis; Finland; Gambia; Hemostasis; Humans; London; Male; Middle Aged; Platelet Count; Risk; Scotland | 1986 |
[Intravenous thrombolysis in myocardial infarction. Influence of the quality of the anticoagulation on the early recurrence rate of angina or infarction].
Topics: Adult; Aged; Anticoagulants; Coronary Angiography; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Recurrence; Retrospective Studies; Streptokinase | 1988 |
Preventive effects of batroxobin on experimental canine coronary thrombosis.
Topics: Animals; Aspirin; Batroxobin; Coronary Disease; Coronary Thrombosis; Disease Models, Animal; Dogs; Electrocardiography; Fibrinogen; Hemodynamics; Heparin; Recurrence; Serine Endopeptidases; Urokinase-Type Plasminogen Activator | 1988 |
[Mechanism of the change in low shear viscosity of whole blood following coronary occlusion].
Topics: Animals; Blood Viscosity; Coronary Disease; Dogs; Electrophorus; Erythrocytes; Female; Fibrinogen; Male | 1988 |
[Detection of cardiac and arterial thrombi by 67Ga-DFO-fibrinogen scintigraphy].
Topics: Adult; Aged; Citrates; Citric Acid; Coronary Disease; Coronary Thrombosis; Female; Fibrinogen; Humans; Male; Middle Aged; Pulmonary Embolism; Radionuclide Imaging | 1988 |
[Fibrinopeptide A and protein C in heart patients with acute coronary syndromes].
Topics: Acute Disease; Aged; Coronary Disease; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Fibrinopeptide A; Humans; Male; Middle Aged; Myocardial Infarction; Protein C | 1988 |
Enhanced myocardial salvage by combined treatment with recombinant single-chain urokinase-type plasminogen activator and recombinant human superoxide dismutase in a canine coronary thrombosis model.
Topics: Animals; Blood Pressure; Coronary Disease; Coronary Thrombosis; Creatine Kinase; Dogs; Female; Fibrinogen; Heart Rate; Hemodynamics; Male; Plasminogen Activators; Recombinant Proteins; Superoxide Dismutase; Urokinase-Type Plasminogen Activator | 1988 |
Relationship between sex hormones and haemostatic factors in healthy middle-aged men.
Topics: alpha-2-Antiplasmin; Antigens; Antithrombin III; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Estradiol; Factor VII; Fibrinogen; France; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Testosterone; Triglycerides | 1988 |
Lipids, lipoproteins, fibrinogen and fibrinolytic activity in angiographically assessed coronary heart disease.
Topics: Adult; Aged; Coronary Angiography; Coronary Disease; Female; Fibrinogen; Fibrinolysis; Humans; Lipids; Lipoproteins; Lipoproteins, IDL; Lipoproteins, VLDL; Male; Middle Aged; Risk Factors; Sex Factors | 1987 |
[Effect of physical training on lipid metabolism and the rheologic properties of the blood of patients with ischemic heart disease].
Topics: Adult; Blood Viscosity; Coronary Disease; Erythrocyte Deformability; Erythrocyte Membrane; Exercise Therapy; Fibrinogen; Hemodynamics; Humans; Lipids; Male; Membrane Lipids; Middle Aged; Rheology | 1986 |
Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study.
Topics: Age Factors; Cholesterol; Coronary Disease; Diabetes Complications; Female; Fibrinogen; Humans; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Menopause; Obesity; Prospective Studies; Risk; Uric Acid | 1987 |
[Protective factors of coronary heart disease and hypertension among the fishermen in the Zhoushan Islands].
Topics: Adult; China; Cholesterol, HDL; Coronary Disease; Diet Surveys; Fibrinogen; Fisheries; Humans; Hypertension; Male; Middle Aged | 1987 |
Paradoxic elevation of fibrinopeptide A after streptokinase: evidence for continued thrombosis despite intense fibrinolysis.
Topics: Cardiomyopathies; Coronary Circulation; Coronary Disease; Coronary Thrombosis; Fibrinogen; Fibrinolysis; Fibrinopeptide A; Humans; Streptokinase | 1987 |
Hypertension and other risk factors in coronary heart disease.
Topics: Adult; Aged; Aged, 80 and over; Coronary Disease; Electrocardiography; Female; Fibrinogen; Humans; Hyperglycemia; Hyperlipidemias; Hypertension; Lipoproteins; Male; Middle Aged; Risk Factors; Smoking | 1987 |
Possible role of fibrinogen in the aggregation of white blood cells.
Topics: Animals; Bacterial Infections; Cell Adhesion; Cell Aggregation; Coronary Disease; Female; Fibrinogen; Humans; In Vitro Techniques; Inflammation; Leukocytes; Male; Neoplasms; Rabbits | 1987 |
[Acute and chronic hemorrheological effects of clopamide in ischemic heart disease].
Topics: Blood Viscosity; Clopamide; Coronary Disease; Dose-Response Relationship, Drug; Erythrocyte Count; Fibrinogen; Hematocrit; Hemoglobins; Humans | 1987 |
[Hemostasis in ischemic heart disease patients undergoing hyperbaric oxygenation].
Topics: Aged; Angina Pectoris; Coronary Disease; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Hyperbaric Oxygenation; Middle Aged; Platelet Aggregation; Prothrombin; Thrombelastography | 1986 |
Importance of continued activation of thrombin reflected by fibrinopeptide A to the efficacy of thrombolysis.
Topics: Coronary Disease; Female; Fibrinogen; Fibrinopeptide A; Humans; Male; Middle Aged; Prognosis; Streptokinase; Thrombin | 1986 |
Heparin effect on plasma fibrinogen in the thrombophilic syndrome.
Topics: Coronary Disease; Fibrinogen; Heparin; Humans | 1986 |
Serum amyloid A concentrations during the course of acute ischaemic heart disease.
Topics: Aged; Amyloid; Coronary Disease; Creatine Kinase; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Myocarditis; Serum Amyloid A Protein; Time Factors | 1986 |
[Changes in the content of fibrinogen and its high-molecular derivatives as affected by the physical training of ischemic heart disease patients].
Topics: Adult; Angina Pectoris; Blood Protein Electrophoresis; Chromatography, Gel; Coronary Artery Disease; Coronary Disease; Exercise Therapy; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Physical Exertion | 1986 |
[Hemorheologic therapy applications in coronary heart disease].
Topics: Blood Viscosity; Coronary Circulation; Coronary Disease; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Fibrinogen; Fibrinolysis; Hemodilution; Humans; Male; Microcirculation; Middle Aged; Pentoxifylline; Pyrrolidines; Rheology; Vasodilator Agents | 1986 |
Plasma fibrinogen, fibrinolytic activity and serum fibrinogen/fibrin degradation products in ischaemic heart disease.
Topics: Angina Pectoris; Coronary Disease; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Myocardial Infarction; Prognosis | 1985 |
Epidemiological characteristics of platelet aggregability.
Topics: Adenosine Diphosphate; Adult; Age Factors; Aged; Alcohol Drinking; Black or African American; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation; Smoking | 1985 |
Fibrinogen: a possible link between social class and coronary heart disease.
Topics: Adult; Coronary Disease; Employment; Female; Fibrinogen; Hemostasis; Humans; London; Male; Middle Aged; Smoking; Social Class; Stress, Physiological | 1985 |
Fibrinogen: a possible link between social class and coronary heart disease.
Topics: Blood Viscosity; Coronary Disease; Fibrinogen; Humans; Stress, Psychological | 1985 |
Hemorrhage vs rethrombosis after thrombolysis for acute myocardial infarction.
Topics: Coronary Disease; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Humans; Infusions, Intra-Arterial; Myocardial Infarction; Recurrence; Streptokinase | 1986 |
Fibrinopeptide A: a marker of acute coronary thrombosis.
Topics: Coronary Disease; Creatine Kinase; Female; Fibrinogen; Fibrinopeptide A; Humans; Isoenzymes; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Time Factors | 1985 |
Haemostatic factors and ischaemic heart disease. The Caerphilly study.
Topics: Adult; Age Factors; Aged; Blood Pressure; Blood Viscosity; Coronary Disease; Fibrinogen; Hemostasis; Humans; Leukocyte Count; Male; Middle Aged; Prospective Studies; Smoking; Thrombin Time | 1985 |
Measurement of antistreptokinase antibodies.
Topics: Antibodies, Bacterial; Coronary Disease; Fibrinogen; Humans; Myocardial Infarction; Streptokinase | 1985 |
Left ventricular thrombosis, wall motion abnormalities, and blood viscosity changes after first transmural anterior myocardial infarction.
Topics: Adult; Aged; Blood Viscosity; Coronary Disease; Echocardiography; Female; Fibrinogen; Heart; Humans; Male; Middle Aged; Movement; Myocardial Infarction | 1985 |
[Changes in the hemostatic system in patients with ischemic heart disease after isovolemic hemodilution].
Topics: Adult; Aged; Blood Coagulation; Blood Viscosity; Coronary Disease; Exercise Test; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemodilution; Humans; Male; Middle Aged; Platelet Aggregation | 1985 |
[Immunologic diagnosis of intravascular blood clotting and intravascular thrombus formation among patients with ischemic heart disease].
Topics: Adult; Angina, Unstable; Autoantibodies; Coronary Disease; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hemagglutination Tests; Humans; Male; Middle Aged; Myocardial Infarction; Thrombin | 1985 |
Plasma fibrinogen--a major coronary risk factor.
Topics: Adult; Aged; Cholesterol; Coronary Disease; Disease Susceptibility; Fibrinogen; Humans; Male; Middle Aged; Risk; Smoking | 1985 |
[Changes of certain indicators of blood coagulation in patients with coronary arteriosclerosis and hypertensive disease].
Topics: Adult; Aged; Arteriosclerosis; Blood Coagulation; Coronary Disease; Female; Fibrinogen; Fibrinolysis; Humans; Hypertension; Male; Middle Aged; Thrombelastography | 1974 |
[Fibrinogen content in blood of patients with disturbances in the coronary blood circulation].
Topics: Coronary Disease; Fibrinogen; Humans | 1966 |
Fibrinolytic activity and coronary-artery disease.
Topics: Anticoagulants; Coronary Disease; Ethylestrenol; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Phenformin; Prognosis | 1968 |
Fibrinolytic activity and coronary-artery disease.
Topics: Adult; Age Factors; Aged; Blood Coagulation Disorders; Blood Coagulation Tests; Coronary Disease; Ethylestrenol; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Obesity; Phenformin | 1968 |
[Coagulation spectrum in coronary sclerosis and infarct].
Topics: Aged; Blood Coagulation; Blood Platelets; Coronary Disease; Dicumarol; Fibrinogen; Fibrinolytic Agents; Heparin; Humans; Myocardial Infarction | 1968 |
Impaired fibrinolytic response to exercise in patients with type-IV hyperlipoproteinaemia.
Topics: Adult; Arteriosclerosis; Cholesterol; Coronary Disease; Fibrinogen; Fibrinolysis; Heart Rate; Humans; Hyperlipidemias; Male; Middle Aged; Oxygen Consumption; Physical Exertion; Plasminogen; Triglycerides | 1970 |
Changes in antithrombin 3 levels following cessation of anticoagulant therapy.
Topics: Aged; Antithrombins; Blood Coagulation Disorders; Blood Coagulation Tests; Coronary Disease; Depression, Chemical; Female; Fibrinogen; Humans; Immunodiffusion; Macroglobulins; Male; Middle Aged; Thrombosis; Warfarin | 1973 |
[Blood coagulation and fibrinolytic system in patients with marked coronary arteriosclerosis].
Topics: Blood Coagulation; Coronary Disease; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Heparin; Humans; Male; Middle Aged; Plasminogen; Thrombelastography; Thrombin | 1970 |
[Fibrinolytic activity of the blood in the human coronary vessels].
Topics: Arteriosclerosis; Blood Specimen Collection; Cardiac Catheterization; Coronary Disease; Coronary Vessels; Electric Countershock; Enzyme Activation; Enzyme Repression; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Heparin; Humans; Hypertension; Myocardial Infarction; Plasminogen; Radiography | 1974 |
[Nonenzymatic fibrinolysis in patients with ischemic heart disease].
Topics: Adult; Aged; Blood Coagulation Tests; Blood Platelets; Coronary Disease; Epinephrine; Fibrinogen; Fibrinolysin; Fibrinolysis; Heparin; Humans; Middle Aged; Myocardial Infarction; Plasminogen; Prothrombin; Thrombin | 1974 |
[Pathogenetic aspects of cellular hemostasis in ischemic heart disease].
Topics: Adenosine Diphosphate; Angina Pectoris; Arteriosclerosis; Basophils; Blood Coagulation; Blood Platelets; Coronary Disease; Fibrinogen; Humans; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation | 1974 |
Incorporation of 131I-fibrinogen in a coronary artery thrombus, detected in vivo with a scintillation camera.
Topics: Animals; Cardiac Catheterization; Coronary Disease; Dogs; Electrocardiography; Electrodes; Fibrinogen; Heart Ventricles; Injections, Intravenous; Iodine Radioisotopes; Male; Scintillation Counting; Technetium; Thrombosis; Ventricular Fibrillation | 1974 |
An evaluation of the utility of benzoyl-DL-arginine-beta-naphthyl-amide for the assay of thrombin activity in blood.
Topics: Animals; Arginine; Benzamides; Cattle; Coronary Disease; Coumarins; Factor VIII; Fibrinogen; Hirudins; Humans; Hydrolysis; Naphthalenes; Protein Binding; Prothrombin; Serum Albumin; Thrombin; Thromboplastin | 1974 |
[Shifts in coagulating and fibrinolytic activity of the blood following the administration of nerobol in patients with coronary atherosclerosis].
Topics: Aged; Arteriosclerosis; Blood Coagulation; Coronary Disease; Female; Fibrinogen; Fibrinolysis; Heparin; Humans; Male; Methandrostenolone; Middle Aged; Prothrombin | 1972 |
[Characteristics of the dynamics of the fibrinogen level and the fibrinolysis indices in the blood of the human coronary bed].
Topics: Angiography; Cardiac Catheterization; Coronary Circulation; Coronary Disease; Fibrinogen; Fibrinolysis; Humans | 1972 |
Chronic intravascular coagulation syndrome associated with atherosclerotic aortic aneurysm.
Topics: Aged; Aortic Aneurysm; Arteriosclerosis; Aspirin; Blood Cell Count; Blood Platelets; Chronic Disease; Coronary Disease; Dipyridamole; Disseminated Intravascular Coagulation; Female; Fibrinogen; Heparin; Humans; Time Factors | 1973 |
[Plasmatic haptoglobin in chronic coronary disease and in myocardial infarct. Physiopathological significance. Diagnostic importance].
Topics: Arteriosclerosis; Chronic Disease; Coronary Disease; Fibrinogen; Haptoglobins; Humans; Myocardial Infarction | 1973 |
Impairment of the diurnal fibrinolytic response in man. Effects of aging, type IV hyperlipoproteinemia, and coronary artery disease.
Topics: Adult; Aging; Circadian Rhythm; Coronary Disease; Factor Analysis, Statistical; Female; Fibrinogen; Fibrinolysis; Humans; Hyperlipidemias; Lipoproteins; Male; Middle Aged; Plasminogen; Triglycerides | 1973 |
[Research on thrombogenesis in chronic obliterating arteriopathies of the extremities].
Topics: Adult; Aged; Arterial Occlusive Diseases; Arteriosclerosis Obliterans; Blood Coagulation Disorders; Chronic Disease; Coronary Disease; Extremities; Female; Fibrinogen; Humans; Lipids; Lipoproteins; Male; Middle Aged; Platelet Adhesiveness; Smoking; Thromboangiitis Obliterans; Thrombosis | 1973 |
Potential significance of plasma viscosity and hematocrit variations in myocardial ischemia.
Topics: Blood Flow Velocity; Blood Pressure; Blood Viscosity; Coronary Circulation; Coronary Disease; Fibrinogen; Heart Ventricles; Hematocrit; Humans; Mathematics; Models, Theoretical; Myocardial Infarction | 1974 |
Editorial: The cause-effect relationship between recent coronary artery occlusion and acute myocardial infarction.
Topics: Autopsy; Coronary Disease; Fibrinogen; Iodine Radioisotopes; Myocardial Infarction | 1974 |
[Coronary thrombosis in acute myocardial infarct, is it a primary or secondary phenomenon?].
Topics: Acute Disease; Aged; Autopsy; Coronary Disease; Electrocardiography; Female; Fibrinogen; Humans; Iodine Radioisotopes; Male; Myocardial Infarction; Necrosis; Thrombosis; Time Factors | 1974 |
Study on the risk factors of coronary heart disease in family aggregates of Verona.
Topics: Age Factors; Blood Glucose; Blood Pressure; Blood Proteins; Calcium; Cholesterol; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Models, Biological; Probability; Prognosis; Sex Factors; Statistics as Topic; Triglycerides; Uric Acid | 1974 |
[Fibrinogen degradation products in the urine after kidney transplantation].
Topics: Autoimmune Diseases; Biodegradation, Environmental; Coronary Disease; Fibrinogen; Graft Rejection; Humans; Immunoelectrophoresis; Kidney Diseases; Kidney Transplantation; Postoperative Complications; Time Factors; Transplantation, Homologous | 1971 |
[On fibrinogen in atherosclerosis and hypertension].
Topics: Arteriosclerosis; Blood Coagulation Tests; Coronary Disease; Female; Fibrinogen; Humans; Hypertension; Male; Middle Aged | 1967 |
Fibrinolytic activity and haemagglutination inhibition immunoassays.
Topics: Adult; Aged; Biguanides; Clofibrate; Coronary Disease; Ethylestrenol; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemagglutination Inhibition Tests; Hemostasis; Humans; Immunoassay; Immunodiffusion; Immunoelectrophoresis; Liver Cirrhosis; Male; Metformin; Middle Aged; Neoplasm Metastasis; Nicotinic Acids; Physical Exertion; Plasminogen; Prostatic Neoplasms; Stimulation, Chemical; Time Factors; Tolazamide | 1970 |
The biological half-life of I-131 fibrinogen.
Topics: Adult; Aged; Aminocaproates; Arteriosclerosis; Blood Coagulation; Coronary Disease; Factor X; Female; Fibrinogen; Fibrinolysis; Hemorrhagic Disorders; Humans; Hypothyroidism; Immunodiffusion; Iodine Isotopes; Male; Neoplasms | 1965 |
[Fluctuations in lipid levels and state of the blood coagulation system in ischemic heart disease].
Topics: Adult; Aged; Blood Coagulation; Blood Coagulation Tests; Cholesterol; Coronary Disease; Factor XIII; Fatty Acids, Nonesterified; Female; Fibrinogen; Fibrinolysis; Heparin; Humans; Lipids; Male; Middle Aged; Phospholipids; Platelet Adhesiveness; Prothrombin; Thrombin; Time Factors | 1972 |
Levels of soluble fibrin monomer complexes in the course of myocardial infarction.
Topics: Adult; Arteriosclerosis; Coronary Disease; Diagnosis, Differential; Fibrin; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Myocardial Infarction; Prognosis; Protamines; Serum Globulins | 1972 |
Blood coagulation and fibrinolysis in a random sample of 788 men 54 years old. I. Correlations between the variables of clotting and fibrinolysis.
Topics: Blood Coagulation; Blood Coagulation Tests; Clot Retraction; Coronary Disease; Factor VII; Factor VIII; Factor X; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Plasminogen; Prospective Studies; Prothrombin; Prothrombin Time; Sampling Studies; Thromboplastin | 1972 |
[Action of Atromid-S on thrombogenic factors].
Topics: Animals; Anticholesteremic Agents; Blood Coagulation; Blood Platelets; Clofibrate; Coronary Disease; Fatty Acids; Fibrinogen; Fibrinolysis; Humans; Hypercholesterolemia; Phospholipids | 1971 |
Atherosclerosis in Africa--studies of coronary arteries, blood lipids and coagulation factors in Uganda.
Topics: Adolescent; Adult; Age Factors; Aged; Blood Coagulation; Calcium; Cholesterol; Coronary Disease; Coronary Vessels; Fatty Acids; Female; Fibrinogen; Humans; Linoleic Acids; Lipids; Male; Middle Aged; New York; Oleic Acids; Palmitic Acids; Phospholipids; Proteins; Prothrombin Time; Thromboembolism; Triglycerides; Uganda | 1971 |
[Effect of emotional stress on indices of blood coagulation, lipid metabolism and functional state of the adrenal glands in healthy persons and in patients with ischemic heart disease].
Topics: Adrenal Glands; Adult; Blood Coagulation; Cholesterol; Coronary Disease; Factor XII; Fatty Acids, Nonesterified; Fibrinogen; Fibrinolysis; Heparin; Humans; Hydrocortisone; Lipid Metabolism; Middle Aged; Phospholipids; Platelet Adhesiveness; Prothrombin; Stress, Psychological; Thrombin; Time Factors | 1971 |
Fibrinogen 'B' in coronary artery disease.
Topics: Adult; Aged; Blood; Blood Coagulation Factors; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardium | 1971 |
Age-induced peculiarities of nutrition and state of blood coagulation system.
Topics: Adult; Aged; Aging; Arteriosclerosis; Blood Coagulation; Cholesterol; Coronary Disease; Dietary Fats; Female; Fibrinogen; Fibrinolysis; Humans; Lipids; Male; Middle Aged; Nutritional Physiological Phenomena; Phosphatidylcholines | 1971 |
Diabetes and atherosclerosis.
Topics: Adult; Age Factors; Aorta; Arteries; Arteriosclerosis; Autopsy; Cholesterol; Coronary Disease; Coronary Vessels; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Female; Fibrinogen; Humans; Insulin; Lipid Metabolism; Lipoproteins; Male; Middle Aged; Platelet Adhesiveness; Sex Factors; Thrombosis; Triglycerides | 1971 |
[Biological half-life of fibrinogen labelled with radioactive iodine I-131 in coronary disease].
Topics: Adult; Aged; Blood Coagulation; Cardiovascular Diseases; Coronary Disease; Ethyl Biscoumacetate; Female; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Myocardial Infarction | 1970 |
The electrophoretic mobility of red cells and platelets and the plasma viscosity in coronary heart disease.
Topics: Adult; Blood Glucose; Blood Platelets; Blood Viscosity; Cholesterol; Coronary Disease; Electric Conductivity; Electrophoresis; Erythrocytes; Fibrinogen; Glucose Tolerance Test; Humans; Male; Methods; Middle Aged; Motion; Rheology; Triglycerides; Uric Acid | 1970 |
Plasma fibrin-stabilizing factor: acquired deficiency in various disorders.
Topics: Acute Disease; Adult; Aged; Anemia, Macrocytic; Anemia, Sickle Cell; Blood Coagulation Disorders; Blood Coagulation Tests; Coronary Disease; Cysteine; Factor XIII; Fibrinogen; Hepatitis; Hot Temperature; Humans; Leukemia; Liver Cirrhosis; Liver Neoplasms; Lupus Erythematosus, Systemic; Lymphoma; Methods; Middle Aged; Myeloproliferative Disorders; Neoplasm Metastasis; Prothrombin Time; Uremia | 1969 |
Drug action--study of plasma protein variations in hyperthrombotic diseases using gel filtration chromatography on agarose.
Topics: Arteriosclerosis; Blood Protein Disorders; Blood Protein Electrophoresis; Blood Proteins; Blood Sedimentation; Cholesterol; Chromatography, Gel; Coronary Disease; Erythrocyte Count; Factor XII; Fibrinogen; Humans; Intracranial Arteriosclerosis; Methods; Molecular Weight; Plasminogen; Polysaccharides; Prothrombin Time; Retinal Vessels; Spectrophotometry; Thrombosis; Ultraviolet Rays | 1969 |
Spontaneous and experimental thrombosis in the mouse placenta.
Topics: Animals; Benzopyrans; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Platelet Disorders; Budd-Chiari Syndrome; Coronary Disease; Female; Fibrin; Fibrinogen; Fibrinolysis; Heparin; Mice; Microscopy; Microscopy, Electron; Placenta; Placenta Diseases; Pregnancy; Pregnancy Complications; Pulmonary Embolism; Renal Veins; Thrombosis; Veins | 1969 |
[Urine fibrinolytic activity (urokinase) in patients with coronary disease].
Topics: Aged; Anticoagulants; Coronary Disease; Fibrinogen; Fibrinolytic Agents; Heparin; Humans; Middle Aged | 1969 |
Detection of left atrial thrombi. Scintillation scanning after administration of 131-I rabbit antibodies to human fibrinogen.
Topics: Animals; Antibodies; Autoradiography; Coronary Disease; Fibrinogen; Heart Atria; Humans; Injections, Intravenous; Iodine Radioisotopes; Rabbits; Radionuclide Imaging | 1969 |
[Studies on the adhesiveness of human blood platelets--the pathophysiological significance of the adhesiveness of the human blood platelets in alimentary lipemia in coronary sclerosis].
Topics: Adhesiveness; Adult; Aged; Arteriosclerosis; Blood Platelets; Calcium; Coronary Disease; Dextrans; Dietary Fats; Female; Fibrinogen; Humans; Hyperlipidemias; In Vitro Techniques; Male; Middle Aged | 1969 |
Thrombolytic agents and lysis of coronary artery thrombosis.
Topics: Animals; Blood Platelets; Coronary Disease; Coronary Vessels; Dogs; Femoral Vein; Fibrinogen; Fibrinolytic Agents; Heart Ventricles; Hemorrhage; Injections; Injections, Intra-Arterial; Injections, Intravenous; Plasminogen; Regional Blood Flow; Serum Globulins; Streptokinase | 1970 |
Plasma protein electrophoretic pattern and blood viscosity in arteriosclerotic heart disease.
Topics: Aged; Anticoagulants; Blood Protein Electrophoresis; Blood Viscosity; Cholesterol; Coronary Disease; Fibrinogen; Humans; Lipoproteins; Myocardial Infarction | 1970 |
Platelet adhesiveness, plasma fibrinogen and factor 8 levels in diabetes mellitus.
Topics: Adolescent; Adult; Age Factors; Aged; Blood Glucose; Blood Platelets; Cataract; Child; Coronary Disease; Diabetes Complications; Diabetes Mellitus; Diabetic Retinopathy; Electrocardiography; Factor VIII; Fibrinogen; Humans; Hypertension; Lipids; Middle Aged; Platelet Adhesiveness; Sex Factors; Surface Properties; Vascular Diseases | 1970 |
The effect, in volunteers, of coffee and decaffeinated coffee on blood glucose, insulin, plasma lipids and some factors involved in blood clotting.
Topics: Adult; Blood Coagulation; Blood Coagulation Tests; Blood Glucose; Caffeine; Cholesterol; Coffee; Coronary Disease; Female; Fibrinogen; Humans; Insulin; Lipids; Male; Middle Aged; Phospholipids; Platelet Adhesiveness; Triglycerides | 1970 |
[Pathogenetic unity of changes in hemocoagulation, blood fibrinolytic activity and several indices of protein-lipid metabolism in coronary arteriosclerosis and hypertensive disease].
Topics: Aged; Blood Coagulation; Blood Proteins; Cholesterol; Coronary Disease; Female; Fibrinogen; Fibrinolysis; Heparin; Humans; Hypertension; Lipids; Lipoproteins; Male; Middle Aged; Prothrombin | 1970 |
[Age characteristics of the changes in the blood coagulation and anticoagulation system in patients with acute coronary insufficiency].
Topics: Adult; Aged; Aging; Angina Pectoris; Antithrombins; Blood Coagulation; Coronary Disease; Female; Fibrinogen; Fibrinolysis; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Prothrombin; Thrombelastography; Thrombin | 1970 |
[Effect of unsaturated fatty acids on the state of the blood coagulation and anticoagulation system in patients with coronary arteriosclerosis].
Topics: Adult; Aged; Antihypertensive Agents; Blood Coagulation; Coronary Disease; Factor V; Factor VII; Fatty Acids; Female; Fibrinogen; Fibrinolysis; Heparin; Humans; Hypertension; Male; Middle Aged; Prothrombin; Thrombelastography; Thrombin; Vasodilator Agents | 1970 |
[Changes in blood coagulation activity following multiple short-term disturbances in coronary circulation in dogs under chronic experimental conditions].
Topics: Animals; Blood Coagulation; Coronary Disease; Disease Models, Animal; Dogs; Fibrinogen; Fibrinolysis; Heparin; Methods; Prothrombin Time; Thrombelastography; Thromboplastin; Time Factors | 1970 |
[State of the blood coagulation and anti-coagulation system in patients with chronic coronary insufficiency in the post-infarct period].
Topics: Blood Coagulation; Chronic Disease; Coronary Disease; Female; Fibrinogen; Fibrinolysis; Heparin; Humans; Male; Myocardial Infarction; Prothrombin; Thrombin; Thrombosis | 1971 |
[Treatment of arteriosclerosis with permanently administered large doses of nicotinic acid].
Topics: Aged; Arteriosclerosis; Cholesterol; Coronary Disease; Female; Fibrinogen; Humans; Lipoproteins; Male; Middle Aged; Nicotinic Acids | 1967 |
[On the problem of atherosclerosis in liver cirrhosis].
Topics: Adult; Aged; Arteriosclerosis; Blood Coagulation Tests; Cholesterol; Coronary Disease; Fibrinogen; Fibrinolysis; Heparin; Humans; Lipid Metabolism; Liver Cirrhosis; Middle Aged; Phospholipids; Thrombelastography | 1967 |
[Problem of the differential diagnosis and therapy of climacteric cardiopathy].
Topics: Adult; Aged; Aging; Angina Pectoris; Aspartate Aminotransferases; Blood Sedimentation; Body Temperature; C-Reactive Protein; Climacteric; Coronary Disease; Diagnosis, Differential; Electrocardiography; Estradiol; Female; Fibrinogen; Heart Diseases; Humans; Leukocyte Count; Male; Menopause; Methyltestosterone; Middle Aged; Myocardial Infarction; Pain; Serum Globulins; Testosterone | 1967 |
Failure of safflower oil hyperlipemia to inhibit limitation of the size of experimental streptokinase-treated myocardial infarction.
Topics: Animals; Blood Coagulation Tests; Coronary Disease; Dogs; Fatty Acids, Essential; Fibrinogen; Fibrinolysis; Hyperlipidemias; Myocardial Infarction; Myocardium; Prothrombin Time; Streptokinase; Thrombelastography | 1968 |
Treatment of thromboangiitis obliterans with clofibrate (Atromid-S).
Topics: Anticholesteremic Agents; Blood Sedimentation; Butyrates; Cholesterol; Coronary Disease; Fibrinogen; Humans; Serum Globulins; Thromboangiitis Obliterans; Thrombophlebitis | 1968 |
[A study of fibrinogen B in coronary disease].
Topics: Coronary Disease; Fibrinogen; Humans | 1968 |
Turnover rate of autologous plasma fibrinogen-14C in subjects with coronary thrombosis.
Topics: Adult; Age Factors; Blood Volume; Carbon Isotopes; Coronary Disease; Fibrinogen; Glutamates; Humans; Male; Middle Aged | 1968 |
[Characteristics of the coagulograms of patients with coronary insufficiency according to the age group].
Topics: Adult; Aging; Blood Coagulation; Blood Coagulation Tests; Coronary Disease; Factor V; Fibrinogen; Fibrinolysis; Heparin; Humans; Middle Aged; Prothrombin Time | 1968 |
[Changes in the indices of the blood coagulation system in chronic coronary insufficiency in relation to the patient's age, degree and length of illness].
Topics: Adult; Age Factors; Aged; Blood Coagulation; Blood Coagulation Tests; Calcium; Chronic Disease; Coronary Disease; Female; Fibrinogen; Fibrinolysis; Heparin; Humans; Male; Middle Aged; Prothrombin Time; Time Factors | 1968 |
[Thrombogenesis in atherosclerosis of the coronary arteries].
Topics: Arteriosclerosis; Blood Coagulation Disorders; Blood Platelets; Coronary Disease; Fibrinogen; Humans; Myocardial Infarction | 1968 |
Erythrocyte sedimentation and soluble fibrin monomer complexes.
Topics: Adult; Animals; Antifibrinolytic Agents; Arthritis, Rheumatoid; Blood Sedimentation; Coronary Disease; Erythrocytes; Fibrin; Fibrinogen; Humans; Middle Aged; Multiple Sclerosis; Neurotic Disorders; Protamines; Rabbits; Rats; Staphylococcal Infections | 1969 |
Serum cholinesterase and euglobulin lysis time in chronic cor pulmonale.
Topics: Adult; Aged; Arteriosclerosis; Cholesterol; Cholinesterases; Coronary Disease; Female; Fibrinogen; Fibrinolysis; Heart Failure; Humans; Hypoxia; Liver; Male; Middle Aged; Pulmonary Heart Disease; Serum Globulins; Time Factors | 1969 |
[On the effectiveness of cocarboxylase in the treatment of patients with coronarocardiosclerosis].
Topics: Adult; Arteries; Blood Coagulation; Blood Coagulation Tests; Blood Pressure; Coronary Disease; Electrocardiography; Female; Fibrinogen; Fibrinolysis; Heart; Heart Ventricles; Heparin; Humans; Injections, Intramuscular; Male; Middle Aged; Muscle Contraction; Phonocardiography; Thiamine Pyrophosphate; Thrombelastography | 1969 |
Pharmacological fibrinolysis.
Topics: Aged; Androsterone; Anticholesteremic Agents; Butyrates; Chlorpropamide; Coronary Disease; Ethylestrenol; Female; Fibrinogen; Fibrinolysis; Humans; Intermittent Claudication; Male; Metformin; Middle Aged; Phenformin; Platelet Adhesiveness; Tolbutamide | 1969 |
Arcus senilis and coronary artery disease.
Topics: Adult; Aged; Aging; Arcus Senilis; Cholesterol; Cornea; Coronary Disease; Eye Manifestations; Female; Fibrinogen; Humans; Lipids; Male; Middle Aged | 1965 |
[Changes in c-reactive proteins, fibrinogenesis and transaminase in coronary insufficiency].
Topics: C-Reactive Protein; Coronary Disease; Fibrinogen; Humans; Transaminases | 1965 |
Plasma fibrinogen patterns in patients with coronary atherosclerosis.
Topics: Adult; Aged; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged | 1966 |
[Qualitative changes in fibrinogen in rheumatism and coronary insufficiency].
Topics: Coronary Disease; Fibrinogen; Humans; Myocardial Infarction; Rheumatic Fever | 1966 |
[The diagnostic importance of determination of serum enzymes in coronary insufficiency].
Topics: Aspartate Aminotransferases; Clinical Enzyme Tests; Coronary Disease; Diagnosis, Differential; Electrocardiography; Fibrinogen; Fructose-Bisphosphate Aldolase; Glucose-6-Phosphate Isomerase | 1966 |